Investing During Coronavirus: Stocks Close Down Thursday as Rally Fails to Hold

These are the top coronavirus stocks to buy right now, with new stock picks updated daily from the sharpest investing minds in the business

Latest Stocks to Buy Updates:


Stocks Close Down Thursday as Rally Fails to Hold

[Thursday, June 4, 4:01 p.m.]
Contributed by Sarah Smith

Well, there goes the rally — at least for now. Stocks closed down on Thursday, but with reopening plans accelerating around the world, it’s likely the market will be headed higher again soon.

It looks like today investors simply couldn’t stomach the combination of ongoing protests and a worse-than-expected jobless claims number. Plus, on the docket for tomorrow is the Bureau of Labor Statistics’ May report. Many experts expect the unemployment rate to hit 20% in that update.

If anything, these reports are a good reminder that despite a push for reopening, there are still wounds in the economy. Not all businesses will reopen, and those that are must still figure out what the new normal looks like.

With all that in mind, the S&P 500 and the Nasdaq Composite closed Thursday in the red. The Dow Jones Industrial Average fared slightly better, closing in the green.

  • The S&P 500 closed lower by 0.34%
  • The Dow Jones Industrial Average closed higher by 0.05%
  • The Nasdaq Composite closed lower by 0.69%

The 2 Best Stocks to Buy for an Airline Recovery

[Thursday, June 4, 3:25 p.m.]
Contributed by Sarah Smith

Boy, American Airlines (NASDAQ:AAL) sparked a nice industry rally today. Shares are up 35% in intraday trading on news that the airline was boosting its flight capacity after some scary months. Next month, it will resume 55% of its July 2019 schedule. According to Reuters’ David Shepardson, the last few months have seen around 20%-25% of American’s typical capacity.

Does this news really mean you should rush to buy AAL stock now? Perhaps not. Some critics are quick to point out that American has its fair share of problems, and its financial situation is much less solid than its peers Delta Air Lines (NYSE:DAL) and Southwest Airlines (NYSE:LUV). In fact, InvestorPlace analyst Matt McCall warned readers today that despite the temptations in broad sector exchange-traded funds, it isn’t the right time to jump all in.

Thankfully, Barron’s Al Root has a clever solution that lets investors profit from the rebound without risking too much. Instead of chasing the passenger carriers just yet, look for better plays. He spoke with Credit Suisse analyst Robert Spingarn, who’s recommending aerospace suppliers Boeing (NYSE:BA) and Airbus (OTCMKTS:EADSY) right now.

Sure, demand for new airplanes and parts dropped in 2020, and Boeing hasn’t resolved its 737 Max crisis yet. But these stocks haven’t gotten a chance at a rebound yet, and Spingarn thinks that rebound is now overdue after others in the aerospace world have bounced off the lows.

Need any more proof? Boeing shares are already up 5% and Airbus shares almost 4% on American’s news. It’s clear a broader industry recovery will benefit these hurting companies.


Alibaba Stock Is a Buy on Its Small Business Innovations

[Thursday, June 4, 3:00 p.m.]
Contributed by Sarah Smith

There’s been a common narrative in retail since the novel coronavirus wreaked havoc on the economy. E-commerce companies win, and brick-and-mortar retailers, particularly those that are small businesses, lose. But what happens when an e-commerce company positions itself as an answer to small business woes? Well, let’s take a look at Alibaba (NYSE:BABA).

Alibaba has long been the Chinese equivalent of Amazon (NASDAQ:AMZN). Each has its own turf, and they’ve grown in separate spheres. Now Alibaba is growing it’s U.S. presence at an impressive rate. According to Business Insider’s Bethany Biron, U.S. buyers have increased 70% year-over-year and transactions by American businesses on Alibaba.com have increased by more than 100%.

The e-commerce star first allowed U.S. companies to make “storefronts” in July 2019, focusing this offering on small and medium-sized businesses. At the time, Retail Brew’s Halie LeSavage wrote this was a clever way for the company to form alliances as the U.S.-China trade war dragged on.

Now, once again, Alibaba is positioning itself as an ally to small businesses. Its new offerings include extended invoice periods, a freight partnership to help with deliveries and virtual trade shows to make up for lost in-person marketing time. This is a smart move, and the solutions could legitimately help small businesses as they pivot and try to get back on their feet.

It also should have investors excited, because it shows Alibaba can succeed even in Amazon’s home market. Small businesses are likely to be wary of Amazon, especially as concerns rise around its treatment of third-party sellers and their data. In other words, pay close to attention to BABA stock.

Shares are up just slightly in 2020, after a steep fall in early March threw the stock off course. But it’s moving higher, and looks like a buy here. InvestorPlace analyst Louis Navellier agrees, writing this week that it’s the perfect growth investment for the post-pandemic world.


5 Vaccine Stocks to Buy for Operation Warp Speed

[Thursday, June 4, 2:21 p.m.]
Contributed by Sarah Smith

All around the world there has been a push for a novel coronavirus vaccine, and researchers — at publicly traded companies, private firms and even some universities — have answered the call. Now, the race is heating up as attention and funding start funneling to a narrowing list of vaccine candidates.

This is all part of President Donald Trump’s Operation Warp Speed, which hopes to rapidly develop, test and manufacture a vaccine in the U.S. By January 2021, he and his administration hope to begin “deploying” the vaccine across the country, using the military as needed. The mission started with a broad list, but now it’s narrowing. According to reporting from The New York Times and Bloomberg, five key companies are moving to the next phase.

Sources told The New York Times’ Noah Weiland and David Sanger that Moderna (NASDAQ:MRNA), Merck (NYSE:MRK), Pfizer (NYSE:PFE), Johnson & Johnson (NYSE:JNJ) and AstraZeneca (NYSE:AZN) are the companies most likely to successfully produce a vaccine, and therefore are the five companies moving on in the process. Bloomberg’s Riley Griffin and Jennifer Jacobs report the same list, but mention two unnamed firms also moving ahead.

There’s a lot to take away from this news. First, it’s a good indicator of which vaccine stocks are likely to keep paying off for investors. Moderna is a smaller firm, but it’s had some of the earliest success in its clinical-stage trials. Dr. Anthony Fauci, the nation’s leading infectious disease expert, said he expects to see its candidate move into the final phases of trials next month. The other names on this list offer a lot of manufacturing power and solid experience in the pharmaceutical world.

Second, there are some key names missing from this list. Investors have rallied behind Inovio Pharmaceuticals (NASDAQ:INO) and Novavax (NASDAQ:NVAX), not to mention countless other innovative names. But Inovio apparently didn’t make the cut. However, BioPharma Dive’s Ned Pagliarulo isn’t ruling out that INO or NVAX is one of the unnamed firms moving onto the final round.

Evaluate your vaccine holdings against this list, and think critically. Operation Warp Speed isn’t the only factor that matters, but it will carry a lot of weight. To me, it seems like those that are advancing seem to be the safest bets here.


Buy XpresSpa Stock for Its Unique Coronavirus Approach

[Thursday, June 4, 12:29 p.m.]
Contributed by Sarah Smith

You’ve likely seen the data from the Transportation Security Administration and heard anecdotes from friends who have chosen to fly again. Yes, demand is returning, and even summer vacation is back on the calendar for many families. But how exactly is this return to the skies happening?

In large part, it’s thanks to efforts to keep airports and planes clean, and then to communicate that elevated safety level to potential passengers. XpresSpa (NASDAQ:XSPA), a company that typically provides services like massages and waxing in airports, is benefiting from this reality.

On Thursday, shares of XSPA stock are up more than 75% in intraday trading. This stock has been on a tear since announcing a partnership with the John F. Kennedy International Airport. Now, while its spa services are closed, it will operate a testing center in one of the airport terminals. This will ensure workers who come in close contact with passengers — like TSA agents and U.S. Customs and Border Control officials — are not infected with the novel coronavirus.

For now, XpresSpa will work on constructing the testing site, which will have nine separate rooms. According to MarketWatch’s Tomi Kilgore, XpresSpa will be able to test 500 employees a day.

Sure, this deal is in one airport, and it affects 500 employees a day. But the company is already working with the Port Authority in New York and New Jersey to offer other testing sites to get transportation services up and running at pre-pandemic levels. If XpresSpa can deliver on this testing site and continue to expand its coronavirus offerings, consider picking up some shares.

Remember, many Americans are counting on increased testing and safety protocols for a safe and large-scale reopening.


7 Defense Stocks to Buy to Protect Your Portfolio Now

[Thursday, June 4, 12:05 p.m.]
Contributed by Sarah Smith

It has been a tough couple of months for Americans. The year started with flaring geopolitical tensions, after the U.S. military struck and killed Iran’s Qasem Soleimani. A pandemic hit — and continues to kill people around the world. Now, the U.S. faces two more crises. Relations with China are on the brink, and social unrest over police brutality has sparked protests around the country.

There’s a lot of uncertainty here. From a purely market-focused view, InvestorPlace analysts John Jagerson and Wade Hansen wrote today that the protests were unlikely to broadly affect stocks. But that doesn’t mean there isn’t good reason to stay informed.

Investing in times of uncertainty is tough, and right now a lot of sectors lack luster. That’s why InvestorPlace analyst Louis Navellier is recommending defense stocks — and no, not just weapons manufacturers. These stocks are reliable, and nothing keeps them down for very long.

If you’re worried about your portfolio, check out Navellier’s seven recommendations now:

  • TransDigm Group (NYSE:TDG)
  • Northrop Grumman  (NYSE:NOC)
  • Lockheed Martin (NYSE:LMT)
  • Mercury Systems (NASDAQ:MRCY)
  • Aerojet Rocketdyne (NYSE:AJRD)
  • BWX Technologies (NYSE:BWXT)
  • Leidos Holdings (NYSE:LDOS)


Stocks Open Lower Thursday on Jobless Claims Report

[Thursday, June 4, 9:31 a.m.]
Contributed by Sarah Smith

It looks like the rally met its match — 1.9 million more Americans filing for initial unemployment benefits. This number came in worse than economists’ consensus estimate, and for many investors, it’s likely a wake-up call that the reopening process isn’t completely smooth.

As Axios’ Courtenay Brown wrote early Thursday, tomorrow morning’s look at the May jobs report is also likely to move the market. Right now, many expect the unemployment rate to hit 19.8%. With all this in mind — plus protests continuing across the nation — the major indices stumbled.

Yes, that’s right. After days of an incredibly resilient rally, the S&P 500, the Dow Jones Industrial Average and the Nasdaq Composite opened in the red.

  • The S&P 500 opened lower by 0.46%
  • The Dow Jones Industrial Average opened lower by 0.37%
  • The Nasdaq Composite opened lower by 0.34%

7 Dental Stocks to Buy as Non-Essential Offices Reopen

[Wednesday, June 3, 4:37 p.m.]
Contributed by Sarah Smith

During the peak of the novel coronavirus in the United States, many non-essential healthcare offices closed. Among them were dentists, causing dental stocks to greatly underperform the broader market so far in 2020. But InvestorPlace’s Will Ashworth now sees these stocks as great buying opportunities.

According to Ashworth, his recommendations are a little contrarian. Many experts are working to predict what post-pandemic healthcare will look like, and some have suggested that tech and diagnostic firms will succeed while dental equipment suppliers will suffer.

But as Ashworth wrote today, dentists will never go out of style. With that in mind, he picked seven dental stocks to buy, specifying that gains were likely to come in the long term. If you’re looking for a serious chance to benefit from an industry-wide rebound, you can’t ignore this.

Here are the stocks Ashworth is recommending now:

  • Henry Schein (NASDAQ:HSIC)
  • 3D Systems (NYSE:DDD)
  • Dentsply Sirona (NASDAQ:XRAY)
  • Patterson Companies (NASDAQ:PDCO)
  • Procter & Gamble (NYSE:PG)
  • SmileDirectClub (NASDAQ:SDC)
  • Envista Holdings (NYSE:NVST)


Dow Adds 500+ Points to Close Higher Wednesday

[Wednesday, June 3, 4:01 p.m.]
Contributed by Sarah Smith

Private payroll cuts slimmed in May, and investors started Wednesday on an optimistic note with that news in mind. As trading progressed, nothing could hold the major indices back, and the Dow Jones Industrial Average closed higher by more than 500 points.

Protests continue across the U.S. in regards to George Floyd’s death at the hands of former Minneapolis police officers. Minnesota officials have now charged three other former officers, and upgraded charges against Derek Chauvin to second-degree murder from third-degree murder.

Other noteworthy news moving stocks comes from tech stars Zoom Video (NASDAQ:ZM) and CrowdStrike (NASDAQ:CRWD). Both companies reported better-than-expected earnings and are leading the market higher on Wednesday.

As the rally continues, the S&P 500 and the Nasdaq Composite joined the Dow in the green.

  • The S&P 500 closed higher by 1.36%
  • The Dow Jones Industrial Average closed higher by 2.05%
  • The Nasdaq Composite closed higher by 0.78%

Is Once High-Flying Amarin Stock a Buy Again?

[Wednesday, June 3, 3:40 p.m.]
Contributed by Sarah Smith

Remember Amarin (NASDAQ:AMRN)? For weeks investors debated its merits, comparing it to other drug companies pursuing treatments for cardiovascular disease. Shares went from 2020 highs above $20 to lows just below $4. Now, AMRN stock has rebounded slightly, but it’s no longer receiving the love and praise it once was.

According to The Wall Street Journal, the company may be getting a second chance.

What happened? In December Amarin’s Vascepa became the first drug to receive U.S. Food and Drug Administration approval for individuals at higher risk of cardiovascular events like heart attacks and strokes. The fish oil treatment was designed for those who were already taking cholesterol-lowering statin medications.

Investors loved this medicinal breakthrough, although some questioned its “fishiness.” Then, shares tanked in March. A court found that patents Amarin had filed on behalf of a generic version of Vascepa were invalid, allowing competitors to step into the space. AMRN stock suddenly became much less attractive.

But now, as The Wall Street Journal’s Jared Hopkins and Betsy McKay reported, doctors are studying heart medications like Vascepa for potential use in novel coronavirus cases. Many patients are experiencing elevated cardiovascular risk while hospitalized, and scientists want to know if there’s a way to prevent those complications. Amarin is answering the call.

According to the company, its Vascepa is now being studied in coronavirus patients. The trial is looking to see if it has antiviral or antimicrobial effects, and whether it can mitigate cardiac damage in those who are sick. A third part of the study is determining whether Vascepa has any anti-inflammatory effects.

Shares are struggling, and it’s unclear if trial results can give AMRN stock a true second chance. However, bullish investors shouldn’t completely discount Amarin’s potential here.


FSD Pharma Stock Climbs on News of Coronavirus Study

[Wednesday, June 3, 3:09 p.m.]
Contributed by Sarah Smith

In huge news for investors, FSD Pharma (NASDAQ:HUGE) stock is up 150% today. The company reported Wednesday morning that the U.S. Food and Drug Administration granted it approval to submit an investigational new drug application (IND). Essentially, an IND is a key step companies must take before conducting a human trial of an investigational drug.

So what is this proposed trial all about? FSD Pharma is working on FSD-201, and yes, it’s for the novel coronavirus. However, unlike candidates from Gilead Sciences (NASDAQ:GILD) and Regeneron (NASDAQ:REGN), FSD-201 isn’t designed to specifically fight the virus. Instead, it’s a treatment for one of its many potentially fatal side effects.

As we previously reported in this blog, Covid-19 comes with a handful of sometimes inexplicable symptoms. These include toe blisters, clotting disorders and organ failure. One of particular interest to FSD Pharma is something called a cytokine storm. According to the company, severe cases of the virus are accompanied by a cytokine storm, which is essentially an extreme immune response. The body works to fight the disease, but it goes into overdrive, and can potentially cause death.

According to a professor at Tufts University, understanding the link between the coronavirus and cytokine storms could be the key to solving the pandemic. If FSD Pharma can make this immune occurrence less deadly, it will restore a lot of confidence and give hope to even the sickest of patients.

As with all companies racing to fight the virus, there’s both a lot of risk and potential reward here. Keep a close eye on HUGE stock.


7 Hotel Stocks to Buy to Get Ahead of the Reopening Rally

[Wednesday, June 3, 12:53 p.m.]
Contributed by Sarah Smith

Pent-up demand really is a powerful catalyst, as Memorial Day weekend crowds proved. Summer vacations are back on Americans’ calendars, and demand for flights and hotels are returning. The travel industry is responding in turn, working to convince consumers a trip to the beach or lake comes with very few risks.

As MarketWatch reported, many brand-name hotels have partnered with the Centers for Disease Control and Prevention to develop new cleaning standards. For many consumers, that will go a long way to restoring peace of mind. Some hotels in Maine are running contests for prizes — like free stays — to attract guests. Hotels in Thailand are offering “luxury quarantine” packages as a way to keep occupancy rates up.

For InvestorPlace’s Chris Lau, these headlines are a sign that it’s time to start buying hotel stocks ahead of an even bigger rally. Granted, he acknowledges that some top summer destinations will likely become remote state parks, and camping doesn’t actually give revenue to big hotels. However, states are slowly encouraging travel and a rally is no doubt coming.

With that in mind, here are seven hotel stocks he’s recommending now:

  • Marriott International (NASDAQ:MAR)
  • Hilton Worldwide (NYSE:HLT)
  • Wynn Resources (NASDAQ:WYNN)
  • MGM Resorts International (NYSE:MGM)
  • Hyatt Hotels (NYSE:H)
  • Royal Caribbean Cruises (NYSE:RCL)
  • InterContinental Hotels (NYSE:IHG)


Upcoming Gaming IPOs Are Reason for Bullish Cheer

[Wednesday, June 3, 11:57 a.m.]
Contributed by Sarah Smith

Gaming has been an escape — and a means of killing newfound time — since the novel coronavirus first began disrupting daily life. Console sales spiked, game sales spiked and the number of people playing online games at any one point hit record highs. Even mobile games found success, and companies like Zynga (NASDAQ:ZNGA) racked up buy recommendations.

Now, Axios’ Dan Primack has some exciting news in the IPO world. Remember, this week marked a major return to initial public offerings — and the biggest debut year to date. According to Primack, two companies are prepping for IPOs, and their businesses center on mobile and casual gaming.

South Korea’s DoubleDown Interactive filed with the U.S. Securities and Exchange commission to raise on Tuesday to raise up to $100 million. DoubleDown develops and publishes mobile and web-based games, including DoubleDown CasinoDoubleDown Fort Knox and Ellen’s Road to Riches. According to Renaissance Capital, the company averages 3 million players per month and brought in $281 million in revenue in the last year.

One key thing to note here is how popular the digital world of gambling has become amid the pandemic. Just today, InvestorPlace’s Mark Hake shared his bullish take on Penn National Gaming (NASDAQ:PENN) — and one of his key areas of interest was its online offerings.

The other key IPO to watch is Playtika. The company is based in Israel, but is owned currently by a Chinese investment group. Like DoubleDown, it produces casino-themed mobile games, and runs apps for poker and solitaire. According to Reuters, the IPO could raise as much as $1 billion.


Wayfair Stock Is Still a Buy as E-Commerce Dominates

[Wednesday, June 3, 10:39 a.m.]
Contributed by Sarah Smith

The novel coronavirus is accelerating adoption of e-commerce. Brick-and-mortar retailers are the biggest losers, and those with strong digital presence are winners. Americans took time in lockdown to embrace home-improvement projects, and a number of stocks standout as a result. Wayfair (NYSE:W), which we’ve recommended in this blog before, is up 100% in 2020 and 700% since March.

No, that isn’t a typo, and the massive rally doesn’t mean that it’s time to sell Wayfair stock. In fact, Piper Sandler analyst Peter Keith is confident shares will keep climbing. According to Barron’s Eric Savitz, the analyst is so confident that he just raised his price target from $220 to $225. Shares currently trade for just under $190.

A big part of Keith’s argument is simply that more consumers are now comfortable with online shopping for various products, including furniture and other home goods. They’ve realized how convenient Wayfair is, so they’ll keep using the site as they tackle home-improvement projects. One key point of evidence for this is that in May, even as states began reopening, Wayfair’s sales did not decelerate.

InvestorPlace’s Josh Enomoto agrees, acknowledging that to many his “buy” recommendation on Wayfair sounds contrarian. He wrote late last week that Wayfair is likely to benefit from three big catalysts, including growth in the real estate market, an improving unemployment landscape and the strength of big cities. In other words, the panic filling the headlines isn’t the full story.

According to Savitz, there’s one more timely catalyst. As protests across the U.S. continue to result in damage to brick-and-mortar retailers, companies with an online focus such as Wayfair will benefit.


4 Silver Stocks to Buy for Pandemic Portfolio Protection

[Wednesday, June 3, 10:17 a.m.]
Contributed by Sarah Smith

We often report in this blog about the power of gold stocks, writing just yesterday about extraordinary gains that are soon to come. But InvestorPlace’s Tezcan Gecgil is encouraging investors not to forget about the power of silver stocks, too.

Yesterday, Gecgil wrote that just like gold, silver can be a powerful portfolio hedge. Some hold the physical metal, others clutch onto silver stocks as fears of inflation rise. Right now, silver is underperforming, and it’s particularly cheap relative to gold. But Gecgil — and many others on Wall Street — believe a rally in silver stocks is just around the corner.

If you agree with Gecgil, or are perhaps just a fan of that scout song, here are the four silver stocks she’s recommending now:

  • Hecla Mining (NYSE:HL)
  • Mag Silver (NYSEMKT:MAG)
  • Silvercorp Metals (NYSEMKT:SVM)
  • Global X Silver Miners ETF (NYSEARCA:SIL)


Stocks Open Higher Wednesday Despite Continued Protests

[Wednesday, June 3, 9:31 a.m.]
Contributed by Sarah Smith

Nope, nothing has changed. Stocks continued their rally Wednesday morning, and so did protests across the United States. Helicopters and additional military units are now present in Washington, D.C. Investors still don’t seem to care as they chase the reopening rebound.

Those bulls were rewarded this morning with an estimate-beating private payroll report from ADP. Economists predicted that U.S. employers would cut 9 million private payrolls in May, but the number instead came in just below 2.8 million. That’s strikingly better than the almost 20 million private payrolls cut in April.

It looks like nothing can shake the rally today — or perhaps for the rest of the week. The S&P 500, the Dow Jones Industrial Average and the Nasdaq Composite once again opened in the green.

  • The S&P 500 opened higher by 0.69%
  • The Dow Jones Industrial Average opened higher by 0.84%
  • The Nasdaq Composite opened higher by 0.59%

Stocks Close Higher Tuesday on Curious Optimism

[Tuesday, June 2, 4:01 p.m.]
Contributed by Sarah Smith

Stocks once again closed higher, on what only can be called curious optimism. Yahoo Finance’s Brian Sozzi, in talking with different market strategists, concluded that investors must not be worried about ongoing protests across the U.S. and the potential for a second wave of the novel coronavirus. Why? As Heritage Capital CIO Paul Schatz said, investors simply believe it all won’t hurt the stock market.

For now, it’s too early to tell if those confident investors are right.

At the same time, some economic indicators are continuing to trend higher. Four companies are prepping for initial public offerings this week, including one IPO that will be the largest year to date. As we reported this morning, a key manufacturing index is trending higher. Plus, the number of Americans filing for unemployment benefits each week has been dropping.

It’s an uneasy balancing act, but the bulls are winning. On Tuesday, the S&P 500, the Dow Jones Industrial Average and the Nasdaq Composite all closed in the green.

  • The S&P 500 closed higher by 0.82%
  • The Dow Jones Industrial Average closed higher by 1.05%
  • The Nasdaq Composite closed higher by 0.59%

Buy Home Depot and Lowe’s Stock as DIY Spirit Grows

[Tuesday, June 2, 3:43 p.m.]
Contributed by Sarah Smith

There’s something about spending endless hours at home that provokes the do-it-yourself mentality. Perhaps it’s the frustration that grows from staring at unsavory parts of a home or garden, or maybe an urge to introduce creativity to time in quarantine. Regardless, DIY spirit is growing, and Home Depot  (NYSE:HD) and Lowe’s (NYSE:LOW) stock are benefiting.

Commenting on this trend, InvestorPlace’s Dana Blankenhorn took a look at both home-improvement stocks. His conclusion was that Home Depot is more popular with contractors, making its business slightly riskier. On the other hand, he sees Lowe’s as better suited for the curious homeowner. First-quarter sales at both companies were up despite the novel coronavirus.

At the time, Blankenhorn cautioned that although each offers a dividend and relatively stable business, a prolonged recession would be damaging to the duo. Now, summer is here and all U.S. states are taking steps to reopen.

That bodes well for the home-improvement stocks here. Consumers that began projects in quarantine will face inspiration from warm weather on weekends, and many white-collar workers will remain at home for weeks and months to come. Plus, as non-essential businesses get the green light to reopen, contractors and other home-improvement businesses will resume work.

Reporting from Retail Dive’s Tatiana Walk-Morris also should bring investors some excitement. In mid-May, Apptopia data showed that downloads of Home Depot and Lowe’s apps were through the roof. Digital sales, in turn, spiked for both companies. This shows that the home-improvement retailers are quickly pivoting to consumer preference.

Today, Walk-Morris shared even more exciting news. Lowe’s is rolling out an augmented reality tool for home-improvement professionals. That way, if consumers don’t feel comfortable opening their homes just yet, important business can continue through virtual design appointments. This keeps professionals and homeowners safe, and speaks highlight of Lowe’s innovative abilities.

It’s clear that Home Depot and Lowe’s are far from boring investments, and they both offer big potential here. Download the apps, start planning and stay safe.


6 Gambling Stocks to Buy as Las Vegas Reopens

[Tuesday, June 2, 3:16 p.m.]
Contributed by Sarah Smith

Over the last several weeks, much of the conversation around casinos has been focused on the hypothetical. Some investors have developed theories about big rebounds when casinos and race tracks reopen. Others have flocked to online betting plays and League of Legends tournaments. Now though, there’s no longer a need to be hypothetical. The Las Vegas Strip reopens Thursday, June 4.

According to CNN’s Matt Villano, Las Vegas will likely still be an escape for tourists, but it will look different. Nightclubs and spas will broadly remain closed, and some large events aren’t returning anytime soon. However, hotels and casinos are reopening — with a few adjustments.

Now that there’s a plan in place, investors have a chance to buy gambling stocks for a more concrete reopening rebound. That’s why InvestorPlace’s David Moadel is recommending gambling stocks now. In his first set of recommendations, he acknowledges that these are speculative plays — just like the games themselves. But they’re beaten-down and ready to shoot higher.

Yesterday, he added one more stock to his “buy” list. According to Moadel, MGM Resorts (NYSE:MGM) is “mangled” but worthy of investor attention right now. That’s because with Las Vegas reopening, it’s only a matter of time before Wall Street hops on the gambling bandwagon. When it does, these names will be big winners.

Here are the six stocks he’s recommending now:

  • Las Vegas Sands (NYSE:LVS)
  • Caesars Entertainment (NASDAQ:CZR)
  • Esports Entertainment (NASDAQ:GMBL)
  • Boyd Gaming (NYSE:BYD)
  • Penn National Gaming (NASDAQ:PENN)
  • MGM Resorts (NYSE:MGM)


Buy CVS Stock on News of Autonomous Delivery Program

[Tuesday, June 2, 2:45 p.m.]
Contributed by Sarah Smith

There are many reasons to like CVS Health (NYSE:CVS) amid the novel coronavirus pandemic. Some locations offer testing, and all carry critical over-the-counter medications and essential goods. As InvestorPlace’s Dana Blankenhorn often highlights, its pharmacy business is top notch. Recent news makes that case even clearer, as CVS moves into robotic prescription delivery.

In a May 28 press release, robotics company Nuro announced it had entered into a partnership with CVS to pilot autonomous prescription delivery. Granted, this is small scale to start. Three zip codes near Houston will participate in the program.

CVS already offers home delivery of prescriptions, but moving into the realm of autonomous delivery is exciting and holds great potential. To start, customers can request their prescriptions for autonomous delivery, and Nuro’s fleet of self-driving Prius vehicles will do the job. Eventually, Nuro will swap the Prius fleet out for its unique R2 robot.

Both Nuro and CVS note the importance of increasing prescription accessibility and convenience — and the novel coronavirus certainly plays into that. In a blog post about the partnership, the Nuro team wrote that such a move can help protect vulnerable people, such as the elderly, as well as simply ensure more Americans can remain safe at home.

That doesn’t mean this partnership will lose its luster as the coronavirus fades, however. If CVS manages to expand its autonomous delivery offerings to more cities, expect it to gain popularity. Americans love convenience, and it doesn’t get more convenient than this. The company is already known for its continued innovation, and it’s also a solid investment. InvestorPlace’s Josh Enomoto recently wrote that CVS is a top “boring stock” to buy. But nothing about robotic delivery is boring.

Whether you agree with Enomoto and appreciate CVS for its reliable pharmacy and health offerings, or you’re bullish on its autonomous delivery moves, it’s safe to say CVS stock is a buy here.


Inpixon Stock Climbs on Contact Tracing Promise

[Tuesday, June 2, 2:00 p.m.]
Contributed by Sarah Smith

Airplanes and cruise ships are two different forms of transportation that involve a lot of passengers in close-knit quarters. For operators, that means finding ways to reassure customers that traveling is safe, and that the novel coronavirus is not an increased threat on the seas or in the sky.

Inpixon (NASDAQ:INPX) CEO Nadir Ali excited investors today with the proposition that his company could play a big role in restoring travel demand. Inpixon is a so-called indoor intelligence company. Before the pandemic, it’s customers were shopping malls, big government offices and hospitals. Inpixon creates indoor maps, helps detect the locations of indoor gusts and provides analysis on indoor data.

Now, it’s looking to become relevant in pandemic-focused contact tracing. On May 12, Inpixon announced its Workplace Readiness Dashboards — a solution designed to help companies reopen. One of the key features of this announcement is that it will help business track the density of certain “zones.” Once a company knows one zone is hotter than another, it can take steps to spread out patrons and keep things safe.

That’s big news in itself, but Ali told USA Today that Inpixon is specifically looking to work with hotels, airlines and cruise ships as they welcome travelers back. That’s even bigger news. From Ali:

“If a certain deck is turning yellow to red, maybe [someone] needs to go make sure [it isn’t too crowded]. … If, God forbid, a patient starts developing symptoms or has come down with COVID-19 or some other virus or flu or something, [the cruise line] could also [ask if] that person can identify themselves,” he explained.”

This announcement is sure to be met with privacy concerns, as Inpixon would rely on information from Wi-Fi, Bluetooth and cell signals. But for investors, it’s another boost of confidence that battered names like Carnival (NYSE:CCL) and American Airlines (NASDAQ:AAL) are potentially profitable investments now. In turn, that makes Inpixon a worthy investment.

Investors agree. Shares are up more than 10% in intraday trading today.


4 Fitness Stocks to Buy as Americans Start Running

[Tuesday, June 2, 1:24 p.m.]
Contributed by Sarah Smith

Fitness has been a hotly debated topic amid the novel coronavirus. Some consumers want gyms open now. Others accept that at-home workouts are different, but just as effective. Major operator Gold’s Gym filed for Chapter 11 bankruptcy protection. In all this chaos, running is gaining popularity.

According to Yahoo Finance reporter Myles Udland, Americans feel more comfortable with solitary fitness options now — marking a shift from group fitness classes and crowded gyms. Private companies that focus on helping athletes train and track their runs are booming. Downloads of the Strava app are up 222% year-over-year.

What does this mean for investors? Udland suggests buying companies that are benefiting — and others that are likely to start benefiting — from an increase in running. A top contender is Nike (NYSE:NKE). The company’s clothing and shoes have an intense following, and the Nike Training Club app saw a year-over-year download spike of 510%.

Dick’s Sporting Goods (NYSE:DKS) and Deckers Outdoor (NYSE:DECK) are other potential fitness winners for investors to watch.

There’s another company not on Udland’s list that is still worth a buy here. According to Barron’s Teresa Rivas, Lululemon (NASDAQ:LULU) could see its market capitalization hit $50 billion. Rivas cites research from analyst John Kernan who has a “buy” rating and $311 price target on the stock.

Similar to Nike, Lululemon has a strong following. Its athleisure is popular at home and at the gym, and the company’s e-commerce options are boosting digital sales. Plus, it doesn’t rely on other retailers for its sales, which helps as brick-and-mortar retail continues to suffer.

So, next time you suit up for a run, consider the brands and apps you rep. Your favorite shoes — and whatever your favorite fitness influencer is recommending — are likely to be great investing opportunities.


Don’t Miss an Extraordinary Opportunity in Gold Now

[Tuesday, June 2, 11:57 a.m.]
Contributed by Sarah Smith

Barron’s Steven Sears shared gripping words with readers today. “As America burns, gold shines.” His commentary was literal, as protests in the U.S. periodically erupt into flames. Stocks have largely brushed off the unrest, even as President Donald Trump suggests further militarizing the country’s response. That doesn’t mean investors aren’t worried, though, as gold begins to rise.

Gold’s attraction now is not surprising, as it’s often known as a “crisis” or “safe-haven” investment. The metal similarly drew attention after the U.S. military killed Iran’s Qasem Soleimani and during the peak of the novel coronavirus crisis.

Some see gold as the perfect way to hedge a portfolio for times of chaos. If markets begin to crumble, those who hold physical gold have their wealth in their hands. Others simply view it as a hedge against inflation. As the Federal Reserve continues with an unprecedented bond-buying program, many investors have expressed fear over post-pandemic inflation rates.

Regardless of the reasoning, InvestorPlace analyst Eric Fry is bullish on gold and is encouraging investors to act now. He wrote this morning that Warren Buffett sees the metal as “lifeless” and “uncivilized,” but that’s not stopping him — or any of the rich people buying and hoarding gold now. In fact, Fry warns that those who take Buffett’s advice will miss out on extraordinary gains as gold shoots higher.

To conclude, Sears has one smart strategy to profit now. He recommends buying the September $165 call for the SPDR Gold Shares ETF (NYSEARCA:GLD) now. If GLD moves above $171, he says the call purchase will begin to generate profits.


8 Battery Stocks to Buy for Post-Pandemic Innovation

[Tuesday, June 2, 10:45 a.m.]
Contributed by Sarah Smith

Remember when Tesla’s (NASDAQ:TSLA) high-tech Cybertruck was enough to create a media frenzy? The novel coronavirus has disrupted so much of daily life, and these innovations weren’t exceptions. 5G. Artificial intelligence. Electric vehicles. They’ve fallen by the wayside, but they’ll be back soon.

According to InvestorPlace’s Josh Enomoto, we actually need this next-generation technology to move forward from the pandemic. And this pivot back to tech is already happening, as evidenced by growing work-from-home solutions and even creative new forms of entertainment. For investors, this means battery stocks are hot names to buy now.

Enomoto wrote today that these battery stocks will quite literally power the future. He mostly looks at the coveted lithium-ion battery, but he’s not ruling out potential found in alkaline batteries and even a tech retailer. Clearly, you don’t want to miss out.

Here’s are the eight battery stocks Enomoto is recommending now:

  • Sociedad Quimica y Minera de Chile (NYSE:SQM)
  • Albemarle (NYSE:ALB)
  • Energizer (NYSE:ENR)
  • Best Buy (NYSE:BBY)
  • Enphase Energy (NASDAQ:ENPH)
  • Panasonic (OTCMKTS:PCRFY)
  • Murata Manufacturing (OTCMKTS:MRAAF)
  • American Battery Metals Corp (OTCMKTS:ABML)


Stocks Open Higher Tuesday as the Rally Continues

[Tuesday, June 2, 9:39 a.m.]
Contributed by Sarah Smith

Protests over George Floyd, who Minneapolis police killed last week, continue around the U.S. and the world. President Donald Trump has continued to up the stakes. At the same time, many fear that these mass gatherings will result in a second wave of the novel coronavirus hitting America sooner than expected. In short, there’s no clear reason for stocks to be rallying.

Alas, stocks opened higher Tuesday as the rally continues. Perhaps investors are inspired by the Institute of Supply Management’s update to its manufacturing index. It hit 43.1 in May, and anything above 42.8 marks that the economy is not in a recession. The report seems to be an unlikely catalyst, but these days, it’s hard to tell for sure.

What will today bring? For now, the S&P 500Dow Jones Industrial Average and the Nasdaq Composite are all opening in the green.

  • The S&P 500 opened higher by 0.33%
  • The Dow Jones Industrial Average opened higher by 0.57%
  • The Nasdaq Composite opened higher by 0.11%

7 Unique Travel Stocks to Buy for Domestic Reopening

[Monday, June 1, 4:35 p.m.]
Contributed by Sarah Smith

Viral accounts of Memorial Day weekend travel prove that consumers are much more confident about reopening than previously expected. Packed beaches and pools show the power of pent-up demand. In fact, even air travel and cruise demand are rebounding after Americans spent months at home.

With this in mind, InvestorPlace analyst Louis Navellier is giving the all-clear signal to look for growth opportunities right now. He’s looking at travel stocks in particular, but not just at any name in the space. For instance, he’s focusing on domestic travel, because many international destinations remain on lockdown and are not accessible to American tourists right now.

Another part of his argument ties in social distancing. He wrote today that consumers are more likely to pick travel destinations that have adult-friendly entertainment, like casinos and race tracks. Plus, bigger casinos are better, because they allow gamblers to space out more to feel safe.

Here are the top out-of-the-box travel stocks Navellier is recommending now:

  • Penn National Gaming (NASDAQ:PENN)
  • Newgioco Group (NASDAQ:NWGI)
  • Churchill Downs (NASDAQ:CHDN)
  • Golden Entertainment (NASDAQ:GDEN)
  • Caesars Entertainment (NASDAQ:CZR)
  • Eldorado Resorts (NASDAQ:ERI)
  • Scientific Games (NASDAQ:SGMS)


Stocks Close Higher Despite Growing Tensions

[Monday, June 1, 4:01 p.m.]
Contributed by Sarah Smith

As trading wraps up on Monday, it’s unclear what caused stocks to reverse course and head higher. Protests continue across the U.S. and President Donald Trump is still stoking tensions with a call to governors to “dominate” the situation in their individual states.

Perhaps, as Axios’ Dion Rabouin wrote this morning, this stock market rally is just too tough to beat. It sure looks like it, as the S&P 500Dow Jones Industrial Average and the Nasdaq Composite all closed in the green.

  • The S&P 500 closed higher by 0.38%
  • The Dow Jones Industrial Average closed higher by 0.36%
  • The Nasdaq Composite closed higher by 0.66%

Buy Eli Lilly Stock as It Begins Key Coronavirus Drug Trials

[Monday, June 1, 3:47 p.m.]
Contributed by Sarah Smith

Eli Lilly (NYSE:LLY) shares are up slightly Monday on news the company has begun human trials of its antibody drug for the novel coronavirus. Unlike other drugs in trial — including Gilead Sciences’ (NASDAQ:GILD) remdesivir — Eli Lilly’s drug was developed specifically for this virus.

In many ways, these human trials are a “milestone” in the race against the pandemic, according to Stat News’ Matthew Herper. AbCellera developed the drug, and now Eli Lilly will work to test and manufacture it. Chief Science Officer Daniel Skavronsky said that the company could potentially have hundreds of thousands or millions of doses ready by the end of 2020.

For now, this early trial is just to test the safety of LY-CoV555. According to Herper, 32 individuals will receive different doses of the drug.

According to the company’s press release, results from this trial should come at the end of June. From there, Eli Lilly will begin testing the drug in non-hospitalized coronavirus patients. But what’s perhaps a bigger catalyst is the preventive angle of LY-CoV555.

What does this mean? Well, vaccines are often not ideal for certain vulnerable populations, making vaccine candidates potentially unhelpful to a very at-risk group. Eli Lilly hopes that its drug — which targets a broad antibody found in patients — could be preventive and protect these populations. Not only does this give it an edge against drug-making peers, it also represents a big catalyst for the stock if the drug is successful in clinical trials.

Keep a close eye on LLY stock. Big things could be headed its way.


5 Micro-Cap Stocks to Buy for Big Gains Now

[Monday, June 1, 2:50 p.m.]
Contributed by Sarah Smith

When searching for stocks to profit off of the novel coronavirus, it’s likely big-name companies are some of the top recommendations. Clorox (NYSE:CLX) and Costco (NASDAQ:COST) have a lot of brand power, and shares didn’t disappoint in the earliest weeks of stay-at-home orders and panic buying. Now, though, InvestorPlace’s Thomas Niel is looking to micro-cap stocks for pandemic gains.

There’s a lot of volatility in the market, and it’s not unheard of these days to see a stock gain 300%-plus in a single day of trading. That’s why micro-cap names that are high risk and high reward hold so much potential.

Niel makes one thing very clear. When pursuing these micro-cap opportunities, investors shouldn’t be betting the ranch. Here’s where he’s looking now:

  • Century Casinos (NASDAQ:CNTY)
  • Funko (NASDAQ:FNKO)
  • Hexo (NYSE:HEXO)
  • iBio (NYSEMKT:IBIO)
  • Mesa Air Group (NASDAQ:MESA)


Gilead Stock Falls Despite New Remdesivir Results

[Monday, June 1, 1:50 p.m.]
Contributed by Sarah Smith

Gilead Sciences (NASDAQ:GILD) seems to have fallen completely out of favor with investors, but the company is still pushing ahead. On Monday, it announced new results about remdesivir, its novel coronavirus treatment that has received emergency-use authorization from the U.S. Food and Drug Administration. For some reason, GILD stock is down 3% in intraday trading.

The study showed that patients with “moderate” cases of Covid-19 that received a five-day course of remdesivir were 65% more likely to have their condition improve than those patients receiving standard treatment. Gilead focused on “moderate” cases, using a scale of severity ranging from not hospitalized to requiring extensive care.

According to BioPharma Dive’s Jacob Bell, this is important because it shows which patients are likely to benefit from such a treatment. Bell also cited Piper Sandler analyst Tyler Van Buren, who believes the five-day remdesivir treatment should be used in all hospitalized patients.

So why is remdesivir not sending GILD shares higher today? Perhaps investors are tired of the back-and-forth results. Or, perhaps it’s because, as InvestorPlace’s Larry Ramer wrote today, many are worried about whether or not Gilead will be able to meaningful profit from remdesivir sales.

Ramer isn’t giving up on GILD stock, and he doesn’t think other investors should either. He wrote this morning that many nations continue to expand approval of the drug, and results are still promising. Plus, unlike the naysayers, Ramer believes remdesivir will “move the needle” for Gilead, making it a stock to buy now.


This Week’s IPO Stocks Should Give Bulls Some Hope

[Monday, June 1, 1:17 p.m.]
Contributed by Sarah Smith

In perhaps the most striking sign that the economy and the stock market are at odds, this week is set to be the biggest IPO week since early February. Unemployment numbers are still climbing and tensions are rising in the U.S. At the same time though, four companies are pushing forward with IPOs as the stock market continues to trend higher.

This morning, Axios’ Dion Rabouin wrote that a “pandemic and protests can’t stop the stock market.” In a separate morning release, Axios’ Dan Primack commented that this week’s planned initial public offerings are a symbol of the market’s “decoupling” from the economy. However, Primack also pointed out that economists are quick to say real-time economic realities are not good market indicators.

So, while many are doubting the legitimacy of this rally, it’s clear that market sentiment has shifted in a big way. A few weeks ago, IPOs were far from almost everyone’s mind. Now, we’ll have four noteworthy public debuts in one week.

What’s on the docket for this week? According to Renaissance Capital, Warner Music Group, which will trade on the Nasdaq Exchange under ticker WMG, will be the largest IPO thus far in 2020. The record label plans to raise $1.7 billion. Shares will be priced between $23 and $26.

This week will also see software-as-a-service provider ZoomInfo debut as ZI, immuno-oncology company Legend Biotech debut as LEGN and biotech Pliant Therapeutics debut as PLRX.


Aytu BioScience Stock Climbs on New Coronavirus Test

[Monday, June 1, 12:28 p.m.]
Contributed by Sarah Smith

Although many Americans are regaining confidence and returning to pre-pandemic routines, testing hasn’t lost importance. For the last several weeks, many have speculated that antibody tests — those that specifically test for antibodies that indicate past infection — could allow big offices and schools to reopen. Why? Scientists believe the presence of these antibodies could mean immunity from the virus.

Clearly, that’s created a lot of demand for these novel coronavirus tests. Riding out the catalyst today is Aytu BioScience (NASDAQ:AYTU). Shares are up over 6% in intraday trading.

According to the company’s early morning press release, the U.S. Food and Drug Administration granted Aytu’s antibody test emergency-use authorization. The company has already ramped up production of its COVID-19 IgG/IgM Rapid Test Cassette, and has 1.4 million test kits now available at its San Diego warehouse.

One warning: Shares trade for less than $2, even after the morning’s rally. With that in mind, be cautious, but keep an open mind. H.C. Wainwright analyst Vernon Bernadino set a price target of $3 today along with a “buy” rating. That’s more than 100% upside from the current price.


7 Fitness Stocks to Buy for Some Post-Pandemic Muscle

[Monday, June 1, 10:50 a.m.]
Contributed by
Sarah Smith

Under stay-at-home orders, Americans purchased comfortable athletic wear and at-home workout equipment. Some were even panic-buying luxury gear while their beloved gyms and fitness studios were closed to stop the spread of the novel coronavirus. But now, states are reopening, and that means these gyms and studios are reopening too.

In some states, gyms were among the first businesses to reopen among growing demand. In others, they will be some of the last. Regardless, the world of fitness will perhaps be permanently changed by the pandemic. After one gym in Atlanta reopened in early May, patrons reported they didn’t feel safe without everyone wearing masks. According to The Wall Street Journal, the compromise was a four-hour period where masks were mandatory.

The Atlantic’s Michael Owen speculated on what this post-pandemic world of fitness will look like. Reduced capacity for group fitness classes. Latex gloves for weightlifting. Pre-booked workout windows. In other words, things will be different.

That’s why InvestorPlace’s Ian Bezek is bullish on a specific group of fitness stocks for the new normal. Instead of rushing to invest in gyms that have yet to fully reopen, he’s looking at athletic wear and at-home fitness companies that are likely to retain many new consumers. Plus, he’s looking at diet-focused brands that will gain popularity as Americans leave quarantine.

Here are the seven stocks he thinks you should buy now:

  • Nike (NYSE:NKE)
  • Peloton (NASDAQ:PTON)
  • Lululemon (NASDAQ:LULU)
  • Under Armour (NYSE:UANYSE:UAA)
  • BellRing Brands (NYSE:BRBR)
  • Hormel Foods (NYSE:HRL)
  • Fitbit (NYSE:FIT)


Stocks Open Lower Monday on U.S. Unrest

[Monday, June 1, 9:31 a.m.]
Contributed by Sarah Smith

Stock futures held up until just before the opening bell, when they dropped further into the red. Protests over the death of George Floyd, who was killed by Minneapolis police last week, dominated much of the news this weekend. Target (NYSE:TGT) has temporarily closed or adjusted hours at more than 200 stores. Amazon (NASDAQ:AMZN) is changing some delivery routes. Elsewhere in the corporate world, companies are publishing statements of support for Floyd’s family and the Black Lives Matter movement.

Although U.S.-China trade tensions have taken a backseat, matters are still escalating. This morning, Bloomberg reported that the nation has asked its top state-run agricultural companies to halt purchases of U.S. agriculture products including soybeans. Many take this as a sign that the phase-one trade deal remains in jeopardy.

The stock market demonstrated resiliency last week, but it’s unclear what today will bring. The S&P 500Dow Jones Industrial Average and the Nasdaq Composite all opened in the red Monday.

  • The S&P 500 opened lower by 0.26%
  • The Dow Jones Industrial Average opened lower by 0.33%
  • The Nasdaq Composite opened lower by 0.24%

Stocks Turn Positive on Trump’s Trade Comments

[Friday, May 29, 4:01 p.m.]
Contributed by Sarah Smith

Bulls didn’t achieve a monumental victory in the stock market today, but they at least pulled off a turnaround. President Donald Trump’s scheduled comments on U.S.-China relations weren’t as bad as expected. He did say the U.S. would move to end special trade treatment toward Hong Kong. However, investors are cheering because he didn’t abandon the existing phase-one trade deal.

Elsewhere in the market, Twitter (NYSE:TWTR) continued its fall, and social media peer Facebook  (NASDAQ:FB) joined it in the red. Who knows what Trump’s latest attack on the platforms will bring next week.

The Dow Jones Industrial Average failed to turn things around, but the S&P 500 and the Nasdaq Composite are headed into the weekend in the green.

  • The S&P 500 closed higher by 0.48%
  • The Dow Jones Industrial Average closed lower by 0.07%
  • The Nasdaq Composite closed higher by 1.29%

GlaxoSmithKline Stock Is a Buy on CRISPR Partnership

[Friday, May 29, 2:02 p.m.]
Contributed by Sarah Smith

Many investors have likely heard about the CRISPR gene-editing technique, especially in association with next-generation healthcare or red-hot biotech stocks. As OneZero writer Emily Mullin put it on Wednesday, the novel coronavirus is giving this science a much more realistic end goal — test kits.

Inspired by at-home pregnancy tests — relatively simple to use for the average consumer — a handful of companies, public and private, are working to make a CRISPR-based coronavirus test. Such a test would beat the costs and inconvenience associated with lab testing, and could deliver results in less than hour.

Notable cons include the potential for test misinterpretation.

For investors, one exciting entrant into this space is pharmaceutical giant GlaxoSmithKline (NYSE:GSK). The company is already working on a vaccine candidate for the coronavirus, but through a partnership with Mammoth Biosciences, it’s also working on a 20-minute test kit.

According to FierceBiotech’s Conor Hale, the test would require an at-home nasal swab and would be sold over the counter. The duo’s offering would greatly improve the accessibility of these diagnostic tools, and using the CRISPR gene-editing technique would ensure more reliable results. The U.S. Food and Drug Administration already granted Sherlock Biosciences emergency-use authorization for a similar test. However, Sherlock’s is not designed for at-home use and requires lab equipment.

So-called “designer babies” and next-gen cancer cures may seem far away, but CRISPR’s use in combating the coronavirus is quite tangible. Getting into a partnership like GSK’s and Mammoth’s sounds like a win-win opportunity for investors.


9 Cheap Stocks to Buy for Pandemic Rebound Potential

[Friday, May 29, 1:32 p.m.]
Contributed by Sarah Smith

There has always been something magical about cheap stocks, and the novel coronavirus makes their appeal even brighter. Why? Even stalwart companies have struggled, which means that solid stocks are now available at discount prices. Plus, some riskier names now come with bigger rebound potential.

That’s why InvestorPlace’s Josh Enomoto recommended nine cheap stocks today. He argues that his list would benefit from both a V-shaped and a prolonged recovery, because regardless of the timeline, his picks are headed up.

So what exactly are his picks? Enomoto is looking to the world of vice, as he thinks pent-up demand will drive a rebound in beer sales and strip club visits. Plus, he’s betting on psychedelic drugs (for medicinal use) and a handful of more recognizable and respectable companies.

Here are the nine cheap stocks he thinks you should buy now:

  • AT&T (NYSE:T)
  • Altria Group (NYSE:MO)
  • RCI Hospitality (NASDAQ:RICK)
  • Molson Coors Beverage (NYSE:TAP)
  • Anheuser-Busch InBev (NYSE:BUD)
  • Yamana Gold (NYSE:AUY)
  • Simon Property Group (NYSE:SPG)
  • ViacomCBS (NASDAQ:VIAC)
  • Champignon Brands (OTCMKTS:SHRMF)


Sonoma Pharmaceuticals Soars on Disinfectant Approval

[Friday, May 29, 12:09 p.m.]
Contributed by Sarah Smith

Has anyone found any Clorox (NYSE:CLX) disinfectant products yet? It seems like whenever I look, shelves are still empty. In other words, virus-fighting disinfectants are still in high demand, and that bodes well for California-based Sonoma Pharmaceuticals (NASDAQ:SNOA).

Shares are up more than 150% in intraday trading on news that Sonoma’s Nanocyn disinfectant and sanitizer product received approval from Australia’s Register of Therapeutic Goods. This approval means that Sonoma can now market its disinfectant as a virucidal agent specifically against the novel coronavirus. Hello, Clorox-esque rally!

Sonoma works with MicroSafe Group, a Dubai-based biomedical company, to produce its Nanocyn product. This means that in Australia, the product will be sold under the Nanocyn brand. In Europe and the Middle East, it will be sold as a MicroSafe product.

MicroSafe CEO Safa Qadumi said that this disinfectant is important for more than one reason. It has a 30-second kill time for viruses, and it’s not toxic. That combination is “landmark” according to Qadumi.

It’s also landmark for Sonoma Pharmaceuticals stock, which could continue to benefit from a spike in sales. Now that it’s able to market its product specifically with Covid-19 in mind, look for consumers to stock up on Nanocyn soon.


Buy Shopify Stock for Its New Pandemic-Driven Solutions

[Friday, May 29, 11:18 a.m.]
Contributed by Sarah Smith

Some, like InvestorPlace’s Joel Baglole, think Shopify (NYSE:SHOP) is running out of growth potential. To be fair, shares are up almost 90% year-to-date and trade at an astronomical forward price-earnings ratio. But investors shouldn’t knock SHOP stock here. In fact, its new e-commerce solutions shows Shopify knows exactly what to do moving forward.

To start, Shopify is a partner in Facebook’s (NASDAQ:FB) much-hyped Facebook Shops rollout. As Baglole writes, it’s not the only e-commerce partner that Facebook has tapped. But Shopify will still get access to Facebook’s 2.6 billion monthly active users as businesses begin selling products directly through social media platforms.

Shopify is also recognizing the needs of small and medium-sized business owners, especially as the novel coronavirus continues to decimate and shift the retail landscape. Its new Shopify Balance will help shop owners track their expenses and make payments. Cards associated with the plan will earn rewards on business expenses. Plus, a new local delivery program will allow merchants to define “local” areas and set special delivery rates within those areas. This will certainly help small businesses get creative.

But perhaps the most exciting new offering is Shopify Pay Installments. Similar to offerings from Klarna and Afterpay (OTCMKTS:AFTPY) — a company we previously praised in this blog — Shopify Pay Installments embraces “buy now, pay later.” This service was gaining serious popularity with retailers and shoppers before the pandemic, but as Retail Dive’s Tatiana Walk-Morris wrote, it’s even more of a logical move now.

Buy now, pay later solutions make even high-priced purchases seem a bit more reasonable. Plus, as consumers continue to struggle financially, every dollar saved in the short term really does matter. Shopify has tapped into a key market, and giving its customers Pay Installments should seriously pay off. With that in mind, make sure to give SHOP stock a chance as it gains further e-commerce dominance.


7 Vaccine Stocks to Buy as the Research Race Heats Up

[Friday, May 29, 10:49 a.m.]
Contributed by Sarah Smith

The 1950s and 1960s had the Space Race. In 2020, investors now have the “coronavirus vaccine race” as companies big and small work to develop, manufacture and market a potential cure for the novel coronavirus. To date, there are over 100 candidates in various stages of development and clinical trial.

Each company in the running has big potential. A vaccine will bring a safer reopening, a return to the “normal” so many Americans miss. Plus, it would represent just how far technology has come as researchers work to develop the vaccine in record time. President Donald Trump is even calling a U.S. initiative Operation Warp Speed, demonstrating his intentions to quickly vaccinate the U.S. population.

In a field with more than 100 candidates, how do you start betting on the winner? InvestorPlace Markets Analyst Luke Lango is rallying behind what he sees as the top seven vaccine stocks. These companies will benefit from their ability to scale production quickly.

Here’s a look at the seven stocks he’s recommending now:

  • Moderna (NASDAQ:MRNA)
  • Inovio (NASDAQ:INO)
  • Dynavax (NASDAQ:DVAX)
  • Novavax (NASDAQ:NVAX)
  • Sorrento (NASDAQ:SRNE)
  • Arcturus (NASDAQ:ARCT)
  • iBio (NYSEMKT:IBIO)


Stocks Open Lower Friday on Rising U.S.-China Tensions

[Friday, May 29, 9:31 a.m.]
Contributed by Sarah Smith

It’s almost the weekend, but investors are getting a rough start in the stock market today. Tech stocks are still struggling, and things aren’t necessarily looking up.

President Donald Trump plans on holding a press conference later in the day to discuss how his administration wants to move forward with China. His administration is pushing back on Beijing’s relationship with Hong Kong, but threats of sanctions, tariffs and limited visas could spell disaster for Silicon Valley.

Plus, Trump is once again taking aim at social media companies after Twitter (NYSE:TWTR) applied new fact-checking and censorship protocols to a handful of the president’s tweets. TWTR shares opened down after tumbling 4.5% on Thursday.

Will weekend enthusiasts be able to pull of a rally by the end of the day? It seems unlikely now, but you never know what is possible. In the meantime, the S&P 500Dow Jones Industrial Average and the Nasdaq Composite are all in the red.

  • The S&P 500 opened lower by 0.21%
  • The Dow Jones Industrial Average opened lower by 0.52%
  • The Nasdaq Composite opened lower by 0.46%

These 6 Companies Will Be Winners After the Pandemic

[Thursday, May 28, 4:34 p.m.]
Contributed by Sarah Smith

It should be abundantly clear that the novel coronavirus has changed “normal” life, and that some of these changes will be permanent in nature. Don’t get me wrong. I’m not saying we are moving to a future devoid of human contact and in-person work. Instead, I’m recognizing that the pandemic is accelerating certain megatrends, and making many consumers familiar with new trends like e-commerce.

That’s why InvestorPlace’s Chris Markoch today recommended six companies that stand to be winners for the next decade. He wrote that these companies have stood out since the market-wide selloff in March, and their underlying trends will continue to accelerate in the future.

His list covers big trends. E-commerce. Telemedicine. Contactless payments. Fintech. We’ve seen how restaurants quickly abandoned cash for in-app payment experiences. Doctors closed non-essential offices in favor of telehealth offerings. Brick-and-mortar retailers have lost out to e-commerce sites. Those trends won’t reverse, they’ll simply accelerate.

To invest for the next decade, here are Markoch’s six recommendations:

  • PayPal (NASDAQ:PYPL)
  • Square (NYSE:SQ)
  • Shopify (NYSE:SHOP)
  • Amazon (NASDAQ:AMZN)
  • Verizon (NYSE:VZ)
  • Teladoc Health (NYSE:TDOC)


6 European Stocks to Buy for an EU Bailout Plan

[Thursday, May 28, 4:12 p.m.]
Contributed by Sarah Smith

In an effort to bail out more tourism-dependent countries, the European Union just unveiled a $2 trillion stimulus proposal. The plan combines over $800 billion in recovery funds with a $1.2 trillion budget for the next seven years. European stocks rose on the news, but some EU member nations are already pushing against it.

Germany and France, among the EU’s wealthiest nations, have been better able to inject cash into struggling companies. As we’ve previously reported in this blog, Greece, which gets much of its revenue from tourism, faces major economic pain and lacks necessary resources to address it.

As with any big-ticket bill, the proposed stimulus is controversial. To start, it would include the issuance of common eurozone debt. Repayments would begin in 2028, and according to The Wall Street Journal, would be funded through bloc-wide taxes and member-state contributions.

The potential “bad guys” in this news have been dubbed the Frugal Four — Sweden, the Netherlands, Denmark and Austria. According to the team at Morning Brew, these northern states are “spooked” at the thought of taking on so much debt on behalf of struggling economies. Investors should prepare for weeks of debate and changes to the proposal, as all 27 nations must agree.

All the debate isn’t preventing a rally in European stocks. Just like how the CARES Act brought hope for the hardest-hit industries, companies in Europe are feeling relief this week. Car maker Renault (OTCMKTS:RNSLY) is up 30% in the last five trading days. Airlines Ryanair (OTCMKTS:RYAAY) and Lufthansa (OTCMKTS:DLAKY) are up 11% and 19%, respectively.

Just like in the United States, banks have been some of the losers. That means on a bailout-driven rally, they’re likely to be some of the winners. Banco Santander (NYSE:SAN) is up 9% in the last five trading days. Societe Generale (OTCMKTS:SCGLY) and BNP Paribas (OTCMKTS:BNPQY) are up 13% and 20%, respectively.

These six stocks are just a start, but they represent investment opportunities on the lessons learned in the U.S. Keep an eye on players in other hard-hit industries, and make sure to tune into the inevitable EU drama over the next few weeks.


Stocks Cut Gains Thursday as U.S. Death Toll Rises

[Thursday, May 28, 4:01 p.m.]
Contributed by Sarah Smith

Today’s rally was just too good to be true. Stocks reversed course, heading into the red, although the S&P 500 remains above the key 3,000 level. So, what happened in the stock market today?

Investors cheered on good news from Novartis (NYSE:NVS) and Arca Biopharma (NASDAQ:ABIO) about novel coronavirus treatments. However, an update that the death toll in the United States has now surpassed 100,000 is disheartening. Plus, investors learned this morning that 2.1 million more Americans filed for unemployment benefits. Every step forward is met with two steps back these days.

Unfortunately, the S&P 500, Dow Jones Industrial Average and the Nasdaq Composite just couldn’t hold onto their early morning gains. Who knows what tomorrow will bring.

  • The S&P 500 closed lower by 0.21%
  • The Dow Jones Industrial Average closed lower by 0.58%
  • The Nasdaq Composite closed lower by 0.46%

Is Amazon Stock a Buy on Pending Zoox Deal?

[Thursday, May 28, 3:13 p.m.]
Contributed by Sarah Smith

Amazon (NASDAQ:AMZN) is, without a doubt, one of the biggest winners amid the novel coronavirus. The company continues to benefit from its e-commerce dominance, its Whole Foods grocery chain and its streaming entertainment library. New moves into the video game world are also drawing praise from investors. And, as The Wall Street Journal reported this week, Amazon is also making another move into the world of self-driving vehicles.

Cara Lombardo and Tim Higgins wrote on Tuesday that Amazon was allegedly in talks to acquire Zoox, a company working on the hardware and software for robot taxis. The duo wrote that after struggling to attract necessary financing, the startup has been struggling. A sale to Amazon could prolong its ideas, and potentially give Amazon an edge in the next-generation car world.

Although the deal has not been confirmed, many predict Amazon would pay no more than $3.2 billion for Zoox. Barron’s Eric Savitz likes the rumors, noting that Amazon could become a leader in the ride-hailing market, knocking out Uber (NYSE:UBER) and Lyft (NASDAQ:LYFT). Sure, those two companies have had a bit of a duopoly, but they aren’t holding up well in the face of a pandemic.

This isn’t Amazon’s first foray into the vehicle realm. It has previously invested in electric truck maker Rivian and Aurora Innovations, a company behind other self-driving tech. With this in mind, some see Amazon’s interest in Zoox as an even more cunning move.

Axios’ Joann Muller wrote yesterday that if anything, Amazon is seeking to improve its logistics offerings as e-commerce demand skyrockets. It is already working with Rivian and Aurora to produce 100,000 electric delivery trucks, and as Muller wrote, it could tap Zoox’s hardware and software to add self-driving or other high-tech features to this plan.

Competition in e-commerce is heating up and Amazon clearly wants to maintain its dominance. It’s not at risk yet, but continuing innovation is key. A purchase of Zoox could one day translate to even more profits for Amazon shareholders.


4 Stocks to Buy for Prolonged Social Distancing

[Thursday, May 28, 3:00 p.m.]
Contributed by Sarah Smith

Pictures of Brooklyn’s Domino Park — where sunbathers relax in chalk circles spaced six feet apart — may seem like a city art experiment. Instead, it’s a sign of the times, as Americans yearn for time in the summer sun while still maintaining expert-recommended social distancing protocols. It’s also a sign of how states are struggling to strike a balance between reopening their economies and protecting concerned consumers.

This push for balance is what inspired InvestorPlace’s Laura Hoy to make four stock recommendations today. Drawing on advice from University of Texas at Austin’s Brad Gold, she argues that the best stocks to buy are ones that will benefit both from reopening and social distancing.

It sounds like a tough ask, but her recommendations deliver just that. The stocks on her list combine work-from-home trends, reopening restaurants and staple American businesses.

Without further ado, here are Hoy’s four recommendations:

  • Dropbox (NASDAQ:DBX)
  • 3M (NYSE:MMM)
  • Starbucks (NASDAQ:SBUX)
  • Raytheon Technologies (NYSE:RTX)


Arca Biopharma Stock Is a Unique Coronavirus Play

[Thursday, May 28, 2:41 p.m.]
Contributed by Sarah Smith

There’s no sense burying the big news. Arca Biopharma (NASDAQ:ABIO) stock is up 340% in intraday trading. Yep, you read that right. Shares opened yesterday below $4 and now trade above $15. This is truly spectacular price action — but there’s good reason for the leap.

Many biotech and pharmaceutical companies have chosen to fight the novel coronavirus through test kits, vaccines and antiviral drugs. We have Gilead’s (NASDAQ:GILD) remdesivir and Abbott Laboratories’ (NYSE:ABT) test kits and over 100 vaccines in the race. But Arca Biopharma is offering something new to the market with its symptom-focused treatment.

To start, Covid-19 typically presents as an infection in the upper portion of the respiratory tract. But, as investors have surely seen in the news, the outbreak comes with a whole host of symptoms. Children are getting blisters on their feet, pregnant women are reporting unique side effects and other patients are seeing far-reaching impacts on various organs. One complaint is a coagulopathy — an inability to form blood clots — specific to Covid-19. It’s not entirely clear what the association is, or why it’s happening in so many patients. But, researchers do know that the presence of this coagulopathy is linked to increase risk of death in Covid-19 patients.

That’s where Arca Biopharma comes in. The company announced that it is developing its AB201 as a treatment for this coagulopathy. One good thing is that the treatment has already been studied for safety and efficacy for other conditions, including Ebola, so it may be able to go through a more rapid process. In its Thursday press release, the company says it hopes to move to Phase 2b and Phase 3 trials by the second half of the year.

Keep a close eye on ABIO stock. One of the most attention-grabbing details of this virus is the various ways in which it impacts human life. As companies like Arca Biopharma work to treat unpredictable symptoms, there’s certainly profits to be made.


Novartis Stock Climbs After Jumping Into the Vaccine Race

[Thursday, May 28, 2:13 p.m.]
Contributed by Sarah Smith

Novartis (NYSE:NVS) may have divested its vaccine business to GlaxoSmithKline (NYSE:GSK) in 2015, but that doesn’t mean the pharmaceutical giant is prepared to sit this fight out. In fact, it dove into the race to develop a novel coronavirus vaccine on Thursday through a partnership with Massachusetts General Hospital and Massachusetts Eye and Ear.

So how exactly does this partnership work? Novartis is contributing through its AveXis gene therapy unit. This unit is already familiar with a specific type of gene therapy delivery tool, known as adeno-associated virus (ADV). The Massachusetts hospital group has already begun developing and researching a vaccine that used this same tool. Its AAVCOVID is in preclinical trials, and could move to Phase 1 human trials by the second half of 2020.

Apparently investors still have an appetite for new vaccine stocks. Despite the fact that there are more than 100 other candidates, 30 of which use this same type of vaccine technology, NVS shares are up almost 3% Thursday in intraday trading.

Why? BioPharma Dive’s Jonathan Gardner wrote today that one particular area of interest is the hospital’s early move to partner with Novartis’ AveXis. The gene therapy unit will be particularly helpful in commercial manufacturing and distribution, which shows that there’s a high level of confidence about the vaccine. In a time where a vaccine is in sky-high demand, such a bold move is likely exactly what investors are looking for.

As we’ve previously reported in this blog, big rewards will come to the vaccine winner. Novartis has a big reputation and a lot of power behind its name. As the race heats up, it’s certainly a contender to watch.


10 Coronavirus Stocks to Buy to Invest Like Jim Cramer

[Thursday, May 28, 1:30 p.m.]
Contributed by Sarah Smith

CNBC’s Jim Cramer has been working since late April on his “Cramer Covid-19 Index.” Just as the name suggests, the TV analyst has been perfecting a portfolio of stocks that are set to outperform the broader market. There are 100 stocks in this index, and Cramer picked each one for an economy he describes as “reeling” amid the novel coronavirus pandemic.

Now that March’s selloff is mostly in the rear-view mirror and economic reports are trending higher, some are calling for a V-shaped — or quick — recovery. But Cramer thinks it’s too soon to give up on what he’s calling “recession stocks.” That’s why, as MarketWatch’s Shawn Langlois wrote yesterday, the analyst is making some changes to the portfolio.

He sold stocks like Digital Realty (NYSE:DLR), Freshpet (NASDAQ:FRPT) and Inovio Pharmaceuticals (NASDAQ:INO). These stocks have been hot, but Cramer is looking for even more defensive names.

If you want to invest like Cramer, here are 10 stocks he just added to his Covid-19 index:

  • DataDog (NASDAQ:DDOG)
  • Splunk (NASDAQ:SPLK)
  • Twilio (NYSE:TWLO)
  • Etsy (NASDAQ:ETSY)
  • Wix.com (NASDAQ:WIX)
  • Chegg (NYSE:CHGG)
  • Target (NYSE:TGT)
  • S&P Global (NYSE:SPGI)
  • Palo Alto Networks (NYSE:PANW)
  • Emergent (NYSE:EBS)


7 Gun Stocks to Buy to Protect Yourself From the Virus

[Thursday, May 28, 11:07 a.m.]
Contributed by Sarah Smith

As InvestorPlace’s Josh Enomoto wrote this morning, the novel coronavirus is creating a wave of fear and scapegoating. In turn, this has caused firearm sales to go through the roof. Sure, Enomoto acknowledges that he’s a bit of a cynic, but he’s likely not wrong. More consumers buying guns means more revenue for the gun manufacturers and retailers. That’s some easy math.

No, this isn’t like gun-toting southerners threatening to shoot into hurricanes to drive them off. In fact, as Enomoto writes, nothing about this investing opportunity is particularly warm and fuzzy in nature. Many Asian Americans have become victims of pandemic-related racial violence, as some falsely believe individuals are to blame for the outbreak.

In response, many Asian Americans are buying firearms. To Enomoto, that represents a growing customer base and a growing investing thesis. If you want to follow his lead, here are seven gun stocks he’s recommending investors buy now:

  • American Outdoor Brands (NASDAQ:AOBC)
  • Sturm Ruger (NYSE:RGR)
  • Vista Outdoor (NYSE:VSTO)
  • Olin Corporation (NYSE:OLN)
  • Sportsman’s Warehouse (NASDAQ:SPWH)
  • Axon Enterprise (NASDAQ:AAXN)
  • Big 5 Sporting Goods (NASDAQ:BGFV)


Pizza Stocks Offer Cheesy Returns Amid the Pandemic

[Thursday, May 28, 10:35 a.m.]
Contributed by Sarah Smith

As consumers have abandoned healthy eating in favor of comfort foods, pizza has become a serious winner. I mean, who doesn’t love pizza? That thinking is why Longbow analyst Alton Stump set new “buy” ratings on Domino’s Pizza (NYSE:DPZ) and Papa John’s (NASDAQ:PZZA) today.

Domino’s reported first-quarter figures on April 23, but since then, it’s seen a “material” spike in business. As Barron’s Teresa Rivas wrote yesterday, comparable-store sales were up 20.9% in May compared to a 7.1% increase in April. No wonder Stump is so bullish on pizza stocks. Based on Domino’s recent report, Stump is confident that DPZ stock will continue to benefit from the novel coronavirus.

DPZ stock trades hands near $370, and Stump raised his 12-month price target to $441.

Papa John’s is a smaller operator, and Rivas says many investors are worried about its longer-term potential. Whereas Domino’s is likely to push through even as states reopen and dine-in restaurant options return, Papa John’s might lose its spark. That’s not stopping Stump, though. PZZA stock currently trades at $77, and the Longbow analyst things it could hit $95 in a year.

Pizza is warm, cheesy goodness nicely packed up in a cardboard box. Woes related to the coronavirus will persist for a long time, and pizza will be there to comfort consumers. If I were you, I wouldn’t bet against pizza stocks.


Stocks Open Higher Thursday Despite Jobless Report

[Thursday, May 28, 9:31 a.m.]
Contributed by Sarah Smith

This week’s rally is looking pretty tough. Investors learned that 2.1 million more Americans filed for unemployment benefits last week, bringing the total to over 40 million. But the mass selling hasn’t started yet. Sure, 2.1 million is a lot better than 6.9 million. Is this “victory” cause for more stock market gains on Thursday?

The S&P 500 and Dow Jones Industrial Average opened higher on Thursday, but the tech-heavy Nasdaq Composite wasn’t so lucky. Earnings from HP (NYSE:HPQ) missed estimates, and investors are wary as U.S.-China trade tensions rise once again.

  • The S&P 500 opened higher by 0.35%
  • The Dow Jones Industrial Average opened higher by 0.74%
  • The Nasdaq Composite opened lower by 0.15%

Stocks Close Higher Wednesday Despite Trade Troubles

[Wednesday, May 27, 4:01 p.m.]
Contributed by Sarah Smith

Nothing could stop Wednesday’s rally, not even renewed trade tensions between the U.S. and China. Today, Secretary of State Mike Pompeo said that Hong Kong was “no longer autonomous” from China, raising concerns about its special trade status and broader U.S.-China relations. A handful of tech companies stumbled on the news.

However, Pompeo’s comments didn’t turn stocks negative. The S&P 500Dow Jones Industrial Average and the Nasdaq Composite all closed well in the green Wednesday. Now it’s just time to wait and see if the SpaceX launch goes as planned.

  • The S&P 500 closed higher by 1.48%
  • The Dow Jones Industrial Average closed higher by 2.21%
  • The Nasdaq Composite closed higher by 0.77%

Goldman Sachs: Look for Companies With ‘Sticky’ Sales

[Wednesday, May 27, 3:49 p.m.]
Contributed by Sarah Smith

Since early March, investors have largely been interested in so-called coronavirus stocks. Grocery stores, makers of comfort foods and take-out focused restaurants were among the winners. Now, as states move forward with reopening plans, Goldman Sachs is highlighting that not all of these winners will remain relevant. So, what stocks are worth holding onto — or buying — now?

In a new note to clients, the firm examined the household penetration of several key consumer products. Based on this research, analysts concluded that most of these demand spikes will be temporary. However, two winners will be hard seltzer and sanitizer (subscription required). What a combo.

Why seltzer and sanitizer? Goldman thinks these products have a certain stickiness to them. Consumers who started buying them will likely continue, as they’ve become part of everyday life. With that in mind, Boston Beer Company (NYSE:SAM) and Procter & Gamble (NYSE:PG) are likely long-term winners according to the analysts.

That makes sense. InvestorPlace analyst Matt McCall is a fan of SAM stock, writing in mid-May that even a pandemic can’t bring it down. Boston Beer’s Truly seltzer has become a consumer favorite, and the company is also embracing innovation. It’s turning expired beer into hand sanitizer.

And InvestorPlace analyst Neil George is a big fan of PG stock. He wrote that it’s one of the best long-term stocks for investors to buy and hold. After shares stalled out, he’s pleased to see the company focusing more on shareholders. Plus, a dividend yield of 2.8% is juicy compared to the S&P 500.


2 Stocks to Buy to Profit From the $32 Billion Resale Market

[Wednesday, May 27, 3:22 p.m.]
Contributed by Sarah Smith

Retailers are struggling, but many experts believe the online resale market is booming. Robb Report’s  Jemima Sissons wrote last week that consumers are “detoxing” luxury wardrobes, posting them on online resale platforms. Others are looking for the right luxury accessories (think designer silk scarves) for pandemic living.

For individual consumers, this trend represents a great way to make a little bit of money back, or to swap out one luxury item for another. Vestiaire Collective reported a 44% increase of new listings in the last month as work-from-home lounge items and sub-$500 goods drew interest. But there’s also a way for investors to benefit from the online resale market — which some say is worth $32 billion.

The first entry point is The RealReal (NASDAQ:REAL). A recent IPO stock, The RealReal is the first publicly traded online resale platform. Its luxury focus has similarly brought it success amid the viral outbreak. In mid-May, it hosted a designer mask sale to support frontline workers.

The RealReal hasn’t been immune from the novel coronavirus, but it’s up almost 40% in the last month. Wealthy customers will soon regain confidence, and that will translate to big rewards for the company.

New reporting from Business Insider’s Hayley Peterson highlights a second investment opportunity in this resale market. Walmart (NYSE:WMT) just announced a partnership with ThredUp. Today, Walmart began selling used clothing, footwear and handbags on the resale platform. Walmart customers get free shipping on $35-plus orders and free returns — two perks not previously available on ThredUp.

Whether you opt for familiar Walmart or newcomer The Real Real, the investing opportunity is solid, and the pandemic is only accelerating things.


Freshpet and Chewy Are Unique E-Commerce Plays Now

[Wednesday, May 27, 2:42 p.m.]
Contributed by Sarah Smith

No matter how smart Fido and Mr. Mittens are, they can’t fully grasp the consequences of the novel coronavirus. For many pets, the pandemic simply means beloved owners are now stuck at home. These pets also represent one constant as Americans face a series of changes: Dogs and cats still need to eat.

Humans grasp that grocery stores aren’t exactly the safest places right now. Pets don’t care about Instacart and strategic shopping trips. They’re simply hungry for food and treats. As consumers balance their care-giving duties with personal health, Freshpet (NASDAQ:FRPT) and Chewy (NYSE:CHWY) have become hot stocks.

In fact, Supermarket News reported that 83% of consumers surveyed now will buy pet products online, although they previously would have opted for the in-store experience. That bodes really well for Freshpet and Chewy stock.

Freshpet bills itself as the future of pet food. Ingredients include locally sourced chicken, cranberries and spinach. Shoppers can get it delivered through Amazon (NASDAQ:AMZN), Instacart and Target’s (NYSE:TGT) Shipt. According to CNBC, Freshpet even caught Jim Cramer’s attention as a great way way to beat the S&P 500 in 2020.

The story with Chewy is similar. Instead of trekking to the grocery store or pet store, shoppers can get food, treats, toys and clothing for the pets delivered right to their door in a signature blue box. Talk about brand recognition. InvestorPlace’s Josh Enomoto is bullish on Chewy, especially for younger investors. He wrote earlier in May that while Chewy’s operations aren’t always ideal (it struggled initially to meet the spike in demand), investors who get in now will certainly reap rewards.

As Freshpet and Chewy continue to rack up analyst praise (subscription required), there’s no denying that they represent the future of pet food. Trust me, your furry friends will appreciate these investments.


Is It Time to Buy AT&T Stock as HBO Max Launches?

[Wednesday, May 27, 1:49 p.m.]
Contributed by Sarah Smith

Today marked the long-awaited launch of AT&T’s (NYSE:T) HBO Max streaming service. For a $14.99 a month customers get access to 10,000 hours of existing TV shows and movies. Top titles include FriendsRick and Morty and the DC films like Wonder Woman. Is this the catalyst AT&T stock has been waiting for?

To be fair, the launch has its critics. HBO Max’s price tag comes slightly higher than other offerings from Disney (NYSE:DIS) and Netflix (NASDAQ:NFLX). But AT&T has certainly stocked the service with an impressive content library. As TechCrunch’s Anthony Ha writes, another downside is the lack of original content on the platform. A reboot of Friends should debut later on, but there’s nothing like the The Mandalorian to immediately excite fans.

But HBO Max should also benefit from all the new eyeballs the streaming world has attracted. Many states are rushing to reopen, but plenty of consumers will opt to stay at home. Plus, many businesses won’t get the green light to reopen for weeks or months to come.

InvestorPlace Markets Analyst Luke Lango doesn’t think it’s a tough question. He’s confident that HBO Max will be a “mega growth catalyst” for AT&T. He wrote last week that its “treasure chest” of content will rival that of Disney+ and help AT&T weather the economic crisis.

Disney+ certainly found success amid the pandemic, as has music streaming platform Spotify (NYSE:SPOT). It’s too early to tell if HBO Max will attract the necessary customers, but the future looks bright. Buy AT&T stock now to ride out this mega growth catalyst, and binge-watch Friends while you wait for the big gains to come.


5 Stocks to Buy for a Slightly Less Global World

[Wednesday, May 27, 1:19 p.m.]
Contributed by Sarah Smith

The novel coronavirus created the perfect geopolitical storm. President Donald Trump, and several other world leaders, have blamed China for allowing the outbreak to infect the rest of the world. Tensions between the U.S. and China are back on the rise after a phase-one trade deal fell by the wayside. International travel has broadly come to a standstill, and many borders are closed.

Experts don’t think this trend will entirely reverse. In a new note to clients, Bank of America’s Kathryn McDonald and Joseph Quinlan wrote that the pandemic won’t create new trends, but accelerate trends that were already in motion, like what they term “de-globalization.”

In the note, the duo writes that this “de-globalization” trend means the U.S. will move its key manufacturing back within its borders. Next-generation technology will come from domestic factories, not from China. McDonald and Quinlan emphasize that a combination of re-shoring and localization was already gaining traction. The pandemic is just making it more attractive.

So how can investors profit in this return back to America? InvestorPlace’s Josh Enomoto predicted that pockets of geopolitical instability, some fueled by U.S.-China tensions, would rattle the lithium market. With that in mind, he recommended Sociedad Quimica y Minera (NYSE:SQM), Orocobre (OTCMKTS:OROCF), Power Metals (OTCMKTS:PWRMF) and Galaxy Resources (OTCMKTS:GALXF). According to Enomoto, these companies don’t source their lithium from China, which makes them much safer investments for 2020 and beyond.

Axios’ Miriam Kramer and Alison Snyder wrote that the space industry is another critical one to watch. For the last decade, U.S. astronauts have relied on Russia to get to space. Today’s SpaceX launch changes that. They question — will this bring about a new era of cooperation, or “Great Power” competition? Without the U.S. as a customer, Russia could turn to China for business.

Although SpaceX is a private company, Tesla (NASDAQ:TSLA) is a unique beneficiary of this de-globalization. According to Barron’s Al Root, each SpaceX success turns into a branding opportunity for Tesla, and potential gains for TSLA stock.

There are countless other opportunities for this de-globalization trend. Look for industries most likely to return to the U.S. (Bank of America names robotics, critical pharmaceutical goods and automation).


StoneCo Stock Surges on Recent Fintech Success

[Wednesday, May 27, 12:46 p.m.]
Contributed by Sarah Smith

There are many reasons to like fintech stocks right now. For many investors, these newer, tech-focused players are free from traditional financial stocks’ bad reputation. Plus, these companies represent the future of payment, often providing cashless solutions perfect for novel coronavirus concerns.

But most conversations about cashless payments — or about fintech in general — stop after mentions of Square (NYSE:SQ) and PayPal (PYPL). Today, Brazil-based StoneCo (NASDAQ:STNE) is looking to spend some quality time in the spotlight. Shares are up more than 27% in intraday trading.

To be fair, StoneCo already made waves in 2018 when Berkshire Hathaway’s (NYSE:BRK.A, NYSE:BRK.B) Warren Buffett purchased a sizable stake. But what attracted Buffett back then, and why does it matter now?

StoneCo’s founders sought to take advantage of the growing trend toward cashless payments in Brazil. Its solutions help merchants with in-store, mobile and online payments. And emerging markets like Brazil are both hard-hit by the pandemic and also racing to adopt electronic payments.

Buffett saw the potential back then, and many investors have since followed in his footsteps. STNE stock struggled amid the outbreak, but has since climbed off its lows. Shares are now down just 15% for the year after touching a 55% loss in April.

On Tuesday afternoon, the company reported earnings that unfortunately missed estimates. Total revenue of $134 million was up 33% year-over-year, but EPS of 11 cents fell 1 cent from 2019. Behind Wednesday’s rally is a year-over-year total payment volume increase of 42.1%.

Investors, like InvestorPlace’s Chris Lau, have long been pounding the table on STNE stock. The pandemic shook the market’s confidence in StoneCo’s potential, but this increase in total payment volume seems to indicate that there’s a rebound in payments coming in Brazil.

As more consumers start spending money, more of those consumers will end up using one of StoneCo’s solutions. You don’t want to miss out.


Target Stock May Be the Perfect Pandemic Buy

[Wednesday, May 27, 11:27 a.m.]
Contributed by Sarah Smith

With a market capitalization of $57 billion, Target (NYSE:TGT) is just a fraction of the size of Walmart (NYSE:WMT). But the smaller retailer has developed an intensely brand-loyal following. And thanks to the novel coronavirus, it looks like it’s about to hit the “target” with shareholders.

Target is doing a lot of things right. It combines fashionable apparel with convenient snack items, affordable-but-trendy home goods with healthcare products. Online sales grew by 141% in the first quarter as consumers flocked to its website for a mix of essential and non-essential purchases.

In the grocery world, Target’s Shipt business is also paying off. Since March, the same-day grocery delivery service has seen its customers double. But according to Supply Chain Dive’s Jeff Wells, there’s another exciting grocery catalyst rolling out. Before the pandemic, Target was testing adding fresh groceries and alcohol to its curbside Drive Up program. After temporarily halting the pilot to focus on keeping employees safe, the program is back.

Sure, COO John Mulligan isn’t sure when the pilot will expand, but he’s optimistic that sooner, rather than later, customers will be ordering milk along with their school supplies and bathing suits for curbside pickup. As the pandemic continues to accelerate curbside offerings, look for Target to become even more of a one-stop shop for consumers.

Target is also heating things up elsewhere in the retail world. On May 21 it announced shoppers would be able to purchase products directly through its Instagram page. After initially entering your shipping and payment information, it will be a two-click process. As Retail Dive’s Tatiana Walk-Morris wrote, this is a great move for Target as in-app purchases gain traction. From the comfort of your couch or bed you can “shop” an image and order what you see.

No wonder InvestorPlace Markets Analyst Luke Lango loves TGT stock so much. With a 2.2% dividend yield and seemingly never-ending retail innovations, it’s the perfect buy to “beat” the pandemic.


7 Cheap Stocks to Buy for Pandemic-Free Power

[Wednesday, May 27, 10:39 a.m.]
Contributed by Sarah Smith

We’ve fallen into quite the rhythm with the market. We get bad news — say, we find out there’s been a spike in novel coronavirus cases. As a result, stocks broadly drop. Then, we get good news — say, a vaccine company has entered a new trial or produced desirable results. Stocks shoot up en masse.

Sure, there are exceptions to this madness. Some companies completely avoided the market-wide selloff in March. Video conferencing plays and providers of personal protective equipment have made a fortune. But what are investors to do with the rest of the madness?

According to InvestorPlace analyst Louis Navellier, this conundrum is why cheap stocks are appealing. Small-cap companies, often without a ton of guaranteed revenue, move more on their own potential than with the broader market. In other words, their operations matter just as much — if not more — than their quarterly reports.

Boy, doesn’t that sound nice? Navellier’s recommendation is part of a big market promise. Buy a few shares for $3 or $4 each and then rake in massive returns, months or years down the line.

If you’re intrigued, here are his seven recommendations now:

  • Kadmon Holdings (NYSE:KDMN)
  • ImmunoGen (NASDAQ:IMGN)
  • Silvercorp Metals (NYSEMKT:SVM)
  • Plug Power (NASDAQ:PLUG)
  • Iamgold (NYSE:IAG)
  • United Microelectronics (NYSE:UMC)
  • Infinera (NASDAQ:INFN)


Stocks Open Higher Wednesday as Reopening Continues

[Wednesday, May 27, 9:31 a.m.]
Contributed by Sarah Smith

It seems like nothing can shake the rally this week. Stocks opened higher again on Wednesday despite President Donald Trump’s stirring of U.S.-China trade tensions. Perhaps helping keep the markets nice and green is a European bailout package and yesterday’s victory in travel stocks.

What will the rest of Wednesday bring? As Trump circles in on China, will we see a repeat of recent market panic? Or, will it be smooth sailing once again?

For now, the bulls are winning. The S&P 500Dow Jones Industrial Average and the Nasdaq Composite are all snug in the green.

  • The S&P 500 opened higher by 0.93%
  • The Dow Jones Industrial Average opened higher by 1.41%
  • The Nasdaq Composite opened lower by 0.17%

25 Stocks to Buy for a Major Wave of Reopening

[Tuesday, May 26, 4:25 p.m.]
Contributed by Sarah Smith

One thing we’ve covered in this blog is the power of reopening. Many consumers are itching to return to hair salons, retailers and restaurants after months of staying inside. InvestorPlace Markets Analyst Luke Lango has long been bullish on this “pent-up demand” catalyst.

A quick glance at social media this weekend should have confirmed this catalyst is real. Americans flocked to the beaches, many without face masks, and visited friends and family. Public health experts are quick to warn against this behavior, but it means money is flowing a little bit more freely.

Lango is confident that this pent-up demand is strong, and that it’s going to make another group of stocks victorious in 2020. He calls this the shift from “staying at home” to “getting out of the house.” With this in mind, he recommended 25 stocks to buy for this trend today.

Here’s a look at the first 10 names on his list:

  • McDonald’s (NYSE:MCD)
  • Starbucks (NASDAQ:SBUX)
  • Dine Brands (NYSE:DIN)
  • Darden (NYSE:DRI)
  • Dave & Buster’s (NASDAQ:PLAY)
  • Six Flags (NYSE:SIX)
  • SeaWorld (NYSE:SEAS)
  • Cedar Fair (NYSE:FUN)
  • Disney (NYSE:DIS)
  • Planet Fitness (NYSE:PLNT)


Stocks Close Higher Tuesday on Hints of ‘Normal’

[Tuesday, May 26, 4:01 p.m.]
Contributed by Sarah Smith

Dare I ask, is this the return to normal investors have been waiting for? The S&P 500 played the flirt, crossing the 3,000 level for the first time since March 5. Traders returned to the floor of the New York Stock Exchange after weeks of working from home. Plus, vaccine news kept stocks steady and offered hope to even the most beaten-down of sectors.

It was a good day in the stock market, to say the least. Novavax (NASDAQ:NVAX) and Merck (NYSE:MRK) made waves with their vaccine news, and travel stocks got a bit of a boost. Delta Air Lines (NYSE:DAL), American Airlines (NASDAQ:AAL) and United Airlines (NASDAQ:UAL) all closed higher by more than 10%.

As investors cling to this optimism, the S&P 500, Dow Jones Industrial Average and the Nasdaq Composite all closed in the green Tuesday.

  • The S&P 500 closed higher by 1.23%
  • The Dow Jones Industrial Average closed higher by 2.17%
  • The Nasdaq Composite closed higher by 0.17%

There’s Still Bullish Magic Behind Disney Stock

[Tuesday, May 26, 3:01 p.m.]
Contributed by Sarah Smith

Disney (NYSE:DIS) is a company with perhaps unrivaled brand loyalty. Consumers drop serious money to attend its  theme parks, and spend weeks obsessing over new releases from its Star Wars and Marvel franchises. Unfortunately, even Disney hasn’t been immune from the novel coronavirus.

That less-than-magical reality is why InvestorPlace analyst Matt McCall has been siding with the skeptics on DIS stock. Until theme parks, movie theaters and resort properties reopen at full capacity, it will be missing out on much-needed revenue. However, McCall sees a bull case for shares near $90.

Sure, that implies a steep drop from its current share price. But hear me out. McCall’s argument makes a lot of sense, especially as he recognizes the value in different catalysts for Disney. For example, he sees “problem child” ESPN becoming a winner in the new normal. Why? Who knows when live audiences will return to sporting events. With that in mind, expect ESPN to log record audiences.

A quick trip to ESPN’s website shows another reason to like it. According to writer Ramona Shelburne, Disney is considering hosting the NBA as it wraps up its season in late July. Its Orlando property would allow a return to game play while still limiting dangerous exposure to the virus.

This news makes McCall’s recommendation sound even more logical. He wrote that a recent NASCAR race drew 6.3 million virtual fans. Can you imagine what a virtual NBA season, hosted on Disney property, would look like?

Whether you support DIS stock at $90, or near its current price of $122, there’s a lot to like. The road to recovery won’t be perfect, but Mickey Mouse is set to steer the company through the tough times ahead.


Barron’s: 15 Stocks to Buy for Big Growth at Value Prices

[Tuesday, May 26, 2:16 p.m.
Contributed by Sarah Smith

To some investors, the novel coronavirus has likely made the split between growth stocks and value stocks feel silly. A lot of solid companies now have “value” prices, and pending rebounds make a lot of beaten-down companies look like “growth” stories.

But as Barron’s Nicholas Jasinski wrote today, there’s more for investors to consider. That’s why Barron’s pulled together 15 stocks that have value prices — with forward price-earnings ratios below 15. Stocks on this list also are expected to grow their earnings per share by 10% each year for the next half decade.

That’s a tall order, but it’s not impossible. Just like the story of “Goldilocks and the Three Bears,” it’s important to find the exact fit.

Here are 15 stocks to consider for investments that fit “just right”:

  • AbbVie (NYSE:ABBV)
  • Albemarle (NYSE:ALB)
  • Alexion Pharmaceuticals (NASDAQ:ALXN)
  • Applied Materials (NASDAQ:AMAT)
  • Ameriprise Financial (NYSE:AMP)
  • Anthem (NYSE:ANTM)
  • Broadcom (NASDAQ:AVGO)
  • Bristol-Myers Squibb (NYSE:BMY)
  • CBRE Group (NYSE:CBRE)
  • Cigna (NYSE:CI)
  • Centene (NYSE:CNC)
  • Cabot Oil & Gas (NYSE:COG)
  • Fifth Third Bancorp (NASDAQ:FITB)
  • Lam Research (NASDAQ:LRCX)
  • Universal Health Services (NYSE:UHS)


Affluent Customers Make Williams-Sonoma Stock a Buy

[Tuesday, May 26, 2:09 p.m.]
Contributed by Sarah Smith

The current angle on retail is grim. Brick-and-mortar shops were closed, and more than 38 million consumers now find themselves unemployed. Americans face mounting economic pressure, and anxiety is limiting their spending, particularly on non-essential items. One thing this narrative doesn’t include is a simple-but-important fact. Rich people are still shopping like rich people.

That’s why Telsey Advisory analyst Cristina Fernandez upgraded Williams-Sonoma (NYSE:WSM) stock to “outperform” from “market perform.” She also slapped an $80 price target on shares, which currently trade hands near $70.

In a note to clients, she wrote that there were three reasons Williams-Sonoma would benefit from the novel coronavirus (subscription required). According to the analyst, the company is already succeeding in increasing its online sales. Plus, its target demographic is affluent customers with over $100,000 in household income. This makes Williams-Sonoma’s home and kitchen products even more attractive to consumers now.

Sure, Williams-Sonoma sounds like an unlikely winner, but the numbers are there. Just as wealthier consumers are stocking up on at-home workout gear like Peloton (NASDAQ:PTON) bikes, it’s clear nice kitchen gear is at the top of many shopping lists.

Shares are up 4.1% in intraday trading on the upgrade. Keep a close eye on WSM and its luxury peers.


7 Travel Stocks to Buy as the World Returns to Normal

[Tuesday, May 26, 12:53 p.m.]
Contributed by Sarah Smith

Depending on where in the U.S. you live, beaches, lakes and public parks looked almost “normal” over the long weekend. Americans flocked to sunbathe as public health experts continue to warn of the dangers the novel coronavirus presents. For investors, consumers’ willingness to return the world of leisure bodes well for travel stocks.

There’s also data to back this up. Axios’ Dion Rabouin reported this morning that air travel demand is “significantly” rebounding. Transportation Security Administration data shows that as lockdowns continue to ease, more passengers are boarding flights.

Before the pandemic, roughly 2 million people were screened at airports each day. At the lows, less than 90,000 people were going through those checkpoints. But things are changing. As Rabouin writes, the TSA screened approximately 350,000 people on Friday, May 22.

There’s another catalyst helping travel stocks. On Monday, Novavax (NASDAQ:NVAX) announced it was ready to begin early trials of its coronavirus vaccine. That has NVAX shares up in intraday trading, but it’s also boosting airline and cruise stocks. Why? In theory, consumers will feel a whole lot safer about travel if they’ve received a vaccine.

Travel demand is surging, with or without a vaccine. With that in mind, travel stocks picked by InvestorPlace’s Will Ashworth are worth another look. He made these recommendations in late April, but he argued they were the top picks as consumers returned to the seas and sky.

Here are his seven recommendations:

  • Royal Caribbean (NYSE:RCL)
  • Southwest Air Lines (NYSE:LUV)
  • LVMH (OTCMKTS:LVMUY)
  • Estee Lauder (NYSE:EL)
  • Hilton Hotels (NYSE:HLT)
  • MGM Resorts International (NYSE:MGM)
  • Booking Holdings (NASDAQ:BKNG)


Novavax’s Vaccine Trial News Is Leading the Market Higher

[Tuesday, May 26, 11:29 a.m.]
Contributed by Sarah Smith

Once again, investors are rejoicing on news that an effective vaccine may be just around the corner. Novavax (NASDAQ:NVAX) announced yesterday that it was beginning early trials of its NVX‑CoV2373 vaccine for the novel coronavirus in Australia. Shares are up almost 14% in intraday trading.

There’s a lot to like here. Very early animal trials found that low doses of the vaccine worked. The human trials, which began today, should yield results by July. As Novavax ramps up production of the vaccine through funding from the Coalition for Epidemic Preparedness Innovations, the company could have 100 million doses ready in 2020 and 1.5 billion doses ready in 2021.

And, as a MarketWatch report noted, Novavax’s vaccine candidate is slightly different than others under investigation. It is a recombinant vaccine, which means that it targets a very specific part of the virus. According to the Department of Health and Human Services, these vaccines typically trigger a stronger immune response.

Based on Tuesday’s rally, investors like what they see. A vaccine means that even the hardest-hit sectors of the economy, like travel, become more viable. That’s why analysts on Wall Street have a strong buy consensus rating on shares. Today, B. Riley analyst Mayank Mamtani set the highest price target yet, putting shares at $53.


Merck Stock Climbs on New Plan to Fight the Coronavirus

[Tuesday, May 26, 11:02 a.m.]
Contributed by Sarah Smith

Merck (NYSE:MRK) came ready for its moment in the spotlight with a three-prong plan to fight the novel coronavirus. As Barron’s Josh Nathan-Kazis wrote, Merck was late to the race, as its big pharmaceutical peers rolled out vaccine and treatment collaborations. However, CEO Ken Frazier said Merck has just been waiting for the right moment, and a proven platform to build a vaccine on.

In a Tuesday press release, the company announced it is working on two vaccines and one antiviral treatment. One vaccine comes through its acquisition of Themis Bioscience, another through a partnership with IAVI. Lastly, Merck is partnering with Ridgeback Bio on an oral antiviral treatment.

According to Frazier, Merck has a lot going for it in this fight. The company has experience developing vaccines and other treatments for HIV and Ebola. Is Wall Street buying it?

MRK shares are up 1.9% in intraday trading, slightly less than the S&P 500. But Mizuho Securities analyst Mara Goldstein upped her price target on shares to $100 this morning. Shares currently trade hands for less than $78.

Merck is a solid company working on three solid solutions. As this race heats up, look for the company to become a true leader.


Stocks Open Higher Tuesday on Vaccine Optimism

[Tuesday, May 26, 9:31 a.m.]
Contributed by Sarah Smith

Boy, it looks like all investors needed was a long weekend to turn things around. The major indices are ready to start the week on the right foot, as the Dow Jones Industrial Average adds 600 points.

To be fair, there’s also a lot of vaccine optimism in the market. Merck (NYSE:MRK) and Novavax (NASDAQ:NVAX) both are making on progress on solutions for the novel coronavirus. Combined, that news is more than enough to counter the World Health Organization’s move to stop trials of hydroxychloroquine.

There’s a lot to like. The S&P 500 and the Nasdaq Composite are also starting Tuesday deep in the green.

  • The S&P 500 opened higher by 2.22%
  • The Dow Jones Industrial Average opened higher by 2.51%
  • The Nasdaq Composite opened higher by 1.86%

10 Stocks to Buy to Invest Like Oakmark’s Bill Nygren

[Friday, May 22, 3:31 p.m.]
Contributed by Sarah Smith

Hopefully we’ve established in this blog that in times of uncertainty, it helps to follow the experts. If nothing else, their pandemic stock picks are a source of inspiration. That’s why value investor Bill Nygren’s top 10 holdings are worth a close look.

Nygren is the manager of the Oakmark Fund (NASDAQ:OAKMX), and he hasn’t exactly had a great year so far. However, after selling American Airlines (NASDAQ:AAL) and picking up some stay-at-home stocks, his fund’s top holdings are a good playbook for the current market.

According to Nygren, it’s important not to get too caught up in the short term. That’s why he’s focusing on companies with strong balance sheets, lots of cash and pandemic-proof businesses. Apparently, that’s not too tall of an order.

Here’s a look at his top holdings now (subscription required):

  • Alphabet (NASDAQ:GOOG, NASDAQ:GOOGL)
  • Netflix (NASDAQ:NFLX)
  • Bank of America (NYSE:BAC)
  • Comcast (NASDAQ:CMCSA)
  • Citigroup (NYSE:C)
  • Facebook (NASDAQ:FB)
  • Charles Schwab (NYSE:SCHW)
  • State Street (NYSE:STT)
  • Capital One Financial (NYSE:COF)
  • TE Connectivity (NYSE:TEL)

2 Stocks to Buy as ‘Coronavirus Branding’ Gains Traction

[Friday, May 22, 2:47 p.m.]
Contributed by Sarah Smith

Early on in this pandemic, we saw how easily the novel coronavirus could destroy a company’s reputation. Cruise operators like Carnival (NYSE:CCL) and Royal Caribbean (NYSE:RCL) instantly became associated with the evils of the virus. Instead of luxurious pools and fruity cocktails, picture panicked passengers trapped in the middle of the ocean. It’s a public relations nightmare.

Granted, these companies are also facing no-cruise orders and major cash crunches. But the public relations element does matter. When ships start sailing again, Carnival and Royal Caribbean must convince consumers it’s safe to board.

That’s why, as Axios’ Felix Felix Salmon wrote, some hard-hit companies are turning to marketing to change their image. It’s a simple formula. Pick a disinfectant company, form a partnership with a research hospital and create a “safe” brand. If a business wants to survive in this new normal, it must convince consumers it’s safe to engage with its products and services.

So, what companies are doing this well? According to Salmon, United Airlines (NASDAQ:UAL) and Hilton (NYSE:HLT) are leading the pack. In this name-dropping exercise, United Airlines has United CleanPlus. It’s distributing Clorox (NYSE:CLX) products at its airports and working with the Cleveland Clinic to keep passengers safe. Hilton is following the exact same formula. The hotel chain is partnering with Reckitt Benckiser (OTCMKTS:RBGLY), the maker of Lysol. It’s also consulting with the Mayo Clinic to keep hotel travelers as safe as can be.

It’s a marketing scheme that likely makes your skin crawl, but it could be a winning strategy. We already knew that Clorox and Reckitt Benckiser were top buys, and their products are in high demand. The next logical move may just be to invest in companies that make reopening feel safer.

That’s exactly why Morgan Stanley’s Brian Pfeifler is bullish on traditional travel names now. Airbnb properties and other short-term rentals won’t feel as “safe” as regularly cleaned hotels with brand power and luxury status. I’ll take my complimentary Clorox wipes now, and recommend you do the same.


RBC: Rewards Outweigh the Risks With Boeing Stock

[Friday, May 22, 1:34 p.m.]
Contributed by Sarah Smith

Boeing (NYSE:BA) has been suffering for a long time. Last year, its 737 Max plane was behind two fatal accidents, and investigators keep digging up more flaws. Then, the novel coronavirus effectively wiped out air travel, and in turn wiped out Boeing’s business. Is it time to sell BA stock and move on?

Not so fast. RBC Capital analyst Michael Eisen made waves Thursday when he gave shares an “outperform” rating and a $164 price target. According to Eisen, the rewards with this investment outweigh the risks.

Boy did his client note make waves in the market. It’s been a long time since Wall Street showed Boeing any love, so shares were up 4% on the day. And Eisen really did show BA stock some love. He thinks the Federal Aviation Administration will give the 737 Max the green light in the third quarter, and predicted that passenger demand will see double-digit growth for several years, propelling shares higher.

It’s 57% year-to-date loss makes these optimism a little hard to believe, but InvestorPlace’s Will Ashworth agrees. He wrote last week that Boeing is one of the top stocks to buy if you’re betting on America. Why? Institutions — not to mention the U.S. federal government — are stepping up to support Boeing. At this point, it’s simply too big to fail.


Curbside Offerings Make Best Buy Stock a Winner Now

[Friday, May 22, 11:40 a.m.]
Contributed by Sarah Smith

Pardon the pun, but Best Buy (NYSE:BBY) stock may truly be one of the best equities to buy right now. Before the pandemic, the consumer electronics supplier was an icon of brick-and-mortar retail, and all of the struggles associated with it. A quick pivot to curbside sales changed everything. Now, analysts are calling Best Buy stock a “winner” and an “e-commerce play.”

Behind the noise is its May 21 earnings report, which unsurprisingly showed a drop in overall domestic revenue. But way more important is its domestic online revenue, which increased more than 155%. Why? In the middle of the fiscal first quarter, CEO Corie Barry pivoted the company to exclusively curbside operations. As Barry said, even without a single customer in its stores, the move helped preserve sales.

That’s why Retail Dive’s Ben Unglesbee wrote Thursday that Best Buy is set to emerge as a “winner.” The quick pivot, combined with consumers’ positive reaction to curbside sales, shows that it’s innovative. It doesn’t hurt that e-commerce giant Amazon (NASDAQ:AMZN) saw its delivery times increase. For many shoppers, curbside pick-up is just more convenient.

Plus, consumer electronics suddenly became hot-button items. Video game consoles were flying off the shelves in the first quarter as Americans found themselves bored at home. Work-from-home accessories like webcams are also in high demand.

Some will surely say that this is only a short-term, unsustainable rally. However, Wall Street doesn’t agree with that argument. Oppenheimer analyst Brian Nagel gave BBY stock a $105 price target, implying more than 30% upside. InvestorPlace’s Josh Enomoto also recently jumped on the Best Buy bandwagon, pointing out its market dominance in the consumer electronics and appliance segments.

If nothing else, Best Best stock is a feel-good buy. Start betting on this old-school retailer’s comeback story, because you don’t want to miss out.


3 Restaurant Stocks to Buy as Diners Return

[Friday, May 22, 10:46 a.m.]
Contributed by Sarah Smith

Restaurants are in a tricky position, but according to President Donald Trump, things could be changing. At a May 18 meeting with top industry executives, he said Moderna’s (NASDAQ:MRNA) early success, among other novel coronavirus breakthroughs, could get diners back in their seats soon.

With that in mind, InvestorPlace’s Tezcan Gecgil rounded up three top restaurant stocks. She’s confident, but she’s looking at at least a two-year timeframe for returns. In other words, these stocks present great opportunities, but you likely won’t see share prices double overnight.

Although the names on her list have struggled, she’s confident their size and brand power will help them persevere. Here’s what she’s recommending now:

  • Denny’s (NASDAQ:DENN)
  • McDonald’s (NYSE:MCD)
  • Starbucks (NASDAQ:SBUX)

Stocks Open Lower on U.S.-China Fears

[Friday, May 22, 9:49 a.m.]
Contributed by Jessica Loder

What a way to start the day before a long weekend.

The Nasdaq, S&P 500 and Dow  Jones were all in the red during the overnight hours, and the opening bell hasn’t changed that trend. It seems like a big part of the nerves comes from fear that the U.S. and China could start butting heads again. According to Yahoo Finance, Thursday saw “senators introducing a bipartisan bill that would sanction Chinese officials and organizations who enforce newly introduced security measures in Hong Kong. This came a day after the Senate passed a bill that would make it more difficult for Chinese companies to list on U.S. stock exchanges.”

That may explain why big-name Chinese companies like Alibaba (NYSE:BABA) and JD.com (NASDAQ:JD) both opening deep in the red on Friday.

Will we see a turnaround? Only the bulls can know that.

  • The S&P 500 is currently down by 0.39%
  • The Dow Jones Industrial Average is currently down by 0.47%
  • The Nasdaq Composite is currently down by 0.32%

Wedbush: Royal Caribbean Stock Is the Best Cruise Buy

[Thursday, May 21, 4:41 p.m.]
Contributed by Sarah Smith

It may not be time to board cruise ships yet, but according to Wedbush analyst James Hardiman, it’s time to start buying Royal Caribbean (NYSE:RCL) stock.

As InvestorPlace’s Bret Kenwell wrote in his daily column, Hardiman said Royal Caribbean was the strongest of its peers. From his note to clients:

“We would argue that RCL had the best momentum headed into the pandemic and see no reason this will not be the case coming out of the pandemic.”

The analyst gave RCL shares an “outperform” rating and a $63 price target. So what should investors make of all that? To start, the rest of Wall Street agrees. Shares are considered a “moderate buy” and have an average 12-month price target just over $60. That implies almost 40% upside.

Even InvestorPlace’s Mark Hake agrees. After writing that Royal Caribbean was approaching “failure,” Hake changed his mind. Now he writes investors should see the current price as a discounted opportunity to get in on a rebound story. Chances are, pent-up demand will get customers back on board sooner than we may think.


Stocks Close Lower Thursday After Morning Jobless Report

[Thursday, May 21, 4:01 p.m.]
Contributed by Sarah Smith

It looks like the bulls just couldn’t shake this morning’s doom and gloom. News that 2.4 million more Americans had filed for unemployment benefits temporarily shook the optimism from the market.

What else moved the market today? AstraZeneca (NYSE:AZN) received more than $1 billion of funding for its novel coronavirus vaccine. Plus, every state in the U.S. is moving forward with some part of a three-phase reopening plan. Will tomorrow bring a rally as we head into the long weekend?

For now, one thing is clear. The S&P 500Dow Jones Industrial Average and the Nasdaq Composite all closed the day in the red.

  • The S&P 500 closed lower by 0.78%
  • The Dow Jones Industrial Average closed lower by 0.41%
  • The Nasdaq Composite closed lower by 0.97%

Don’t Miss Out on 2 New ‘Accelerated Income Generators’

[Thursday, May 21, 3:31 p.m.]
Contributed by Andrew Taylor

Last night, investing legend Louis Navellier revealed his Accelerated Income Project for the very first time…

And it was incredible.

He showed folks how he uses his advanced, high-speed computer system to target the safest, most-lucrative income opportunities on the market.

One of the past investments it found produced a payout yield of 209% in seven months…

Another generated 88% in four months…

And a third produced 169% in just over a year.

Those are just three of dozens of examples.

And the curious thing is these gains didn’t come from options, bonds, dividends or any of the other traditional investments folks think of when it comes to earning income.

They came from a special type of investment Louis calls “accelerated income generators…”

Which can hand you an incredible amount of hold-in-your-hand cash in no time.

And as Louis was doing research for his new income project, he found a way to target them left and right…

In fact, he just targeted two more not too long ago…

And in a few hours he’ll officially add them to his Accelerated Income Project “buy list.”

You can learn how to access Louis’ two brand-new recommendations — and all of his new income research — by going here.


JD.com Stock Is a True E-Commerce Winner

[Thursday, May 21, 1:40 p.m.]
Contributed by Sarah Smith

It’s true that many e-commerce companies are winning in the face of the novel coronavirus, but perhaps none is as strong as JD.com (NASDAQ:JD). The Chinese company quickly adapted as the outbreak hit its home country, and has now emerged victorious.

According to Supply Chain Dive’s Emma Cosgrove, JD.com’s operating costs hit an all-time low this quarter. In other words, high demand and cost-cutting measures combined to fight added operating costs from the pandemic. American rival Amazon (NASDAQ:AMZN) faces a different reality as it anticipates dedicating its entire Q2 operating profit to cover new delivery expenses.

So what is working for JD? According to the company, in-house logistics and innovations like delivery drones helped it in its early fight against the coronavirus. Plus, the e-commerce giant’s new grocery offering sourced local produce, countering supply-chain disruptions at larger food suppliers.

Shares are up almost 50% year-to-date, and analysts keep sending JD stock love in the form of buy ratingsInvestorPlace Markets Analyst Luke Lango even said it was one the top 15 stocks to buy in 2020. Why? He thinks the company is well-equipped to navigate any logistics challenges and will benefit from the growing popularity of e-commerce in China.

JD.com is doing something right, and it’s paying off. Look for operating costs to keep falling, especially as pandemic-driven expenses disappear. JD stock is an excellent investment for an e-commerce future.


7 Stocks to Buy Now With Strong Balance Sheets

[Thursday, May 21, 1:05 p.m.]
Contributed by Sarah Smith

It’s a nerve-wracking time to be an investor. On one hand, billionaires like Warren Buffett and David Tepper aren’t buying up stocks. The unemployment figures keeps climbing — now it’s above 38 million. Plus, even big companies are facing a cash crunch as the novel coronavirus weighs on their operations.

On the other hand, vaccine developers like Moderna (NASDAQ:MRNA) have the potential to send the Dow Jones Industrial Average higher by 3% in a day. Some solid companies now have more reasonable share prices and make great buy-the-dip candidates. How is an investor supposed to balance all of the chaos and make decisions?

InvestorPlace’s Will Ashworth has a great solution. Don’t run from the markets and cash out, but also focus your money on companies with strong balance sheets. These companies have the cash to weather even a prolonged downturn, but you’ll still benefit from rebound action.

Here are seven stocks he’s recommending now:

  • Visa (NYSE:V)
  • Nike (NYSE:NKE)
  • Johnson & Johnson (NYSE:JNJ)
  • Microsoft (NASDAQ:MSFT)
  • Apple (NASDAQ:AAPL)
  • McDonald’s (NYSE:MCD)
  • Coca-Cola (NYSE:KO)


AstraZeneca Stock Climbs After Receiving Vaccine Funding

[Thursday, May 21, 11:39 a.m.]
Contributed by Sarah Smith

Another day, another vaccine developer making big moves in the market. After Moderna (NASDAQ:MRNA) and Inovio Pharmaceuticals (NASDAQ:INO) got some time in the spotlight this week, it’s AstraZeneca’s (NYSE:AZN) turn. Shares are are up a modest 2.9% in intraday trading.

In an early morning press release AstraZeneca shared it had received $1 billion from the Biomedical Advanced Research and Development Authority. This funding comes as part of President Donald Trump’s Operation Warp Speed designed to ramp up production and distribution of vaccines for the novel coronavirus.

According to the Trump administration, the private-public partnership will combine AZN’s vaccine success with the U.S. government’s ability to scale manufacturing. This deal should ultimately make 30 million doses of the vaccine available by September.

Additionally, AstraZeneca said today that in partnership with the University of Oxford, it will still have 400 million doses ready at some point in the fall. Through its work with university researchers, it also nabbed $79 million from the United Kingdom’s government.

Will this private-public partnership be the model for vaccine development moving forward? It sounds like a win for investors, as it brings confidence that Americans will be first in line to receive vaccines. Now all we need is for a vaccine to work.


2 Restaurant Stocks to Buy as Grocery Prices Rise

[Thursday, May 21, 11:17 a.m.]
Contributed by Sarah Smith

One of the big themes of 2020 so far is that restaurant stocks are out, and grocery store stocks are in. However, that trend may be about to reverse as grocery prices rise. According to CNBC’s Thomas Franck, meat and eggs led prices higher by 2.6% in April. That’s the biggest one-month jump since 1974.

More Americans are cooking meals at home, and panic over the novel coronavirus hasn’t subsided. That means plenty of shoppers are still focused on “stocking up” and demand for key groceries is high. At the same time, we’ve previously reported in this blog on a host of supply-chain issues. Together, these catalysts are combing to raise prices at a very inopportune time.

For Wedbush analyst Nick Setyan, this inflation is a good sign things are turning around for restaurants. The analyst believes that while delivery and pick-up options have somewhat helped restaurants, they aren’t making up for dine-in demand. If groceries become less accessible, that will change.

That’s why, as Barron’s Teresa Rivas writes, Setyan is bullish on two particular restaurant stocks. He likes Jack in the Box (NASDAQ:JACK) and Texas Roadhouse (NASDAQ:TXRH). According to Setyan, JACK stock will benefit from the chain’s popularity among burger lovers. And because Texas Roadhouse is seen as a “value’ restaurant, TXRH stock should also get a nice boost.

Setyan gave each stock an “outperform” rating. He has a 12-month price target of $80 on JACK and $73 on TXRH. If anything, it’s a great way for investors to profit from an otherwise gloomy reality.


10 Stocks to Buy to Invest Like Hedge Fund Pros

[Thursday, May 21, 10:28 a.m.]
Contributed by Sarah Smith

Are you hungry for a hot dog? I sure am, especially as the weather heats up. It turns out, hedge funds are also hungry for hot dogs, but not the BBQ treat.

In the hedge fund world, hot dogs are top-owned stocks outperforming the S&P 500. Right now, these standout names matter even more, because hedge funds are known for riding out volatility better than most individual investors.

So why should individual investors care? It’s true that hedge funds aren’t particularly accessible. Individuals must be “accredited” — in other words, they must be worth a lot of money — to participate. Well, a recent survey of 342 hedge funds just shed some light on their favorite stocks. As the novel coronavirus disrupts the market, following in the footsteps of these volatility pros isn’t a bad idea.

Here is a list of the 10 top-owned stocks now (subscription required):

  • Amazon (NASDAQ:AMZN)
  • Microsoft (NASDAQ:MSFT)
  • Allergan (NYSE:AGN)
  • Facebook (NASDAQ:FB)
  • Alphabet (NASDAQ:GOOG, NASDAQ:GOOGL)
  • Netflix (NASDAQ:NFLX)
  • Fidelity National Information Services (NYSE:FIS)
  • Apple (NASDAQ:AAPL)
  • Visa (NYSE:V)
  • Charter Communications (NASDAQ:CHTR)


Stocks Sink Thursday as the Jobless Total Climbs

[Thursday, May 21, 9:31 a.m.]
Contributed by Sarah Smith

We’ve seen this before, but it still hurts. Investors learned this morning that another 2.4 million Americans filed for unemployment benefits. That means over 38 million people lost their jobs as a result of the novel coronavirus. It’s jarring to say the least.

Let’s digest this a bit more. Stock futures headed into the red on the news, despite the fact jobless claims are declining. That’s likely because as states reopen, investors were hoping for an even smaller figure today.

Unfortunately, that wasn’t the case. The S&P 500Dow Jones Industrial Average and the Nasdaq Composite all opened lower this morning.

  • The S&P 500 opened lower by 0.07%
  • The Dow Jones Industrial Average opened lower by 0.12%
  • The Nasdaq Composite opened lower by 0.02%

Is It Time to Buy Penn National Stock as Casinos Reopen?

[Wednesday, May 20, 4:34 p.m.]
Contributed by Sarah Smith

Penn National Gaming (NASDAQ:PENN) made some investors happy on Wednesday. Shares of the popular stock closed higher by almost 13% on news it was reopening casinos in Mississippi. As we’ve previously reported in this blog, PENN and its gambling peers have been high-flying equities as investors bet on a big recovery for the industry.

InvestorPlace’s Bret Kenwell included Penn National as one of the top movers in the stock market today. As Kenwell wrote, it got approval to reopen 10 casinos. Five locations in Louisiana reopened on Monday, and 5 in Mississippi will reopen tomorrow. It’s not a lot, but any return to normal is worthy of praise.

With that in mind, many InvestorPlace contributors are bullish on the name. Nicolas Chahine wrote that the rally can take shares 35% higher. Laura Hoy wrote that while there’s risk in the space, Penn National is the best play.

There’s one more thing to note. JPMorgan analyst Joseph Greff just reiterated his “buy” rating on PENN stock today. Although his 12-month price target of $28 doesn’t imply much upside, it’s still nice to know Wall Street is rooting for the company too.


Stocks Close Higher Wednesday, Reversing Earlier Losses

[Wednesday, May 20, 4:01 p.m.]
Contributed by Sarah Smith

Wow, bulls are clearly the winners on Wednesday. It seems like after Moderna (NASDAQ:MRNA) betrayed investors’ trust on Tuesday, confidence and optimism are back in the market.

So, what happened on Wednesday? Inovio Pharmaceuticals (NASDAQ:INO) released its own vaccine news, the Federal Reserve warned of long-lasting impacts to the economy and Amazon (NASDAQ:AMZN) and Facebook (NASDAQ:FB) hit new highs.

There’s a lot to rally behind, but there are still lurking threats from the novel coronavirus. The World Health Organization reported that new cases jumped a record amount across the world in the last 24 hours.

The major indices are ignoring that for now at least, as the S&P 500Dow Jones Industrial Average and the Nasdaq Composite all closed in the green.

  • The S&P 500 closed higher by 1.67%
  • The Dow Jones Industrial Average closed higher by 1.52%
  • The Nasdaq Composite closed higher by 2.08%

Plug Into Coronavirus Potential With Spotify Stock

[Wednesday, May 20, 3:35 p.m.]
Contributed by Sarah Smith

Spotify (NYSE:SPOT) is another unlikely winner in our new world. At the start of state-wide lockdowns, many experts predicted shares would tumble. That’s because many streamers use commute and gym to listen to music and podcasts. Instead, Spotify actually saw user growth. More consumers started plugging in while lounging around the house, and especially while cooking.

Some, like InvestorPlace Markets Analyst Luke Lango, doubt Spotify stock’s potential. Lango wrote last week that any reason for a rally has come and gone. News today may change that.

Joe Rogan is famous in the podcast world. His Joe Rogan Experience is popular on Apple (NASDAQ:AAPL) and Alphabet’s (NASDAQ:GOOG, NASDAQ:GOOGL) streaming platforms. Now, Spotify gets the exclusive rights.

Each month, there are approximately 190 million downloads of the Joe Rogan Experience. And according to the Wall Street Journal, this deal values it at $100 million.

This is a big win for Spotify, and it now has even more solid footing in the fight against Apple and YouTube. But according to the team at Morning Brew, there’s even more to like between the lines. Part of the rights deal includes video — something new to the Spotify podcast world. Apparently, consumers are shifting to video streaming over audio streaming in lockdown, and Spotify wants to embrace that.

When the Joe Rogan Experience debuts on Spotify in September, the full video podcasts will be available. As Spotify strengthens its lead in this popular media niche, especially as it lines up with pandemic behavior shifts, expect it to be a long-term winner.


Barclays: 8 Stocks to Buy for the Next Pandemic Rebound

[Wednesday, May 20, 2:38 p.m.]
Contributed by Sarah Smith

Stocks tumbled hard, and then some names seriously rebounded. Investors who missed out on those early quarantine rallies in companies like Amazon (NASDAQ:AMZN) and Activision Blizzard (NASDAQ:ATVI) are probably kicking themselves.

But, Barclays analysts think there’s reason to be optimistic. Investors piled into e-commerce and video game companies, but some hard-hit sectors still haven’t felt any love. Getting in now will create ample room to profit.

As reopening plans progress, Barclays believes ride-hailing names, travel companies and digital advertising plays are likely to rebound the most (subscription required).

With that in mind, they’re recommending eight stocks now for bold investors. Here’s the list:

  • Uber (NYSE:UBER)
  • Lyft (NASDAQ:LYFT)
  • Booking Holdings (NASDAQ:BKNG)
  • Expedia (NASDAQ:EXPE)
  • TripAdvisor (NASDAQ:TRIP)
  • Facebook (NASDAQ:FB)
  • Alphabet (NASDAQ:GOOG, NASDAQ:GOOGL)
  • Snap (NYSE:SNAP)


Is Penny Stock Phunware Set to Be a Coronavirus Winner?

[Wednesday, May 20, 2:09 p.m.]
Contributed by Sarah Smith

I’ll start with the basics here. Phunware (NASDAQ:PHUN) is a tiny company that specializes in fully integrated software. Right now, its mobile-first solutions for healthcare businesses are driving a lot of investor attention. After announcing a partnership with Hewlett Packard Enterprise (NYSE:HPE) today, shares are up 195%.

Granted, shares are up 195% and still trade at $1.97. HPE has a healthcare unit, and now that unit will have access to Phunware’s full suite of pandemic offerings. As a “full-stack” company, Phunware’s software helps with customer engagement, management and monetization.

So what exactly are these pandemic offerings? It can send mobile messages en masse, alerting patients of novel coronavirus test sites, appointment options and nearby confirmed cases. Phunware also promises to facilitate virtual visits, provide a patient portal and manage prescription refills. It truly manages the whole mobile medical experience.

For investors, it looks like the small company’s top-notch portfolio and the weight of its new partner are driving the excitement. Phunware’s penny-stock status is definitely reason for concern, but if it continues to expand its reach with relevant products, it could be a big winner.


Hungry for Some Profit? Buy Blue Apron Stock Now.

[Wednesday, May 20, 1:43 p.m.]
Contributed by Sarah Smith

Let’s take stock of the food situation real quick. You can brave a grocery store, or if you’re lucky, get in an order with a delivery service like Instacart. You can order delivery and pick-up from several restaurants, and companies like Grubhub (NYSE:GRUB) facilitate that process.

As a consumer, thinking outside of the box opens your lockdown-approved food options. As an investor, these options represent major potential. No, I’m not talking about eating with mannequins at reopened restaurants. I’m talking about meal delivery companies like Blue Apron (NYSE:APRN).

Blue Apron has received a lot of criticism since its IPO. Sure, the idea sounded promising, but the demand just wasn’t there. Consumers signed up for meal kits and then canceled subscriptions. But now that grocery shopping is considered dangerous and eating out is limited, Blue Apron is a winner.

According to The New York Times’ David Gelles, Blue Apron is seeing meaningful improvements. CEO Linda Kozlowski said the company saw a 27% increase in demand in early April. New customers came rushing for meal kits, and old customers returned or increased their plans.

Kozlowski’s comments highlighted two other key details. At the start of the lockdowns, Blue Apron actually cut advertising spending, and still saw a flock of new customers. To me, that’s proof it’s a household name, even if households weren’t all ordering before. Additionally, as it sources ingredients from smaller companies, Kozlowski maintains that supply-chain impacts have been minimal.

Is it time to buy a stock that once was a joke on Wall Street? InvestorPlace Markets Analyst Luke Lango thinks so. He wrote in early May that while Blue Apron will certainly see some churn, many of its new customers will stick around. The long-term impacts of the pandemic are so unknown that a meal kit may be the comfort households need.

One more thing to note. Privately held Thrive Market is another winner in this meal-kit revolution. The company specializes in healthy foods and eco-friendly cleaning products. Although the timeline is unclear, CEO Nick Green is prepping the company for an IPO.


7 Stocks to Buy for a Contact-Tracing Future

[Wednesday, May 20, 12:57 p.m.]
Contributed by Sarah Smith

In February, many Americans likely had never heard of social distancing. Now, that phrase, and the guidelines associated with it, dominates our collective vocabulary. Is “contact tracing” set to do the same? If so, investors ought to get in now to profit.

According to the Centers for Disease Control and Prevention, contact tracing is a key part of the path toward recovery from the novel coronavirus. If an individual tests positive, healthcare workers will identify all other individuals they were in contact with. From there, those individuals are informed of the situation and given preventive steps. Some — if not all — would be called in for testing.

In theory, all contact tracing requires is a little bit of old-fashioned sleuthing. Patients must be honest, and then healthcare workers can dig through the rest. But many that have Big Tech leanings are proposing a different solution.

Countries like South Korea and Singapore used tech to digitally track and map all confirmed cases. Some in the U.S. want to do the same, and Big Tech is stepping up with the offerings. Right now, concerns around privacy are dominating the conversation. Regardless, you don’t want to miss out.

InvestorPlace’s Chris Markoch pushed through the controversy and rounded up the top seven stocks involved in contact tracing. These make solid buys in an area of public health innovation. Here’s his list:

  • Apple (NASDAQ:AAPL)
  • Alphabet (NASDAQ:GOOG, NASDAQ:GOOGL)
  • Alibaba (NYSE:BABA)
  • Tencent Holdings (OTCMKTS:TCEHY)
  • SAP SE (NYSE:SAP)
  • Deutsche Telekom (OTCMKTS:DTEGY)
  • Conduent (NASDAQ:CNDT)


Inovio Pharmaceuticals Stock Climbs on Early Vaccine Win

[Wednesday, May 20, 12:27 p.m.]
Contributed by Sarah Smith

Just two days after Moderna (NASDAQ:MRNA) moved the market with a novel coronavirus vaccine update, Inovio Pharmaceuticals (NASDAQ:INO) is looking to do the same. An early morning press release has shares up about 9% in intraday trading. It’s not as big as some of the recent swings we’ve seen, but perhaps investors are wary after scientists questioned the veracity of Moderna’s report yesterday.

According to the release, Inovio has published its preclinical findings in a peer-reviewed journal, Nature Communications. This data shows that its INO-4800 vaccine successfully generated antibodies for the coronavirus in mice and guinea pigs, its animal test group.

So, what are the next steps? Reuters’ Deena Beasley wrote this morning that Inovio began Phase 1 human trials in April. This early round of study is designed to show whether a vaccine is safe, and whether it can trigger an immune response. Inovio anticipates releasing data from that study in June.

From there, Inovio is targeting Phase 2 and 3 trial start dates in July or August. The company has been a leader in the fight against the coronavirus, but as InvestorPlace’ s Mark Hake wrote this morning, it lacks the manufacturing power of its larger rivals. Plus, it is choosing to pursue an innovative-but-challenging approach to vaccine design.

Regardless of the challenges, InvestorPlace analyst Louis Navellier is bullish on INO stock. He wrote yesterday that investors should add it to their high-growth biotech holdings, and that its potential goes way beyond the coronavirus.

Keep a close eye on the stock. Its June report is likely to move the market, in one direction or another, and good vaccine news would mean great things for shareholders.


5 Telemedicine Stocks to Buy as This Megatrend Ramps Up

[Wednesday, May 20, 11:35 a.m.]
Contributed by Sarah Smith

There are many reasons that the adoption of telemedicine has so quickly accelerated. It’s simply convenient, taking out the time and hassle associated with doctor’s appointments. And as the novel coronavirus has made clear, it’s a whole lot safer.

Many non-essential practices closed offices, rushing to adopt new telemedicine solutions. Plus, Americans were encouraged to consider virtual appointments even when offices were open to be considerate to fellow patients and doctors.

InvestorPlace analyst Matt McCall has long been bullish on telemedicine and other similar tech “megatrends.” He’s been recommending industry leader Teladoc (NYSE:DOC) for more than two years. Now, he’s also highlighting Apple (NASDAQ:AAPL) and Alibaba (NYSE:BABA), as the two tech giants move into telemedicine and other healthcare offerings.

It’s fair to ask if this trend will slow down once more offices reopen and pandemic fears subside. But, McCall doesn’t think so. As he wrote this week, the pandemic kicked telemedicine into “overdrive.”

Before the coronavirus massively disrupted healthcare, many consumers likely associated telemedicine with simple appointments. Perhaps they thought it was an option for the common cold or a quick prescription refill — not a real substitute for in-person appointments.

Now, The New York Times describes how patients are receiving virtual physical therapy and routine care for chronic health conditions. Others are turning to telemedicine platforms for abortion and cancer care. In just a few short weeks, telemedicine has stepped up as a pretty good mirror for in-person offerings.

Sure, doctors still need physical appointments for many conditions, and we’re definitely not headed to a telemedicine-only world. But the convenience and capability of telemedicine is now burned in consumers’ minds, and doctors are embracing the tech like never before. That certainly sounds like “overdrive” to me.

InvestorPlace’s Ian Cooper has two more standout telemedicine plays. He recently recommended CVS Health (NYSE:CVS) and Anthem (NYSE:ANTM), as the two traditional companies embrace virtual offerings — and bring brand recognition to the online space.


Buy Verizon Stock for its Attractive BlueJeans Acquisition

[Wednesday, May 20, 11:00 a.m.]
Contributed by Sarah Smith

Verizon (NYSE:VZ) just fast-tracked its acquisition of BlueJeans, and its future is looking bright. No, it didn’t just get a well-fitting pair of jeans. For less than $500 million it snapped up the smaller video conferencing company, hoping to add to its own offerings.

VZ announced the deal in mid-April, as video conferencing picked up a loyal following. BlueJeans is a business-to-business video conferencing provider, and it’s certainly smaller than rival Zoom Video (NASDAQ:ZM). One plus is that’s enterprise-focused, as opposed to Zoom that has welcomed schools, companies and bored individuals alike. That should translate to more paying customers.

In a quick turnaround, Verizon announced that the deal closed Monday, and investors should be paying attention. Not only is video conferencing hot right now, the BlueJeans deal makes VZ attractive for the long term. Its clients are often in the telemedicine or online learning worlds.

Plus, Verizon is a leader in the growing 5G trend. The novel coronavirus is certainly going to disrupt work, healthcare and education for the foreseeable future, and it could have a permanent impact. With that in mind, Verizon’s tech offerings just got a lot more attractive.

Need more convincing? InvestorPlace’s Josh Enomoto wrote that Verizon stock is one of the top so-called coronavirus stocks to buy now. Wireless services, and the rest of Verizon’s tech, are becoming even more important in our new world.


2 Digital Advertising Stocks to Buy for a Virtual Election

[Wednesday, May 20, 10:31 a.m.]
Contributed by Sarah Smith

It’s hard to think about the upcoming presidential election when so much of day-to-day life is still driven by the novel coronavirus. But, as we remain at home, President Donald Trump and former Vice President Joe Biden are going head to head. For two digital advertising stars, this could been a big revenue boost.

As we’ve previously reported in this blog, it’s a tough time to be in the digital ad business. Big clients — like those in the travel and leisure world — are pulling way back on spending. For Facebook (NASDAQ:FB) and Alphabet (NASDAQ:GOOG, NASDAQ:GOOGL), a virtual campaign trail could help fill that revenue gap.

Initial projects called for campaign spending to hit $6 billion, but according to Axios’ Sara Fischer, that figure will be closer to $6.7 billion. At least $2 billion will go exclusively to online video campaigns. Without the usual in-person events that mark a ramping up of campaigning, these online ads will become increasingly important in determining November’s outcome.

Facebook and Alphabet are the biggest names in the digital advertising space, and Fischer writes that they will see most of the inflow. On Monday, InvestorPlace’s Bret Kenwell wrote that FB stock is a buy on the next dip. Although advertising is under pressure, it’s not “falling apart.”

We’re living in a world of mail-in ballots and social media advertising. Don’t miss out on big companies leading that world.


Stocks Open Higher Wednesday as Moderna Slumps

[Wednesday, May 20, 9:31 a.m.]
Contributed by Sarah Smith

Investors haven’t forgiven Moderna (NASDAQ:MRNA) on Wednesday, but stocks are still opening in the green. With a report still clouding its early results, the vaccine maker opened down after dropping 10% in Tuesday trading.

However, another vaccine maker is bringing hope to Wall Street today. Inovio Pharmaceuticals (NASDAQ:INO) reported that its vaccine candidate produced antibodies for the novel coronavirus in guinea pigs and mice. Sure, it’s not humans, but it’s still an exciting step. Shares of INO were up almost 15% in pre-market trading.

Will Inovio’s victory be enough to sustain a rally in the stock market today? Let’s wait and see. Until then, the S&P 500Dow Jones Industrial Average and the S&P 500 are all ready for success.

  • The S&P 500 opened higher by 1.27%
  • The Dow Jones Industrial Average opened higher by 1.25%
  • The Nasdaq Composite opened higher by 1.35%

Big Tech Turns Up the Heat With Big Retail Deals

[Tuesday, May 19, 4:43 p.m.]
Contributed by Sarah Smith

Oh, the retail apocalypse. Brick-and-mortar retailers continue to dig their own graves, especially as the novel coronavirus weighs on shopping. On Tuesday, it looks like Pier 1 (OTCMKTS:PIRRQ) will become the next big name filing for bankruptcy — and potentially, liquidation.

But as InvestorPlace’s Bret Kenwell wrote in his daily column, Big Tech is upping the stakes in retail. Facebook (NASDAQ:FB) announced a new Shops feature that will allow businesses to set up “storefronts” on Facebook and Instagram. Kenwell said eventually, Facebook will allow product sales through Messenger, Instagram Direct and WhatsApp.

Elsewhere in the tech world rumors are swirling that Amazon (NASDAQ:AMZN) is looking to acquire J.C. Penney (NYSE:JCP). The latter just filed for bankruptcy, and Amazon sees the deal as a way to beef up its e-commerce apparel offerings. Oh, the irony. Amazon killed the department stores, and now is seeking to acquire them.

InvestorPlace analyst Eric Fry wrote today that it’s important to get on the right side of the technochasm, the tech-fueled split between the “haves” and the “have nots.” It’s clear companies like Amazon and Facebook have what it takes to profit. Dying retailers like Pier 1 and J.C. Penney do not.

Investors agree. FB shares were up 1.7% in the stock market today, while AMZN shares added about 1%.


Stocks Slip Tuesday on Moderna Vaccine Concerns

[Tuesday, May 19, 4:01 p.m.]
Contributed by Sarah Smith

Yesterday, Moderna (NASDAQ:MRNA) took the entire stock market higher when it announced its early trials showed promising results. On Tuesday, doubts over the company’s report took stocks down.

According to reporting from Stat News’ Helen Branswell, several scientists are questioning Moderna’s report, claiming it didn’t provide enough context. Other experts that Branswell spoke with said it was odd the National Institute for Allergy and Infectious Diseases did not comment on the findings. Plus, Moderna does not have a history of publishing its findings in peer-reviewed journals.

Even tech stocks couldn’t hold up as that report shoved away yesterday’s optimism. The S&P 500Dow Jones Industrial Average and the Nasdaq Composite all closed Tuesday in the red.

  • The S&P 500 closed lower by 1.05%
  • The Dow Jones Industrial Average closed lower by 1.59%
  • The Nasdaq Composite closed lower by 0.54%

Is the Vroom IPO a Way to Play Coronavirus Car Trends?

[Tuesday, May 19, 3:31 p.m.]
Contributed by Sarah Smith

Yesterday, online car marketplace Vroom filed for a listing on the Nasdaq Exchange under the ticker VRM. It’s surprising to see a company push forward with initial public offering plans, especially as many have opted for delays amid the novel coronavirus.

Critics, or perhaps simply realists, have pointed out that Vroom is not profitable. It also hasn’t been immune to the pandemic, as car sales dropped and the company furloughed one-third of its employees. As Axios’ Kia Kokalitcheva writes, demand has returned to pre-crisis levels, but sales now come with lower profits for Vroom.

Perhaps what’s most interesting is the coronavirus-driven market potential. As we reported yesterday, there’s reason to believe that consumers will opt to purchase cars instead of taking public transportation. With that in mind, traditional automakers like General Motors (NYSE:GM) and Ford (NYSE:F) saw a rally on Monday.

There’s another angle to Vroom that could be a big post-IPO catalyst. Car buyers simply find the car they want on Vroom’s website, supply necessary paperwork and complete financing through partner banks. Then, Vroom delivers the car to the buyer — no face-to-face contact necessary — and gives a seven-day test drive window. Will this contactless shopping truly be the future for car sales?

If you’re not ready to rally behind an IPO stock, InvestorPlace analyst Louis Navellier has a better option for you. Just this morning he recommended Carvana (NYSE:CVNA), for very similar reasons. He wrote that in a post-pandemic world, he expects shoppers to use Carvana for its contactless buying experience. Whether it be Vroom or Carvana, you don’t want to miss out.


5 Sin Stocks to Buy Now for Post-Pandemic Partying

[Tuesday, May 19, 3:03 p.m.]
Contributed by Sarah Smith

In many ways, the novel coronavirus is making Americans more socially responsible. Consumers are choosing to prepare more of their own meals, using allotted time outdoors to exercise and washing their hands — a lot. But InvestorPlace’s Thomas Niel is convinced that once lockdowns ease, many will take the opportunity to party.

As Niel writes, it’s been surprisingly hard to “sin” in quarantine. Alcohol stocks are hurt by the decline in on-premise sales, although it’s now easier than ever to get beer, wine and liquor delivered straight to your door. Some fear drops in cannabis demand are on the way as consumers move away from non-essential purchases. Oh, and it’s hard to spend money at a casino when all of the casinos are closed.

What’s beautiful to investors in this world of vice is that while consumers are on lockdown, they’re building up demand. When things reopen, that pent-up demand will turn into big spending. That’s why Niel is betting on a big rebound — and a bigger party for shareholders.

Here are the five sin stocks he’s recommending now:

  • Altria Group (NYSE:MO)
  • Constellation Brands (NYSE:STZ)
  • Diageo (NYSE:DEO)
  • MGM Resorts (NYSE:MGM)
  • Molson Coors (NYSE:TAP)


Dynavax Stock Soars as Investors Await Vaccine Update

[Tuesday, May 19, 2:32 p.m.]
Contributed by Sarah Smith

Dynavax Technologies (NASDAQ:DVAX), a small biopharmaceutical company, is soaring Tuesday. Shares shot up over 40% at one point in after-hours trading, and are hovering at 20% gains right now. So what exactly is driving this rally?

The company specializes in vaccines, and has entered the race to develop a candidate for the novel coronavirus. But, Dynavax isn’t working alone. Since early March, it has announced partnerships with the University of Queensland, the Coalition for Epidemic Preparedness InnovationsValnevaSinovac Biotech and Clover Biopharmaceuticals.

These companies bring their own skills and technology, and Dynavax offers its adjuvant, which it uses in a hepatitis B vaccine. Such an adjuvant should increase the effectiveness of the vaccine.

Through CEPI, Dynavax has even offered its adjuvant to any other companies that could improve their candidates. DVAX stock is up almost 80% in the last month.

Yesterday, the company really got investors excited. In a filing with the U.S. Securities and Exchange Commissions, it said it plans to provide an update on these partnerships today. Dynavax said in this filing it anticipates at least one of its partners will move into a Phase 1 vaccine trial by July.

Keep a close eye on the news, and the company’s investor relations page. Any update on its partnerships could mean big gains both today and in the long term.


Buy ShiftPixy Stock as U.S. Restaurants Reopen

[Tuesday, May 19, 1:44 p.m.]
Contributed by Sarah Smith

Restaurants around the country are struggling as dine-in options remain very limited, if not completely prohibited. Demand for take-out and delivery services is there, but consumers are eating more at home and spending less on non-essential items. As a result, at least 8 million restaurant workers in the United States have been laid off or furloughed.

But what happens when restaurants reopen? Do the employees all come rushing back? Those questions have largely been left out of the conversation. That is, until today. ShiftPixy (NASDAQ:PIXY), a gig employment platform, is climbing 90% in intraday trading because its solutions aim to answer those questions.

The small-cap company just entered a new partnership with an operator of Del Taco (NASDAQ:TACO) restaurants in New Mexico. Those locations will now use ShiftPixy’s solutions to “combat” the novel coronavirus’ impact on the restaurant industry.

One solution allows native delivery. Although services like Grubhub (NYSE:GRUB) and DoorDash help keep the lights on, their steep commissions seriously hurt restaurants. With ShiftPixy, restaurants can more easily manage their own in-house delivery, to save money on commissions and create better relationships with consumers.

Another solution helps restaurants get their workers back once they reopen, and also helps part-time restaurant workers find shifts. Known as a human capital management tool, ShiftPixy is working to better organize gig employees as restaurants around the country fight through the chaos.

It’s clear investors like the potential here, especially as the solutions address a very real problem. Keep a close eye on PIXY stock. If the company keeps picking up customers, good things are surely in store.


10 Stocks to Buy to Invest Like Stanley Druckenmiller

[Tuesday, May 19, 1:20 p.m.]
Contributed by Sarah Smith

When the market is thrown into chaos, it’s nice to know how the biggest players in the investing world are handling things. Stanley Druckenmiller, like many ordinary, individual investors, is loading up on stay-at-home stocks.

His Duquesne Family Office opened new positions in high-flying tech companies, and closed positions in big bank stocks, Snap (NYSE:SNAP), Marathon Oil (NYSE:MRO) and FedEx (NYSE:FDX).

Remember, Druckenmiller is most known for his work with George Soros, and his previous firm, Duquesne Capital. He’s had a rough couple of years as his fund underperformed the S&P 500. But, he’s known for quick trades and is worth almost $5 billion.

As the famous investor eyes stocks that benefit from the novel coronavirus, he’s also quick to criticize the market. He recently told CNBC that he doesn’t like how the market looks here, citing a “bad” risk-reward balance. In that context, his pandemic plays make a lot more sense.

So, if you want to invest like Druckenmiller, this is your chance. Here are his top 10 holdings right now (subscription required):

  • Amazon (NASDAQ:AMZN)
  • Netflix (NASDAQ:NFLX)
  • Facebook (NASDAQ:FB)
  • Workday (NASDAQ:WDAY)
  • Microsoft (NASDAQ:MSFT)
  • Alphabet (NASDAQ:GOOGL)
  • PayPal (NASDAQ:PYPL)
  • Barrick Gold (NYSE:GOLD)
  • Activision Blizzard (NASDAQ:ATVI)
  • Alibaba (NYSE:BABA)


6 Stocks to Buy as the Coronavirus Changes Medicine

[Tuesday, May 19, 12:24 p.m.]
Contributed by Sarah Smith

For many Americans, the novel coronavirus is ushering in a new understanding of public health. Consumers are wearing face masks, washing their hands and following new social distancing protocols. At the same time, the pandemic is highlighting just how much the medical world has changed — and will continue to change in the months and years to come.

Inovio Pharmaceuticals (NASDAQ:INO) developed its vaccine candidate in just three hours. Now, President Donald Trump is ramping up Operation Warp Speed to “deploy” a vaccine across the U.S. by January 2021. And months before most investors caught on to the outbreak, Canada’s BlueDot used an artificial intelligence-powered algorithm to spot a “flu-like outbreak” in China.

According to Axios’ Bryan Walsh, this scientific innovation is just the beginning. As consumers continue to demand next-generation healthcare before the next pandemic, Walsh predicts that gene-editing tech will proliferate, healthcare will merge more with AI and a whole host of other biotech innovations will capture investor and consumer attention.

So, how can you profit from this trend? InvestorPlace’s Ian Cooper rounded up his favorite gene-editing stocks in March, commenting on the excitement this revolution holds. Doctors are touting the potential to reverse blindness and cure HIV, all by “hacking” a patient’s genes. With this in mind, Cooper recommends CRISPR Therapeutics (NASDAQ:CRSP), Editas Medicine (NASDAQ:EDIT) and Intellia Therapeutics (NASDAQ:NTLA).

Plus, InvestorPlace analyst Matt McCall has long been bullish on this futuristic healthcare. Back in September he highlighted Illumina (NASDAQ:ILMN) and Guardant Health (NASDAQ:GH). The former offers genome sequencing products, while the latter specializes in liquid biopsies.

If you’re not sure about all this gene-editing hype, there’s an even easier way to get in on the trend. Ever since Apple (NASDAQ:AAPL) signed a deal with Orangetheory Fitness, McCall has been excited about the Apple Watch’s potential. As consumers opt for health-tracking devices, look for those device makers to seriously profit from all the data.

The future of healthcare will be a whole lot more connected, and hopefully a whole lot more profitable, for the sector’s earliest investors.


10 Lithium Stocks to Buy for Post-Pandemic Innovation

[Tuesday, May 19, 11:00 a.m.]
Contributed by Sarah Smith

Innovation drives the market, even in times of chaos. Companies that are embracing remote-work and telemedicine solutions are thriving, while companies stuck in the days of brick-and-mortar retail are just inches away from bankruptcy filings. But there’s a more speculative, and potentially more rewarding, sector of innovation out there right now.

Lithium is a key commodity used in electronics, and it’s really gaining attention thanks to electric vehicles. This year hasn’t been kind to lithium stocks, especially as supply-demand imbalances and the U.S.-China trade war tanked the lithium market.

That might all be about to change. InvestorPlace’s Josh Enomoto is keeping a close eye on geopolitics, and he’s tracking a storm brewing between the United States and China. With an election approaching, Enomoto predicts President Donald Trump will do just about anything to get back in the White House, including pulling away from that country’s lithium supply.

That’s bad news for some companies, but not for the 10 lithium stocks Enomoto is recommending. He’s looking at countries that rely on lithium supplies in Canada, Australia, Argentina and Chile. According to Enomoto, lithium-based tech is the future. As mining strategies improve and prices stabilize, these stocks could seriously shoot for the stars.

Here are his 10 buy recommendations now:

  • Albemarle (NYSE:ALB)
  • Sociedad Quimica y Minera (NYSE:SQM)
  • Tesla (NASDAQ:TSLA)
  • Orocobre (OTCMKTS:OROCF)
  • Livent (NYSE:LTHM)
  • Power Metals (OTCMKTS:PWRMF)
  • Lithium Americas (NYSE:LAC)
  • Galaxy Resources (OTCMKTS:GALXF)
  • American Battery Metals (OTCMKTS:ABML)
  • Pilbara (OTCMKTS:PILBF)


Nancy Lazar: Middle America Is the New Emerging Market

[Tuesday, May 19, 10:37 a.m.]
Contributed by Sarah Smith

Nancy Lazar consistently ranks as one of the top economists on Wall Street. She’s racked up accolades from institutional investors, and she’s considered one of the most influential women in U.S. finance. Clearly, she knows what she’s talking about.

And in a new interview with Barron’s Leslie Norton, Lazar talked about how the novel coronavirus is bringing a “regime change” that favors stockpickers. Although she initially downplayed the threat of the pandemic, she quickly adjusted her models and is ready to pick post-crisis winners.

Lazar has identified several key themes for stockpickers. The first is that as a result of the virus, the era of China dominating economic growth is over. In other words, it’s no longer the “top” emerging market. Instead, Lazar thinks Middle America — literally, the center of the United States — is the next key region. With that in mind, she’s looking for companies headquartered in that region.

No, Middle America isn’t the sexiest region. Investors tend to gravitate toward Silicon Valley’s tech offerings, or New York’s bustling finance and startup names. But Lazar has been bullish on Middle America for almost a decade. She’s been confident that one day, manufacturers will return en masse. Plus, as investment dollars flow to the region, smaller companies will be delightful acquisition targets.

One more takeaway. Lazar, like many others, believes consumer trends are likely to change permanently. She’s primarily betting on companies in technology, healthcare and consumer staples categories, as spending shifts to new trends.

So, pull out a map, start doing some research and get betting on Middle America.


Stocks Open Slightly Lower Tuesday After Massive Rally

[Tuesday, May 19, 9:31 a.m.]
Contributed by Sarah Smith

Phew. It looks like bulls are taking a bit of a rest Tuesday morning, after a simply amazing rally in the market on Monday. This break comes as Walmart (NYSE:WMT) and Home Depot (NYSE:HD) report earnings. Plus, investors learned that construction — specifically of single-family homes — dropped 25.4% in April.

There should still be some optimism today, but there’s nothing like Moderna’s (NASDAQ:MRNA) victory so far to lift shares. Are we in store for another rally, or a calm day of trading? Looks like we’ll have to wait and see.

The S&P 500Dow Jones Industrial Average and the Nasdaq Composite all opened slightly lower Tuesday.

  • The S&P 500 opened lower by 0.22%
  • The Dow Jones Industrial Average opened lower by 0.32%
  • The Nasdaq Composite opened lower by 0.09

Buy Gilead Stock as the European Union Fast Tracks Sales

[Monday, May 18, 4:35 p.m.]
Contributed by Sarah Smith

It seems as if the entire stock market forgot about Gilead Sciences (NASDAQ:GILD) in the blink of an eye. Instead, headlines about Moderna (NASDAQ:MRNA) and Sorrento Therapeutics (NASDAQ:SRNE) capture investor attention for a day or two at a time.

However, InvestorPlace’s Bret Kenwell highlighted another major victory for Gilead in his daily column. The European Union is racing to fast track sales of remdesivir, its proposed treatment for the novel coronavirus. The European Medicines Agency has already issued compassionate-use authorization, similar to emergency-use designations granted by the U.S. Food and Drug Administration.

However, despite a lack of more conclusive data, demand for remdesivir is rising. To appease that demand, the EMA is looking to issue a “conditional marketing authorisation” — which would allow sales of the drug for one year within the EU, even without all the data.

GILD stock didn’t feel the effects of this victory, instead falling by 2% on the day. However, InvestorPlace’s Larry Ramer thinks it’s the perfect time to buy. He wrote on Thursday that good news, including pending action in the EU, is a clear upside catalyst. With this in mind, investors should buy shares before the masses catch on to their potential.


Dow Adds 900+ Points as Investor Optimism Returns

[Monday, May 18, 4:01 p.m.]
Contributed by Sarah Smith

The sun may not be shining outside my apartment window, but a quick look at the stock market makes the day seem bright. That’s thanks to comments from Federal Reserve Board Chair Jerome Powell, vaccine updates from Moderna (NASDAQ:MRNA) and a nice spike in crude oil prices.

Moderna was certainly a big winner, closing higher by 20%. Peer vaccine makers Novavax (NASDAQ:NVAX) and Vir Biotechnology (NASDAQ:VIR) also soared on the day. Plus, Moderna’s big update even sent consumers stocks like TripAdvisor (NASDAQ:TRIP) higher as investors anticipate what a safe and effective vaccine could mean.

It’s safe to say it was a good day in the markets. The S&P 500Dow Jones Industrial Average and the Nasdaq Composite each saw gains of more than 2.4%.

  • The S&P 500 closed higher by 3.15%
  • The Dow Jones Industrial Average closed higher by 3.85%
  • The Nasdaq Composite closed higher by 2.44%

5 Bank Stocks to Buy on a Federal Reserve Rally

[Monday, May 18, 3:16 p.m.]
Contributed by Sarah Smith

Bank stocks are struggling in 2020, but investors likely are missing the bigger picture. On one hand, cruise operators and movie theater companies are down hard, but that’s because lockdowns and social distancing measures directly impact their business. On the other hand, many experts argue that bank stocks are only suffering because of 2008 flashbacks.

Granted, there’s more to the picture than that. Barron’s Carleton English wrote today that bank profits will continue to be weak, and some dividends are at risk. The big banks already moved away from buyback programs to preserve cash.

Those words of warning aren’t stopping investors on Monday. Comments from Federal Reserve Board Chair Jerome Powell have given renewed confidence to the market, and bank stocks are winning big. Powell clarified that he doesn’t see another Great Depression on the horizon, although the downturn in the market will still be “sharp.”

So, what should investors do? InvestorPlace Markets Analyst Luke Lango maintains that it’s most important to remember 2020 isn’t a repeat of 2008. The financial system is in a better place this time around, and banks face much more regulation than they did in the previous crisis.

Lango has been bullish on the big banks throughout the novel coronavirus-induced downturn. Just last week he recommended buying shares now to benefit from a post-pandemic rebound.

Here are the five names he thinks you should buy:

  • Bank of America (NYSE:BAC)
  • JPMorgan (NYSE:JPM)
  • Wells Fargo (NYSE:WFC)
  • Goldman Sachs (NYSE:GS)
  • Citigroup (NYSE:C)


FedEx Stock Gains as it Tries to Hit Amazon Where it Hurts

[Monday, May 18, 2:49 p.m.]
Contributed by Sarah Smith

Amazon (NASDAQ:AMZN) has, without a doubt, been one of the biggest winners in the locked-down world. Consumers are turning to it’s e-commerce site for essentials and impulse purchases, and the company is also benefiting from grocery store, video game and streaming trends.

However, rival FedEx (NYSE:FDX) is no longer playing around. One of the biggest consumer complaints about Amazon is that its one-day and two-day shipping guarantees have fallen by the wayside as it struggles to keep up with demand. Seeing an opening, FedEx just announced a partnership with Microsoft (NASDAQ:MSFT) that has shares up 10% in intraday trading.

According to Bloomberg’s Thomas Black and Dina Bass, the deal will combine Microsoft’s cloud services with FedEx’s shipping expertise. FedEx will get better data on potential delays, and be able to reroute packages as needed to keep shoppers happy. At the same time, Microsoft’s Azure nabs a win, taking a potential customer from Amazon’s AWS.

Plus, FedEx Surround won’t cost consumers any extra. The pilot program is set to launch in summer 2020, and could mean big things for a company struggling to keep up with the pocketbook of Amazon CEO Jeff Bezos.

It’s hard to say if this is a winning proposition in the long term, but it sure sounds good. Keep a close eye on this partnership, and consider picking up FedEx shares here.


Buy Spirit Airlines Stock for the Future of Air Travel

[Monday, May 18, 2:25 p.m.]
Contributed by Sarah Smith

Budget airlines, or low-cost carriers, had a bad rap before the novel coronavirus decimated air travel. Consumers criticized added baggage fees, delayed flights and destinations that weren’t exactly close to hub cities. But Barron’s Darren Fonda writes that these carriers are “leading the pack” in recovery.

In fact, everything that drew criticism before the pandemic could become a catalyst in the new world. For one, consumers may be more willing to spend extra on anything associated with “safety,” like social distancing seats. Business travel is typically associated with Delta Air Lines (NYSE:DAL) and United Airlines (NASDAQ:UAL), but leisure travel is likely to rebound first. Just think about all the companies already promoting “WFH forever” models.

Plus, these budget airlines have leaner operations, as Fonda writes. That could mean it’s easier for them to sustain the added costs of social distancing, like removing middle seats.

With this reality in mind, Spirit Airlines (NYSE:SAVE) is set to be a major post-crisis winner. Shares are up 25% in intraday trading, as new figures from the Transportation Security Administration show travel was down 91% year-over-year for the week ending May 15. That sounds horrible, but it’s an improvement from earlier 96% year-over-year drops.

It’s always nice to know that Wall Street agrees with investors. Evercore ISI analyst Duane Pfennigwerth raised his 12-month price target on shares to $12, and set a “buy” rating today. With a share price just below $10, don’t miss out on some rebound-driven upside in SAVE stock.


7 Stocks to Buy as Electronic Payments Gain Traction

[Monday, May 18, 1:54 p.m.]
Contributed by Sarah Smith

Some future-minded individuals are predicting a complete end to cash payments. Sure, that sounds pretty radical, but it’s unfolding as I write this. Paper money has been targeted as a risky medium — businesses have moved away from accepting cash to stop the spread of the novel coronavirus. Heck, I even paid online for an individual McDonald’s (NYSE:MCD) milkshake this weekend.

It is likely that cash will return, but the pandemic is certainly accelerating the adoption of electronic payment options. That’s why some like InvestorPlace’s Chris Lau see stocks in this space as some of the hottest buys right now.

Lau wrote today that it’s clear consumers are getting more comfortable with electronic payments. Plus, businesses are increasingly embracing these platforms as they struggle to keep their doors open. In all, this is a big win for the payments companies.

Plus, in a post-pandemic world, we won’t all stop whipping out our phones to make payments. With that in mind, here are seven stocks Lau is recommending now:

  • PayPal Holdings (NASDAQ:PYPL)
  • Square (NYSE:SQ)
  • Visa (NYSE:V)
  • Mastercard (NYSE:MA)
  • American Express (NYSE:AXP)
  • Coupa Software (NASDAQ:COUP)
  • Global Payments (NYSE:GPN)


Gear Up and Start Buying Stock in the Big Three Automakers

[Monday, May 18, 1:21 p.m.]
Contributed by Sarah Smith

Not to beat a dead horse, but it’s been a rough year so far for carmakers. Consumer spending dropped, demand dropped and state lockdowns forced production to come to a halt. Year-to-date performances for General Motors (NYSE:GM), Ford (NYSE:F) and Fiat Chrysler (NYSE:FCAU) are ugly.

That’s all changing, and it’s evident in the share prices. GM stock is up more than 10% in intraday trading, and Ford and FCAU shares are up around 8%. Why? Plants are reopening.

According to reporting from Morning Brew, Monday marked massive reopenings at plants across the U.S. Yes, they will be operating at reduced capacity for the near future, and workers will take new safety precautions. A total of 133,000 employees will be back to work by the end of the week.

Granted, renewed production doesn’t mean renewed demand. But, it’s a big step in the right direction. As we’ve previously reported in this blog, the future of transportation could be headed back toward vehicles. Subways, bus systems and ride-hailing services have become symbols of outbreak.

Plus, InvestorPlace’s Joel Baglole wrote last week that investors would be wrong to ignore the upside potential in Ford stock. Ford and its peers have some cash, and reopenings are underway. If it can get through 2020 and tackle projects like electric vehicles, it’s set for massive gains.

Investors should get ready for a rebound, and keep an eye out for new sales figures. As more consumers return to work, it will be important to know how many opt for new cars instead of getting on the train.


8 Vaccine Stocks to Buy for Operation Warp Speed

[Monday, May 18, 12:58 p.m.]
Contributed by Sarah Smith

Vaccine stocks are heating up the stock market today, especially after Moderna (NASDAQ:MRNA) shared its first results from human trials. But there’s an even bigger catalyst lurking behind some of the top names in the race to develop a vaccine for the novel coronavirus.

On Friday, President Donald Trump and the U.S. Department of Health and Human Services launched Operation Warp Speed, something the president has likened to the Manhattan Project. As the name suggests, this is a mission to produce and distribute an effective vaccine across the U.S. with “warp speed” — or by January 2021.

As part of the operation, Trump is even calling for the deployment of military trucks and planes, as well as individual soldiers to administer vaccines when the time comes. There are 14 vaccines in the study, and eventually researchers will narrow it to eight, and then even lower. It’s not clear exactly which vaccines are on the short list, but investors could make some informed guesses.

InvestorPlace’s Ian Cooper is obviously hot on Moderna, but he also recently recommended Inovio Pharmaceuticals (NASDAQ:INO) and BioNTech (NASDAQ:BNTX), thanks to its vaccine partnership with Pfizer (NYSE:PFE).

Beyond that, The Wall Street Journal’s Peter Loftus added Johnson & Johnson (NYSE:JNJ), Sanofi (NYSE:SNY) and AstraZeneca (NYSE:AZN) to the list of companies farther along in the raceGlaxoSmithKline (NYSE:GSK), another big-name pharmaceutical, is collaborating with Sanofi to scale up production.

Remember, there are over 100 candidates out there. This list of vaccine stocks combines big pharmaceutical power with manufacturing capability and a little bit of clinical-stage innovation. May the best vaccine — and the most diligent investors — win.


Are You Investing in 5G’s $56 Trillion Upgrade All Wrong?

[Monday, May 18, 12:15 p.m.]
Contributed by Nicholas Stern

It’s no exaggeration to say the breakthroughs made possible by 5G will dwarf the economic impact of the internet.

The next generation of mobility will increase download speeds by 100x. If you’ve experienced any janky or lost connections recently, you’ll appreciate the upgrade.

But 5G means a lot more than faster smart phones.

It makes possible breakthroughs that were previously the stuff of sci-fi fantasy. I’m talking about self-driving cars, remote robotic surgeries, virtual and augmented reality, billions of connected devices known as the internet of things (IOT), telehealth, smart cities and factories, and more.

Add it all up and you’re looking at technological innovations worth more than $56 trillion.

And if anything, Covid-19 has only accelerated 5G’s importance for the future. When your health or your job are literally on the line, faster connections at home become not just a nice feature to have, they turn into a necessity.

The same goes for the factory floor. Indeed, the manufacturing sector has been at the forefront of 5G’s rollout.

According to TechRepublic, wireless connections in factories will grow even faster than fixed-line connections from 2019 to 2030, reaching over 5 million 5G connections by 2025.

Nearly three-quarters of managers and plant directors surveyed by ABI Research said they planned on upgrading their communications networks in the next two years, with more than half saying 4G and 5G are necessary to meeting that goal.

Getting ahead of the trend, Federated Wireless has joined with Amazon’s (NASDAQ:AMZN) Web Services and Microsoft’s (NASDAQ:MSFT) Azure to offer connectivity-as-a-service for businesses setting up 4G and 5G networks for IOT tools.

Again, a post-pandemic world will demand faster, more efficient supply chains and production lines informed with data fed by countless connected sensors. 5G connectivity will enable this shift.

Years from now, we’ll look back at the creation of 5G the way we look back at the buildout of America’s railroads. More importantly, it’s setting up the best chance many people will ever get to make small investments and turn them into life-changing wealth.

But most people are going about it the wrong way. It’s why InvestorPlace analyst Matt McCall recently let people know about a 5G wealth-building opportunity that could be 20 to 30 times larger than the buildout.

Click here to learn more.


Jerome Powell Says Market Won’t See a ‘Great Depression’

[Monday, May 18, 11:40 a.m.]
Contributed by Sarah Smith

Last week, Federal Reserve Board Chair Jerome Powell issued a warning about the economy, and stocks tumbled. This week, it looks like he’s trying to soften that blow. A quick look at the major indices shows that it’s working.

On Sunday, a 60 Minutes interview with Powell brought a little more clarity to his warning. He maintains that we certainly aren’t looking at a V-shaped economy recovery — and that the downturn will be very “sharp.”

But he also made clear that the United States isn’t going to see another Great Depression. Why? Before the market downturn, Powell argues that the financial system and the economy were in good shape. Downward pressures are coming from the novel coronavirus, an external factor.

Although he’s still not rushing toward negative interest rates, he says the Federal Reserve has massive potential through its lending programs to keep the economy from depression. Powell is also pushing for legislators to up stimulus spending.

From the interview:

“In the long run, and even in the medium run, you wouldn’t want to bet against the American economy. This economy will recover. It may take a while. It may take a period of time. It could stretch through the end of next year.”


5 Gambling Stocks to Buy for a Post-Pandemic Jackpot

[Monday, May 18, 11:11 a.m.]
Contributed by Sarah Smith

Live sporting events are mostly on hiatus, and casinos around the world remain closed. That should mean instant death for gambling stocks. Instead, these names are sparkling in the spotlight because of their major rebound potential.

Sure, they face serious headwinds right now, and it’s not clear when those issues will truly fade. But consumers’ urge to gamble hasn’t disappeared. Recent reporting from The Guardian indicates that frequent gamblers are actually betting more as they’re stuck at home.

As these individuals turn to higher-stakes online casino games and slot machines, it’s clear gambling won’t disappear in a post-pandemic world. When casinos and sports events return, casual gamblers will similarly return to the pastime. Frequent gamblers will make the switch back to in-person bets.

This reality is exactly what has InvestorPlace’s David Moadel hot on top gambling stocks now. He wrote this morning that in preparation for a rebound, investors should seek out stocks in the sector with big turnaround potential.

Here are five stocks he’s recommending right now:

  • Las Vegas Sands (NYSE:LVS)
  • Caesars Entertainment (NASDAQ:CZR)
  • Esports Entertainment (NASDAQ:GMBL)
  • Boyd Gaming (NYSE:BYD)
  • Penn National Gaming (NASDAQ:PENN)


Moderna Stock Climbs 25% on Early Trial Results

[Monday, May 18, 10:44 a.m.]
Contributed by Sarah Smith

Investors were in a rough spot after last week. It seemed like the novel coronavirus was destined to weigh on the economy for months to come, and state reopening plans lost their luster. That all changed Monday morning when Moderna (NASDAQ:MRNA) reported its mRNA-1273 vaccine candidate showed promising early results.

Moderna has been testing its vaccine in eight healthy volunteers. Key takeaways from early results are that the vaccine is safe and successfully triggers an immune response. Now, the company is preparing to ramp human trials to deliver a final vaccine as quickly as possible.

Further rounds of study will include two doses of the vaccine, and examine their effects on different age groups. According to its Monday press release, Phase 3 trials could begin as early as July.

As we’ve reported in this blog, a vaccine winner will see serious share-price victory. That’s because many see a vaccine as the key to safely and wholly reopening the United States. With that in mind, MRNA stock is up more than 20% in intraday trading.

Although shares have gained more than 320% in 2020, InvestorPlace’s Ian Cooper still thinks it’s a buy. He wrote Thursday that it’s one of the top biotech stocks to buy right now. Dr. Anthony Fauci, the nation’s top infectious disease expert, even called Moderna’s vaccine technology “quite impressive.”


Stocks Surge Higher Monday on Vaccine News

[Monday, May 18, 9:31 a.m.]
Contributed by Sarah Smith

Friday’s rally was unexpected, but it’s carrying over to quite a robust open in the stock market on Monday. News that Moderna’s (NASDAQ:MRNA) vaccine candidate for the novel coronavirus showed promise in early trials is seriously shaking things up.

And that shake up is needed after a gloomy week of trading. After several experts, including Federal Reserve Board Chair Jerome Powell, called for longer-lasting misery, vaccine optimism looks like the perfect cure.

With that in mind, the S&P 500Dow Jones Industrial Average and the Nasdaq Composite all opened well in the green on Monday.

  • The S&P 500 opened higher by 2.47%
  • The Dow Jones Industrial Average opened higher by 2.92%
  • The Nasdaq Composite opened higher by 1.71%

Microsoft Looks to Be a Return-to-Work Winner

[Friday, May 15, 4:30 p.m.]
Contributed by Sarah Smith

In case you’ve been living under a rock, the novel coronavirus is changing everything. We went from rushing to work each morning in crowded offices or kitchens or brick-and-mortar retailers to record layoffs and a lot of working from home. In that noise, work-from-home solutions like Microsoft’s (NASDAQ:MSFT) Teams and Zoom Video (NASDAQ:ZM) became winners.

Now, states are reopening, and many Americans are pushing to reopen businesses. Microsoft is ready to make that pivot, aligning itself as a return-to-work stock. Today, along with UnitedHealth (NYSE:UNH), it announced ProtectWell. According to InvestorPlace’s Bret Kenwell, this was some of the biggest news in the stock market today.

ProtectWell is both an app and a set of workplace protocols to help companies transition back to the office. Unlike proposals from competitors, this app doesn’t involve any contract tracing technology. What it does feature is screening for the novel coronavirus and privacy-focused testing options.

Microsoft and UnitedHealth are big players in their respective industries, and together they should have a lot of power. MSFT shares outperformed the market today, closing higher by 1.5%.


Stocks Flip Morning Losses to Close Friday in the Green

[Friday, May 15, 4:01 p.m.]
Contributed by Sarah Smith

The stock market looked pretty grim this morning. Retail sales fell 16.4% in April — a record move for that figure. Earlier this week investors heard cautionary tales from famed David Tepper and Federal Reserve Board Chair James Powell. Oh, and yesterday we learned 2.98 million more Americans filed for unemployment benefits.

But it’s almost the weekend. That means investors did their best to turn things around, getting the S&P 500 into positive territory on the day. The move higher comes as Sorrento Therapeutics (NASDAQ:SRNE) closed higher by 160%. No, that’s not a typo.

Fortunately, things were similarly rosy for the Dow Jones Industrial Average and the Nasdaq Composite. Everyone’s ready for Saturday and nobody wants to get the party started on a bad note.

  • The S&P 500 closed higher by 0.39%
  • The Dow Jones Industrial Average closed higher by 0.25%
  • The Nasdaq Composite closed higher by 0.79%

In These ‘Trying Times’ Sprout Social Stock Is a Top Buy

[Friday, May 15, 3:42 p.m.]
Contributed by Sarah Smith

We’ve all seen the emails. “Company XYZ is here for you in these trying times.” Cute graphics, comforting messages and all sorts of discounted products are making the rounds on branded social media pages. Businesses are working to find themes that resonate with consumers, and ways to capture spending even as it falls at record pace.

According to InvestorPlace Markets Analyst Luke Lango, that’s exactly why Sprout Social (NASDAQ:SPT) stock is a buy right now, and for the next 10 years. No, it’s not a platform for vegans or tree-hugging millennials. It’s a social media management company, and it’s the best of its kind.

Plus, as Lango writes, brands and consumers are grasping onto the digital world as the physical world continues to face pandemic disruptions. SPT stock is up 44% year-to-date, and it just saw its revenue grow 31% year-over-year. Those aren’t numbers to roll your eyes at.

So what’s the deal? Brands essentially have to hop on the social media bandwagon to reach potential customers. Now, they really need to be social media savvy. Some brands are even upping their spending on social media campaigns at a time when the digital advertising world seems bleak.

As more companies opt for social media management, Sprout will win. In the next decade, Lango anticipates 450% upside.


Barclays: Buy PG&E Stock As It Preps to Exit Bankruptcy

[Friday, May 15, 2:22 p.m.]
Contributed by Sarah Smith

PG&E (NYSE:PCG) filed for bankruptcy protections in early 2019. It faced enormous costs after its equipment caused devastating wildfires in California. Shares have dropped over 70% in the last two years, although they are in the green for 2020.

The company’s fortunes could be changing, and Barclays analysts like its trajectory. If PG&E can exit bankruptcy by June 30, it could participate in a California-based fund to compensate victims of the wildfires. It has been at odds with California Gov. Gavin Newsom, and Utility Dive reported in November 2019 that California mayors wanted to turn the company into a public utility.

Analyst Eric Beaumont thinks this June 30 deadline is reasonable. That’s why he upped his rating to “overweight” from “equal weight” and set a $15 price target. Shares currently trade near $11.

One big question moving forward is how PG&E will raise the cash it needs. But the firm thinks it won’t have to sell more than $9 billion in new shares to reorganize. From there, as Beaumont and his peers expect utilities to improve later in 2020, the future looks brighter.


5 Virtual Reality Stocks to Buy for the Next Virus

[Friday, May 15, 1:56 p.m.]
Contributed by Sarah Smith

On one hand, there’s surely no one out there eager to start thinking about the next major viral outbreak. On the other hand, investors would be smart to get ahead. Virologists predict animals currently carry 750,000 diseases with the power to infect humans. Planning for the next pandemic will help you profit.

Attention-grabbing articles from AxiosThe Atlantic and The New York Times have speculated our next pandemic will be made better by virtual and augmented reality. Kaitlyn Tiffany writes that augmented-reality filters on Instagram are allowing for a certain digital communal experience made impossible in the physical world by social distancing. Ina Fried writes that virtual-reality headsets will make remote work and learning easier, and more engaging, the next time around.

Why aren’t these technologies more relevant now, as the novel coronavirus continues to change life? Kevin Roose writes that in many ways, the tech just isn’t ready. What is ready is expensive, or cumbersome or it has been out of stock for weeks.

That’s why companies, and investors, should prepare for the next pandemic. On Thursday, Apple (NASDAQ:AAPL) announced its purchase of NextVR, a strong indication future products will lean more toward this futuristic technology. In fact, InvestorPlace’s Brad Moon wrote in February that Apple was one of the top five stocks to buy to cash in on this trend.

At the time, he wrote that combined revenue from AR and VR products is set to hit $571.2 billion by 2025. Although Apple is known for existing tech like iPhones and Air Pods, Moon argues that these industry leaders have the power to win in the future. Why? They’ll buy up NextVR and other small firms, and use their market dominance to keep winning.

Here are four other stocks Moon thinks could be AR and VR winners:

  • Facebook (NASDAQ:FB)
  • Sony (NYSE:SNE)
  • Microsoft (NASDAQ:MSFT)
  • Alphabet (NASDAQ:GOOG, NASDAQ:GOOGL)


7 Gold Stocks to Buy to Protect Your Portfolio

[Friday, May 15, 1:25 p.m.]
Contributed by Sarah Smith

March was a bad month in the markets, and then April saw stocks rocket higher. Against their better judgement, many experts were likely hoping for a V-shaped recovery. Unfortunately, that seems like “wishful thinking” now, writes InvestorPlace analyst Louis Navellier.

We’re just two weeks into May, and things are looking a little rough. Retail sales are still dropping, and Americans are still filing for unemployment benefits. Plus, states’ reopening plans aren’t smooth sailing.

With this in mind, Navellier is recommending gold stocks now. He likes that gold has historically been a top portfolio hedge, and that the current gold supply is lower than usual. While demand continues to rise, you certainly wouldn’t be a fool to follow suit and buy some gold shares now.

Here are Navellier’s seven recommendations:

  • Eldorado Gold (NYSE:EGO)
  • Iamgold (NYSE:IAG)
  • Harmony Gold (NYSE:HMY)
  • Yamana Gold (NYSE:AUY)
  • B2Gold (NYSEMKT:BTG)
  • Drdgold (NYSE:DRD)
  • Kinross Gold (NYSE:KGC)


Tesla Stock Is a Buy as Elon Musk Wins Once Again

[Friday, May 15, 1:00 p.m.]
Contributed by Sarah Smith

It’s just as easy to hate Tesla (NASDAQ:TSLA) CEO Elon Musk as it is to love him. He has fearlessly led his electric vehicle company to rousing success, but he also uses social media much like a diary. One day, he’s worried about the TSLA stock price being too high, the next he’s fighting with legislators from Alameda County — home to his Tesla plant.

In what should have been a stock-driving win, Musk got his way. After threatening to reopen the plant without approval, and challenging police to arrest him first, he got that approval. Now, he just has to ensure certain safety protocol are in place.

TSLA stock is up almost 91% year-to-date, but Musk’s recent victory hasn’t triggered a rally. In fact, shares are down in intraday trading on Friday. Is this a sign it’s time to cash out and run?

InvestorPlace’s Bret Kenwell doesn’t think so. He wrote that of all automotive stocks, Tesla may be the only one to buy now. Yes, its margins are thin, it’s in a capital-intensive business and it’s cyclical. But even in a pandemic Tesla’s shareholders love the company and its leader.

Perhaps that loyalty is all it needs for success.


5 Stocks to Buy for Post-Pandemic Mental Health Demand

[Friday, May 15, 12:13 p.m.]
Contributed by Sarah Smith

Some pandemic investing opportunities feel like victory — like vaccine or treatment stocks. Purchasing shares of a company that could soon have a life-saving drug on its hands is the ultimate win-win scenario. Another pandemic-driven investing opportunity, based on new reporting from Axios’ Miriam Kramer, doesn’t have that same effect.

Yesterday Kramer discussed how the coronavirus was triggering a “crisis” in American mental health. At the end of April, 28% of Americans reported worsening mental health. All this time at home, for some, translates to heightened incidents of sexual and domestic abuse. For others, social distancing policies and stay-at-home orders have amplified conditions like depression and anxiety.

These are sobering thoughts, and Kramer questions how the healthcare system will respond after the pandemic. Will we see a rush toward therapy and prescription drugs? And how long will that rush last?

InvestorPlace’s Josh Enomoto recently made stock recommendations with that question in mind, especially as he anticipates more Americans seeking traditional and non-traditional treatment. Enomoto opted for a “quirky” focus, encouraging investors to buy Champignon Brands (OTCMKTS:SHRMF) and MindMed (OTCMKTS:MMEDF).

These companies represent the cutting-edge research happening in the mental health world. Champignon specializes in psychedelic drugs with a therapeutic focus, researching ketamine and medicinal mushrooms. Similarly, MindMed focuses on the mental health benefits from psychedelics.

But it’s even more likely Americans will seek out traditional mental healthcare. That’s why Teladoc (NYSE:TDOC) looks like a good play, especially as it has been quick to add a variety of medical professionals to its platform. And as Kramer predicts we’ll see an increase in depression and anxiety diagnoses, traditional drugmakers are also a good bet. Consider Pfizer (NYSE:PFE) and Eli Lilly (NYSE:LLY) — the makers of Prozac, Zoloft and Xanax.

Together, these five stocks represent a solid bet on growing demand, and a combination of current and future treatment options.


Don’t Miss the Bullish Opportunity in Applied DNA Stock

[Friday, May 15, 11:18 a.m.]
Contributed by Sarah Smith

Yesterday, it appeared another novel coronavirus superstar was emerging. Applied DNA Sciences (NASDAQ:APDN) shot from a May 13 closing price of $8.89 to close yesterday at $15.21. Why? It received emergency-use authorization from the U.S. Food and Drug Administration for its test kit.

But Thursday’s share-price victory didn’t last long. APDN stock is now down 20% in intraday trading, perhaps as news from Sorrento Therapeutics (NASDAQ:SRNE) takes center stage. What’s more likely is that investors panicked over the company’s earnings call Thursday evening.

As not all aspects of Applied DNA’s business qualify as essential in New York, it has seen significant year-over-year drops in revenue, and its net loss also widened by 10%.

Investors shouldn’t be so quick to discount this opportunity. As we previously reported in this blog, there are three types of test kits. This new offerings from Applied DNA is a true diagnostic test — the type of test many consider to be the most expensive and least accessible.

And according to CEO Jim Hayward, APDN’s test has several advantages over other tests with emergency-use authorization. From Hayward:

“Regarding the economics of our COVID-19 diagnostic test, we expect the test to be profitable starting at day 1. We have been careful in choosing our kit components, and have worked closely with our domestic supply chain partners to develop safeguards for continued supply of necessary reagents. We’ve made sure that the manufacturing process for our test kit is as simple as possible, allowing the company to scale with demand.”

Yesterday’s price action reflects a common narrative in our new normal. Looking to the future, remember that testing will continue to ramp. With that in mind, APDN and its test-kit peers could very well be lucrative stocks to buy.


Sorrento Therapeutics Stock Soars on Coronavirus News

[Friday, May 15, 10:41 a.m.]
Contributed by Sarah Smith

Wow. Shares of Sorrento Therapeutics (NASDAQ:SRNE) are almost 90% higher in intraday trading. It’s not even noon yet!

This impressive climb, unsurprisingly, comes on the back of novel coronavirus news. On Friday, the California-based biotech company said that an antibody it’s been developing was successful in blocking the virus, at least in a lab setting. After four days of incubation, it blocked the virus 100% of the time.

As TechCrunch’s Darrell Etherington writes, this news is so inspiring because the antibody could form the basis for a drug cocktail used to treat Covid-19. Sorrento, like many others in the race to develop a treatment, is worried that the virus could mutate, making it hard to pin down an effective drug.

If later-stage trials find the same results, this antibody will be the first in Sorrento’s planned cocktail. It will then use its COVI-SHIELD technology to incorporate several more antibodies, aiming to address fears of mutation. According to a May 8 press release, Sorrento is hoping to develop three antibodies.

Keep a close eye on SRNE stock. While Sorrento isn’t exactly a household name, any company able to deliver a safe and effective treatment will win big. And for today, it’s a reason to be a bullish, especially after a gloomy start to trading.


Stocks Plummet Friday on Grim Retail Sales Report

[Friday, May 15, 9:31 a.m.]
Contributed by Sarah Smith

It would be easy to imagine that Americans are filling their hours at home with online shopping — and certainly, there is some of that going on. But 36.5 million people have filed for unemployment benefits, and fears of a long-lasting recession are curtailing consumer spending.

Investors got a shocking look at consumer spending levels Friday morning. Retail sales in April fell by 16.4%, worse than the drop in March. Economists were predicting a drop of 12.3% — so it’s safe to say Friday’s surprise really is hurting the market.

Stock futures promptly flipped, after a positive close Thursday. The S&P 500Dow Jones Industrial Average and the Nasdaq Composite all are opening deep in the red.

  • The S&P 500 opened lower by 0.94%
  • The Dow Jones Industrial Average opened lower by 0.87%
  • The Nasdaq Composite opened lower by 1.15%

Analysts Are Jumping on the Cisco Stock Bandwagon

[Thursday, May 14, 4:37 p.m.]
Contributed by Sarah Smith

Cisco Systems (NASDAQ:CSCO) reported fiscal third-quarter earnings on Wednesday and analysts loved the results. As InvestorPlace’s Bret Kenwell wrote in his daily column on the stock market, analysts hopped on board the company’s bandwagon with buy ratings and higher price targets.

Revenue of $12 billion represented an 8% year-over-year decrease, while earnings per share of 79 cents increased 1% year-over-year. In a normal quarter these results may not be so rousing, but in this new normal, slight revenue and earnings beats had Wall Street cheering.

Here’s the short list of analysts hopping on board (note that shares closed May 14 at $43.85):

  • Barclays analyst Tim Long set a $50 price target.
  • Citigroup analyst Jim Suva set a $48 price target.
  • Raymond James analyst Simon Leopold set a $49 price target.
  • JPMorgan analyst Samik Chatterjee set a $50 price target.
  • UBS analyst John Roy set a $51 price target.

So, are you ready to follow this list of analysts and buy CSCO stock? InvestorPlace’s Brad Moon is. He wrote at the end of April that accelerated work-from-home trends make Cisco a hot stock, particularly as it’s home to Webex and Duo Security, two solutions made increasingly popular by the novel coronavirus.


Stocks Reverse Course to Close Thursday in the Green

[Thursday, May 14, 4:01 p.m.]
Contributed by Sarah Smith

Are investors getting ready for the weekend, or what? News that 2.98 million more Americans filed for unemployment benefits, combined with Wednesday’s comments from Federal Reserve Board Chair Jerome Powell, had stocks down hard this morning. In early afternoon trading, that all changed.

As we wrote this morning, with so much uncertainty, such a rally is hard to rule out. Crude oil prices are also up on the day, which could be helping drive the market turnaround. Perhaps investors are just looking to end the week on a better note.

Regardless of the reason, it’s a nice relief after several rough days of trading. The S&P 500Dow Jones Industrial Average and the Nasdaq Composite all closed Thursday in the green.

  • The S&P 500 closed higher by 1.15%
  • The Dow Jones Industrial Average closed higher by 1.62%
  • The Nasdaq Composite closed higher by 0.91%

The Bull Case for Beyond Meat Stock Is Getting Meatier

[Thursday, May 14, 3:13 p.m.]
Contributed by Sarah Smith

We previously reported in this blog that Beyond Meat (NASDAQ:BYND) was getting a serious boost from the novel coronavirus. Consumers were embracing a doomsday prepper mindset and stocking up on plant-based alternatives as grocery stores run out of chicken and beef.

This growth story looks even juicier now. Just take a look at all the catalysts the company has working in its favor, as shares are up almost 80% year-to-date.

On top of the prepper angle, Beyond Meat moved into China through a partnership with Starbucks (NASDAQ:SBUX) at the tail end of April. Now, consumers there can order plant-based beef spicy and sour wrap. It’s long been true that China is the hottest growth market, so this move could bring big things to the leading plant-based meat company.

But what is perhaps the biggest catalyst for BYND stock is also the gloomiest. As The Wall Street Journal’s Kimberly Chin reported earlier in May, sales more than doubled in the past quarter as consumers stocked up in panic. Where’s this interest coming from? It seems like each day we learn more about devastating meat shortages and virus outbreaks at U.S. meat processors.

Beyond Meat isn’t free from criticism, as some investors feel that it has climbed too high, too fast. And others point out that while it is doubling sales, the plant-based meat doesn’t truly rival the traditional meat market.

However, it’s undeniable that Beyond Meat represents something big. As it moves into China’s reopening economy and helps patch the hole in the food supply chain caused by meat shortages, investors should certainly consider BYND stock now.


Credit Suisse: Buy CVS Stock for Its Aetna Acquisition

[Thursday, May 14, 2:43 p.m.]
Contributed by Sarah Smith

Investors have focused on CVS Health (NYSE:CVS) this year, particularly as it sells critical health supplies and over-the-counter medicines. In other words, it’s a convenient stop in pandemic shopping.  InvestorPlace’s Dana Blankenhorn has long been hot on the name, writing in late March about its makeover plans and its decision to offer tests for the novel coronavirus.

But Blankenhorn wasn’t convinced CVS was simply a coronavirus play. He wrote at the time it was a “winner beyond the coronavirus pandemic,” particularly as it moved into managed care with its Aetna acquisition. Today, Wall Street is backing up that argument.

Credit Suisse analyst Erin Wright boosted CVS stock to a “buy” rating, maintaining a $75 price target. Shares currently trade near $62. According to Wright, CVS is a defensive business. But most attractive is its entry — through Aetna — into the world of Medicare Advantage (subscription required).

As the analyst wrote, Medicare Advantage is a fast-growing business. What is MA? It’s where a private health insurer provides Medicare benefits. Blankenhorn writes that CVS’ entry into this space is what differentiates it from Walgreens (NASDAQ:WBA) and makes it a competitor with UnitedHealth (NYSE:UNH). InvestorPlace’s Mark Hake writes that this deal has also made CVS more of a go-to pharmacy, and CVS has recorded some notable changes in its prescription filling.

While the pandemic has thrust CVS to the forefront of consumer thought, the stock is likely to be a winner in a whole new era of healthcare.


12 Stocks to Buy for Better-Than-Expected Earnings

[Thursday, May 14, 2:10 p.m.]
Contributed by Sarah Smith

Goldman Sachs derivatives strategist John Marshall has a wake-up call for investors. In a post-pandemic world, historical earnings won’t be accurate predictors of future earnings. But when will Wall Street catch up with this reality?

According to Barron’s Steven Sears, Marshall’s message isn’t cause for panic. Instead, see it as an opportunity to profit. If Wall Street continues to underappreciate newly powerful companies, investors who see through low estimates can score big.

Still don’t get it? Just think about all of the trends that the novel coronavirus is accelerating. Just a few weeks ago, Wall Street wasn’t nearly as hot on work-from-home plays or consumer staples. How then will analysts be able to accurately predict earnings when things settle?

The Goldman strategist takes it a bit further, listing 12 stocks he thinks are buys now. He argues that these names are all set to beat estimates in a big way. Here’s what he’s watching:

  • Allstate (NYSE:ALL)
  • Morgan Stanley (NYSE:MS)
  • Baxter International (NYSE:BAX)
  • Iqvia Holdings (NYSE:IQV)
  • Boeing (NYSE:BA)
  • Parker-Hannifin (NYSE:PH)
  • United Rentals (NYSE:URI)
  • Whirlpool (NYSE:WHR)
  • Peloton Interactive (NASDAQ:PTON)
  • T-Mobile (NASDAQ:TMUS)
  • Twitter (NYSE:TWTR)
  • Western Digital (NASDAQ:WDC)


5 High-Quality Stocks to Buy Under $10

[Thursday, May 14, 1:46 p.m.]
Contributed by Sarah Smith

Investors always love cheap stocks — and can you blame them? Imagine buying shares for $2, $3 or even $5 and watching them skyrocket to $10, $20 or even $50. That would be a huge win, and it’s why we look for cheap stocks under $10 each week.

During a pandemic, it’s not surprising that cheap stocks are even more popular. A market-wide selloff earlier in March created a lot of discount buys. However, the selloff also proved that some stocks simply aren’t resilient enough for a turbulent market.

So how do you know which cheap stocks actually have any potential?

That’s where InvestorPlace’s David Moadel comes in. Today, he rounded up five high-quality companies with cheap share prices. Here’s what he’s watching now:

  • Nokia (NYSE:NOK)
  • Nio (NYSE:NIO)
  • Esports Entertainment Group (NASDAQ:GMBL)
  • U.S. Energy (NASDAQ:USEG)
  • U.S. Auto Parts Network (NASDAQ:PRTS)


Follow the Insiders and Buy Harley-Davidson Stock

[Thursday, May 14, 12:57 p.m.]
Contributed by Sarah Smith

It’s often a good sign when a company’s insiders start buying up shares. Fidelity’s Peter Lynch has made that idea famous. He said that insiders could sell shares for any reason. But there’s only one reason he said insiders would buy shares — they think the price will go up.

With that time-tested advice in mind, let’s turn to Harley-Davidson (NYSE:HOG) stock. As InvestorPlace’s Ian Bezek wrote in late April, HOG shares could certainly benefit from additional stimulus money. It’s an iconic company that almost all consumers are familiar with. It also has a particular level of brand loyalty.

Unfortunately, though, most consumers probably aren’t buying motorcycles during the novel coronavirus pandemic. “Fun” purchases like Harley-Davidson’s bikes have been put on the back burner in favor of essentials like health supplies and food. And that honestly makes sense.

For HOG stock, that logic has made 2020 an ugly year. Shares are down about 50% year-to-date. Clearly the motorcycle company faces quite a few hurdles.

But those hurdles aren’t stopping CEO Jochen Zeitz from giving investors a bullish angle. He officially became CEO on May 7, and on May 8 he spent $2.1 million for almost 98,000 shares. That’s the first insider purchase Harley-Davidson has seen since 2017.

There’s always more than a simple purchase to consider when evaluating insider buying, but Argus Research analyst David Coleman likes what he sees. He upped his rating on HOG stock to “buy” and gave it a $30 price target. Shares currently trade just below $19.

As Barron’s Bill Alpert writes, Coleman likes Harley-Davidson because he’s confident its strategic plan will help it survive the crisis. Once it does, he says the company’s fortunes will rebound next year to hit $4.1 billion in sales and earnings per share of $3.35.

There’s nothing like riding off into the sunset with a nice purchase of Harley-Davidson stock.


Europe’s Big Reason to Be Bullish on Travel Stocks

[Thursday, May 14, 11:21 a.m.]
Contributed by Sarah Smith

According to the team from Morning Brew, the European summer vacation could be a reality this summer, depending on your country of origin and your desired destination.

That’s right, in an effort to salvage tourism-dependent economies, the European Union rolled out its plan to allow summer travel on Wednesday. Health and safety measures are a priority, and it’s not clear whether all EU countries will hop on board the plan. For now, it looks like Austria and Germany plan to partially reopen their shared border tomorrow. Other countries are slated to follow suit over the coming weeks.

Greece, another country devastated economically, supports allowing travel between EU countries starting June 15, as long as there is a plan to test travelers for the novel coronavirus in place.

As Morning Brew highlights, the plan will likely only allow European travel for EU countries. Travelers from places like the United States may not be allowed, at least for a few more weeks. But this bold move could be exactly what investors are looking for.

InvestorPlace’s Will Ashworth wrote at the end of April that travel stocks had been some of the worst performers in 2020. That makes a ton of sense. Cruise ships became a symbol of mass outbreak, and air travel fell to rock-bottom levels. It’s hard to backpack through Europe when you’re under a stay-at-home order that bans non-essential movement.

But Ashworth was surprisingly bullish on travel stocks, even then. He wrote that over the next decade, top names in the sector should see massive gains. Investors who get in at cheap prices will see handsome rewards. In other words, buying a battered travel stock now could help you pay for your European vacation when lockdowns fully lift.

Here’s a look at seven travel stocks Ashworth is recommending now:

  • Royal Caribbean (NYSE:RCL)
  • Southwest Air Lines (NYSE:LUV)
  • LVMH (OTCMKTS:LVMUY)
  • Estee Lauder (NYSE:EL)
  • Hilton Hotels (NYSE:HLT)
  • MGM Resorts International (NYSE:MGM)
  • Booking Holdings (NASDAQ:BKNG)


6 Vanguard ETFs to Buy to Weather the Coronavirus Storm

[Thursday, May 14, 10:22 a.m.]
Contributed by Sarah Smith

InvestorPlace analyst Neil George has been surviving — and thriving — in market crises since 1987. Through his work, he’s navigated the dot-com crash, the SARS outbreak in China and the Great Recession. Now, he’s using his skills to help investors survive the crisis caused by the novel coronavirus.

He often looks at individual stocks and bonds, but today he took a deep dive into Vanguard ETFs. According to George, the Vanguard fund family is one of the best. And the sectors he chose ETFs from are perfect to help investors actually profit despite the chaos. That’s one of the fundamental things he looks for in his Profitable Investing model portfolios.

So if you’re looking to invest in solid ETFs through a qualified retirement account, or you just like the opportunities that these funds present, Neil George has your back. He’s looking at sectors like utilities, and even real estate investment trusts, to find opportunity.

Here are six Vanguard ETFs that he’s recommending now:

  • High Dividend Yield ETF (NYSEARCA:VYM)
  • Real Estate ETF (NYSEARCA:VNQ)
  • Utilities ETF (NYSEARCA:VPU)
  • Information Technology ETF (NYSEARCA:VGT)
  • Intermediate-Term Corporate Bond ETF (NASDAQ:VCIT)
  • Tax-Exempt Bond ETF (NYSEARCA:VTEB)


Buy Cloud Computing Stocks to Survive the Recession

[Thursday, May 14, 10:01 a.m.]
Contributed by Sarah Smith

Don’t let fears about the state of the economy keep you from profiting now. Instead, look to areas with big growth potential that are supported by massive, accelerating trends. InvestorPlace analyst Louis Navellier is doing just that — and he’s recommending cloud computing stocks right now.

He wrote yesterday that cloud computing stocks are perfect recession-proof plays “hiding in plain sight.” How often do you think about the technology behind the TikTok videos you watch, the video calls you schedule or the photos you share to keep in touch with your friends? Well, it’s time you start thinking.

As the novel coronavirus has thrust so much of our world online, cloud computing technology is increasingly important. Plus, Navellier writes that this trend is only accelerating. Just look at how successful companies like Amazon (NASDAQ:AMZN) and Microsoft (NASDAQ:MSFT) are.

So where should you look? Navellier has been recommending ServiceNow (NYSE:NOW) in his Growth Investor portfolio since July 2018, and it’s since gained 100%. Clearly you don’t want to miss out on this cloud computing trend.

Read more of Navellier’s thoughts on this technology, and what’s coming next, here.


Stocks Slip Thursday on New Jobless Reports

[Thursday, May 14, 9:31 a.m.]
Contributed by Sarah Smith

Is it really Thursday again already? Looks like it. And it also looks like it has been a couple of rough days for the market. This morning, investors learned that another 2.98 million Americans had filed for unemployment benefits, bringing the novel coronavirus total above 36 million.

This number hasn’t always had a market-moving impact, but stocks are slipping lower Thursday. Perhaps that’s because investors weren’t done digesting comments yesterday from Federal Reserve Board Chair Jerome Powell and legendary investors like Stanley Druckenmiller and David Tepper.

With as much uncertainty in the world as there is, Thursday could still see a rally. But for now, the S&P 500Dow Jones Industrial Average and the Nasdaq Composite are all opening in the red.

  • The S&P 500 opened lower by 1%
  • The Dow Jones Industrial Average opened lower by 0.99%
  • The Nasdaq Composite opened lower by 0.84%

Dow Gives Back 500+ Points on Renewed Virus Fears

[Wednesday, May 13, 4:01 p.m.]
Contributed by Sarah Smith

Wednesday’s trading was yet another example of just how divided the nation is over the novel coronavirus — and how unpredictable the stock market is.

States continue to reopen, and headlines cheered Florida Gov. Ron DeSantis’ welcoming of professionals sports. This gives fans, networks and hard-hit teams something to look forward to. At the same time, Federal Reserve Board Chair Jerome Powell targeted “premature” reopenings with warnings of suffering and long-term pain.

One day the market focuses on the positives, like the return of professionals sports. The next day, fears over the novel coronavirus dominate. Wednesday saw the latter. The S&P 500Dow Jones Industrial Average and the Nasdaq Composite all closed deep in the red.

  • The S&P 500 closed lower by 1.75%
  • The Dow Jones Industrial Average closed lower by 2.17%
  • The Nasdaq Composite closed lower by 1.55%

Investors Support Sanofi Stock on U.S. Vaccine Promise

[Wednesday, May 13, 3:46 p.m.]
Contributed by Sarah Smith

Paris-based Sanofi (NYSE:SNY) isn’t rocketing higher in the market Wednesday, but it is outperforming the major indices. Shares are down just 0.2% in intraday trading, while the S&P 500 is down 2.2%.

It turns out investors are always willing to play a game of “I’ll scratch your back if you scratch mine.” What do I mean? Well, the United States was the first country to fund Sanofi’s vaccine candidate for the novel coronavirus. Now partnered with GlaxoSmithKline (NYSE:GSK), it hopes to produce at least 600 million doses each year.

According to a Bloomberg report, Sanofi CEO Paul Hudson is disappointed with the lack of support from European nations, driving his Wednesday announcement. Perhaps to spark some funding competition, he shared that the U.S. is currently entitled to the largest pre-order of doses. Granted, the U.S. may only beat out other countries by a few days or a few weeks.

Keep a close eye on Sanofi shares. It’s likely broader market influences, like early comments from Federal Reserve Chairman Jerome Powell, are keeping the announcement from having a better effect. Tomorrow could bring more gains as Sanofi ups its bullish appeal amid the pandemic.


Buy PepsiCo Stock As Snacks Go Direct to Consumers

[Wednesday, May 13, 2:32 p.m.]
Contributed by Sarah Smith

One theme that we have reported on frequently in this column is the power of snack foods amid the novel coronavirus outbreak. Consumers are stocking up on Oreo cookies with as much aggression as they’re hoarding meat or face masks. That’s meant good things for food stocks with a strong grocery store hook. For investors, it has been a chance to profit on easy, family friendly business models.

Now, PepsiCo (NASDAQ:PEP) is looking to get in on the snack surge. According to reporting from Retail Brew, the company is rolling out two direct-to-consumer channels to embrace “blanket fort life.” Through Snacks.com and PantryShop.com, shoppers can buy both snack and drink bundles and individual Frito Lay chip products.

This makes a lot of sense, and it shows PepsiCo’s ability to innovate quickly. While grocery store snacks are hot, the company missed out on e-commerce opportunities. If consumers plan on social distancing for several more weeks, it’s likely they’ll be more comfortable buying comfort food online.

Plus, as we reported earlier today, PepsiCo is taking big moves in the digital advertising space, even as it backs away from long-standing network campaigns. The company was the first to get in on a new partnership between The Trade Desk (NASDAQ:TTD) and TikTok, reaching consumers in the Asia-Pacific region with a chip-focused campaign.

It’s important for companies like PepsiCo to have direct reach to consumers, both through e-commerce and innovative advertising. InvestorPlace’s Josh Enomoto wrote yesterday that PEP is one of the top stocks benefitting from virus tailwinds. Why? Cheap, comforting snacks like soda and chips are often recession-resistant and should continue to benefit in 2020 and beyond.


12 Stocks to Buy That Could Be Takeover Targets

[Wednesday, May 13, 2:11 p.m.]
Contributed by Sarah Smith

At the beginning of the pandemic, Massachusetts Sen. Elizabeth Warren and New York Rep. Alexandria Ocasio-Cortez called for a temporary ban on big corporate mergers. Their logic? Mergers serve to boost the economic power of large corporations while smaller players suffer the effects of the outbreak.

Undeterred by the proposal, rumors of a tie-up between Uber (NYSE:UBER) and Grubhub (NYSE:GRUB) began swirling yesterday. Many investors think a deal would make sense — it would help consolidate the food delivery industry, and help Uber as its ride-hailing business suffers.

But this deal represents a lot. For one, it stands in stark contrast to several deals that failed as a result of the novel coronavirus. The Uber-Grubhub opportunity also is a reminder to investors that takeover bids can be great buying opportunities.

With that in mind, Barron’s compiled a list of 12 other stocks to watch for potential takeovers. Here’s what you should be watching now:

  • Steel Dynamics (NASDAQ:STLD)
  • L Brands (NYSE:LB)
  • Moog (NYSE:MOG.A)
  • Yelp (NYSE:YELP)
  • Etsy (NASDAQ:ETSY)
  • Splunk (NASDAQ:SPLK)
  • Pure Storage (NYSE:PTSG)
  • II-VI (NASDAQ:IIVI)
  • Corteva (NYSE:CTVA)
  • Reliance Steel (NYSE:RS)
  • Flowserve (NYSE:FLS)
  • Woodward (NASDAQ:WWD)


EverQuote Stock Is Set to Be a Coronavirus Winner

[Wednesday, May 13, 1:54 p.m.]
Contributed by Sarah Smith

One thing that is undeniably true is that the novel coronavirus made the online world much more appealing. Heck, I even convinced my grandmother to try out a Zoom Video (NASDAQ:ZM) call a few weekends ago, and she loved it. Now she’s a videoconferencing pro.

Consumers are turning to online shopping for essentials, groceries and even hair products while salons remain closed in many states. But InvestorPlace Markets Analyst Luke Lango is bullish on another sector that’s headed to the web.

Data suggests that insurance companies — long driven by in-person policy sales — are embracing an online model. According to Canadian Underwriter, this trend started before the pandemic. Insurance markets think Generation Z shoppers will prefer online policy sales because online shopping is associated with brand loyalty, refunds and accessible product information.

Lango thinks EverQuote (NASDAQ:EVER) stock is set to seriously benefit from this trend, especially as the pandemic forces consumers to turn online for all sorts of purchases. His new modeling estimates a share price over $100 within just a few years, and earnings per share of $3 by 2025.

So what exactly is EverQuote? Like Amazon (NASDAQ:AMZN) brought shopping online and Expedia (NASDAQ:EXPE) brought the travel industry online, Lango sees EverQuote leading the way for insurance. That’s because it’s a top online marketplace for insurance policies.

Need another reason to be bullish on EverQuote stock? Its first-quarter earnings showed revenue up 56% year-over-year and the company raised its full-year guidance. That’s impressive.


Don’t Ignore the Hidden Potential in Gilead’s Generics Plan

[Wednesday, May 13, 1:20 p.m.]
Contributed by Sarah Smith

Have investors soured on Gilead Sciences (NASDAQ:GILD) stock? Over the last few weeks it has been a market leader. Good news for its novel coronavirus candidate remdesivir drove whole indices up. Bad news took them down, hard. But now Gilead can’t seem to win back favor.

On Wednesday, Gilead announced that it now has five licensing agreements with generic drug manufacturers. When I heard the news, I assumed this would have GILD shares higher in intraday trading. These manufacturing agreements will allow remdesivir to reach 127 countries, including many low-income and middle-income nations. Plus, plans to scale up manufacturing to that degree seem like a bullish indication of remdesivir’s potential.

Instead, Gilead is down with the market, to the tune of 0.4%.

According to BioPharma Dive’s Jacob Bell, some of the concern comes from advocacy groups like Public Citizen, which question how many low-income individuals these agreements will help. These groups say half the world’s population lives outside of the included countries.

This is an extremely valid point, but is it the sole reason investors aren’t cheering the news? While advocacy groups help shape the philanthropic reach of remdesivir, don’t ignore the bullish messaging here. Investors also shouldn’t ignore the potential coming to generic drug makers.

If remdesivir gets the green light, Mylan (NASDAQ:MYL), Hetero LabsJubilant Life Sciences and Ferozsons Laboratories stand to benefit from associations with the life-saving drug.

InvestorPlace’s Larry Ramer agrees. He wrote today that GILD stock is set to prove the bears wrong, and that it’s time to see the blockbuster potential in remdesivir. Despite Gilead’s choice to donate thousands of doses, he still sees a chance for $3.4 billion in sales in 2020. A coronavirus cure and $3.4 billion? That’s not something to scoff at.


Buy The Trade Desk Stock for Its TikTok Partnership

[Wednesday, May 13, 12:36 p.m.]
Contributed by Sarah Smith

One of my favorite quarantine habits involves getting comfy, grabbing my tablet and watching hours of short videos on TikTok. If you haven’t heard of it, it’s a social media platform from China’s ByteDance. It features short-form video content, often with dance challenges, short comedy bits or cute pets.

TikTok is taking the world by storm. The Verge’s Ashley Carman reported in April that the platform surpassed 2 billion downloads, and much of its growth came in the first quarter as people were stuck at home. It is simply an inspiring growth story.

Some experts warn that ByteDance is threatening the dominance of rival Tencent (OTCMKTS:TCEHY) which similarly invests in social media, online gaming and entertainment. And while ByteDance remains private, there is speculation an IPO is just around the corner.

If you still don’t get TikTok’s potential, take this reporting from Axios’ Shane Shavitsky. Tweens and teens on the app have a lot of sway in “vaulting” songs to the top of the Billboard charts. Just this week, Doja Cat’s “Say So” earned a No. 1 ranking, after a 17-year-old user created a viral dance. This business model is so solid that Pitchfork’s Alphonse Pierre says Drake’s “Toosie Slide” was a calculated move to succeed on TikTok.

Now, hopefully you see what I mean. For individual investors, there’s a great way to buy into this massive opportunity. The Trade Desk (NASDAQ:TTD) — which is a success story in its own right — recently launched a partnership with TikTok to get ad clients easy access to the platform. The new offering launched in Thailand, led by a campaign from PepsiCo (NASDAQ:PEP). Just like connected TV boosts the success of TTD stock, TikTok should be a major catalyst.

TikTok users have a lot of consumer power, and The Trade Desk is a great play on the future of digital advertising. That’s why InvestorPlace Markets Analyst Luke Lango says TTD stock is one of the top stocks to invest in for a “post-coronavirus whipsaw.” With a new partnership under its belt, it’s too good to ignore here.


7 Stocks to Buy That Have Strong Upside Potential

[Wednesday, May 13, 11:41 a.m.]
Contributed by Sarah Smith

Just a few weeks ago, finding a stock that was in the green year-to-date was like winning the lottery. Now, though, the S&P 500 is far off its 2020 lows, and many stocks are flaunting eye-grabbing gains. Does that mean there are no more bargain opportunities for bottom-fishing investors?

No. InvestorPlace’s Ian Bezek wrote today that if investors don’t see bargains right now, they’re not looking in the right place. Almost 100 companies in the S&P 500 are still down more than 40%. Talk about opportunity.

With that in mind, here are seven stocks he’s recommending now:

  • Anheuser-Busch InBev (NYSE:BUD)
  • Tyson Foods (NYSE:TSN)
  • General Electric (NYSE:GE)
  • Altria (NYSE:MO)
  • Nordstrom (NYSE:JWN)
  • Boston Properties (NYSE:BXP)
  • Sysco (NYSE:SYY)


Bill Miller: A Vaccine Will Trigger an Airline Stock Rally

[Wednesday, May 13, 11:10 a.m.]
Contributed by Sarah Smith

Airline stocks have had a rough year, and investors like Warren Buffett are kissing the sector goodbye. Many predict that demand will suffer in the long term, especially as consumers adopt new attitudes toward hygiene and remote work.

But Bill Miller, the legendary investor behind Miller Value Partners, has a strong counter to that argument. He sees a bet against airlines as a bet against the development of a novel coronavirus vaccine (subscription required):

“If you don’t own the airlines, then you’re making a bet against the vaccine. People love flying and don’t worry about catching polio or smallpox, if there is a vaccine. … If there is a vaccine, that will eliminate all the issues people have about flying and these [stocks] will come back very, very quickly.”

Plus, Miller thinks all the bad news about air travel is already priced into airline stocks. That’s why he is maintaining stakes in Delta Air Lines (NYSE:DAL), United Airlines (NASDAQ:UAL) and American Airlines (NASDAQ:AAL). To be fair, he doesn’t snub Buffett for making a decision to sell. He just sees a great opportunity for value investors in the sky.

Just this morning, InvestorPlace’s Chris Lau wrote in agreement. He says that although airline stocks are a bit of a gamble, American Airlines has a huge margin of safety. Lau thinks AAL stock has 80% of upside ahead. That’s a great reason to pick up shares now.


Don’t Miss Out on the Sportsbook ‘Gold Rush’

[Wednesday, May 13, 10:49 a.m.]
Contributed by Sarah Smith

Let’s get a few things straight. Live sports are on a hiatus, at least for the most part, and ESPN is left to broadcast game reruns and marble races. As Axios’ Kendall Baker writes, even when live sports do return, America will see a “no-fans era” in stadiums.

The data backs that up. A recent poll found that only 24% of respondents are “very likely” or “somewhat likely” to attend a live game as soon as restrictions are lifted. Why? Americans want a vaccine for the novel coronavirus first.

Those combined points paint a pretty awful picture for the sports world. But at the same time, sportsbook companies — companies that accept bets in retail locations or online — are forging ahead. DraftKings (NASDAQ:DKNG) stock has been incredibly hot in recent weeks, and it’s up 4% in intraday trading. Turns out famous investor George Soros is also bullish on the company.

DraftKings, FanDuel and Penn National Gaming (NASDAQ:PENN) are racing to attract bettors despite the lack of live sports. And to an extent, it’s working. The companies saw a record number of wagers for the NFL virtual draft in April, and MarketWatch’s Weston Blasi writes that virtual NASCAR races and League of Legends games are upping the stakes.

This odd reality makes DKNG and PENN surprising pandemic options for investors to consider. DKNG shares are up 156% year-to-date, while PENN shares are down 30%. Is either stock a good buy now?

InvestorPlace analyst Matt McCall thinks the long-term picture is extremely bullish for DraftKings, so if you’ve already bought shares then you’re in luck. If you’re still on the sidelines, he recommends waiting for a pullback — it’s clear DKNG has already climbed pretty far in 2020. McCall feels similarly about Penn National Gaming, which has a stake in Barstool Sports. It’s a long-term winner, but the road ahead could be tough as casinos reopen.

In short, sportsbook operators are surprisingly resilient amid a pandemic. DKNG and PENN represent entry to a huge market opportunity, and they’ll be stocks to buy on a near-term pullback, if not now.


Stocks Cut Morning Gains After Fed Remarks

[Wednesday, May 13, 9:31 a.m.]
Contributed by Sarah Smith

Stock futures were trending higher Wednesday, at least until Federal Reserve Chairman Jerome Powell gave some prepared remarks on the state of the economy. Unsurprisingly, Powell doesn’t see everything as rosy, and in fact cited several key points that could make full economic recovery take even longer.

As for his buddies on Capitol Hill, Powell is urging for more fiscal support. He calls out those with “the power to tax and spend” to help boost the economy, even if such measures would be costly. His remarks also come as Republicans and Democrats continue to debate another round of stimulus funding.

His message wasn’t apocalyptic, but no one likes thinking about a long recovery. The S&P 500Dow Jones Industrial Average and the Nasdaq Composite all dramatically flipped into the red.

  • The S&P 500 opened lower by 2.05%
  • The Dow Jones Industrial Average opened lower by 0.41%
  • The Nasdaq Composite opened lower by 2.06%

Snap Up Uber and Grubhub Stock if the Rumors Are True

[Tuesday, May 12, 4:37 p.m.]
Contributed by Sarah Smith

InvestorPlace’s Bret Kenwell touched on news that had the stock market in an uproar Tuesday in his daily column. According to The Wall Street Journal’s Cara Lombardo, Uber (NYSE:UBER) is looking to take over food delivery competitor Grubhub (NYSE:GRUB) in an all-stock deal.

Grubhub has not confirmed or denied the rumors, but shares closed higher by 29% today. This comes as consumers turn en masse to restaurant delivery, as dine-in options remain closed in almost all states. Plus, Uber has seen a massive decline in its main ride-hailing business, leading it to focus more heavily on its Uber Eats.

Boy, that’s some news. Kenwell wrote that such a deal wouldn’t be surprising. Grubhub executives also hinted that consolidation in the food delivery industry “makes sense.”

InvestorPlace Markets Analyst Luke Lango loves the sound of this deal. He wrote that Grubhub stock is now a “scorching-hot buy” on the rumors. If the deal goes through — which Lango thinks it will — both Uber and Grubhub are stocks to buy.


Stocks Close Lower Tuesday Despite Morning Push

[Tuesday, May 12, 4:01 p.m.]
Contributed by Sarah Smith

This morning, we reported that investors were seemingly ignoring warnings from Dr. Anthony Fauci, the nation’s top infectious disease expert. But perhaps that changed, as stocks reversed course and headed lower. Even Vice President Mike Pence will now isolate himself, as his spokeswoman tested positive for the novel coronavirus.

Across the U.S. businesses continue to reopen. A big problem is the lack of agreement. President Donald Trump, state governors, CEOs and public health experts can’t seem to form a unified plan.

If Fauci’s warnings hold true, states rushing to reopen could be in for “suffering” in the near future. With that in mind, the S&P 500Dow Jones Industrial Average and the Nasdaq Composite all headed into the red to close the day.

  • The S&P 500 closed lower by 2.05%
  • The Dow Jones Industrial Average closed lower by 1.89%
  • The Nasdaq Composite closed lower by 2.06%

Tilray Stock Looks Like a Buy as It Navigates the Pandemic

[Tuesday, May 12, 3:32 p.m.]
Contributed by Sarah Smith

Canada’s cannabis darling Tilray (NASDAQ:TLRY) has had a rough year, just like many other cannabis stocks. Shares are down more than 55% year-to-date, and 85% over the last 12 months. Many investors were hoping a Monday night earnings report would turn things around. Unfortunately, shares are down 7.5% in intraday trading.

But not all investing experts are selling Tilray stock. MarketWatch’s Max Cherney wrote Tuesday that the novel coronavirus has not actually hurt the company’s operations. And, digging through the results, there may even be room for optimism.

For the first time ever, Tilray saw higher sales of medical cannabis abroad than at home in Canada. Overall, the pot producer did see sales increases in March and April over January and February. Many experts predict consumers will turn to marijuana while they are stuck at home.

Despite these results, or perhaps because of them, InvestorPlace’s Nicolas Chahine remains bullish on Tilray stock. He wrote today that shares will once again surpass $11, although the road ahead isn’t easy. What’s driving his argument? He sees higher international sales as a sign Tilray is expanding. The pandemic is keeping this success under the radar, but it’s not something to ignore.

As Chahine writes, look for new legislation in the U.S. and abroad. Anything that can help Tilray move forward is a good sign for cannabis bulls, and for Tilray stock.


4 Stocks to Buy With Major Fund Manager Support

[Tuesday, May 12, 3:08 p.m.]
Contributed by Sarah Smith

One great way to get stock ideas is through looking at what top fund managers are buying. That’s exactly what Morningstar’s Susan Dziubinski did, working with managers from Diamond Hill and Dodge & Cox to discover which consumer stocks are trending right now.

Like some of Dziubinski’s other picks, her four-stock list focuses on consumer plays. Two names on her list focus on the increasing popularity of snack foods while consumers are stuck at home. Another is a bet on a rebound in the travel industry.

What they all have in common is that fund managers are buying up shares. Here are the four names Dziubinski is watching now:

  • Cognizant Technology Solutions (NASDAQ:CTSH)
  • Kellogg (NYSE:K)
  • Mondelez (NASDAQ:MDLZ)
  • Booking Holdings (NASDAQ:BKNG)


7 Tech Stocks to Buy That Go Beyond Videoconferencing

[Tuesday, May 12, 2:46 p.m.]
Contributed by Sarah Smith

Tech stocks have been making waves recently, but as InvestorPlace’s Chris Lau writes, investors have mostly focused on stocks benefiting from remote work trends. Overlooking other tech megatrends, though, could mean forgoing serious profits.

Lau is bullish on big trends like artificial intelligence and 5G — and for good reason. Although the novel coronavirus has dampened international hype around those trends, they aren’t going anywhere. In fact, the pandemic is likely accelerating these trends. Ignoring them is a great way to lose money.

InvestorPlace also spoke with Dirk Hackbarth, a professor of finance at Boston University. One thing Hackbarth highlighted is that while American companies have historically led these megatrends, it’s time for investors to take Chinese companies seriously.

That’s especially true as China’s economy appears to be rebounding faster. From Hackbarth:

“To the extent that China’s economy may rebound before the U.S. reaches its trough this year, it will provide another advantage for Chinese firms, such as Alibaba and Baidu, to better compete with the likes of Microsoft and Alphabet.”

So, while you’re looking for the latest opportunity in videoconferencing, make sure to keep an open mind. Other tech trends, especially led by Chinese companies, represent major potential.

Here are seven tech stocks Lau is watching now:

  •  Facebook (NASDAQ:FB)
  • Amazon (NASDAQ:AMZN)
  • Alibaba (NYSE:BABA)
  • Microsoft (NASDAQ:MSFT)
  • Intel (NASDAQ:INTC)
  • Logitech (NASDAQ:LOGI)
  • Qualcomm (NASDAQ:QCOM)


Buy Fastenal Stock for Protective Equipment Potential

[Tuesday, May 12, 2:13 p.m.]
Contributed by Sarah Smith

Fastenal (NASDAQ:FAST) is likely not a stock that investors think about everyday. The company distributes safety equipment, fasteners and other industrial products as part of the wholesale supply chain. Its clients include construction businesses, food processors and local governments.

Thanks to the novel coronavirus, Fastenal is getting its time in the spotlight. Sales of its safety equipment were up 120% year-over-year in April, and FAST stock is up about 7% for the year. CFO Holden Lewis said that “surges” in safety equipment sales were certainly responsible for its performance.

According to Industrial Distribution, these safety equipment sales are changing the game, especially as sales of its fastener products continue to hurt. Fastenal saw 11,000 accounts make safety purchases in April that had not made similar purchases since October 2019.

But beyond the headlines, there’s a bigger opportunity. Fastenal is an otherwise boring company that doesn’t usually hold conference calls for its sales numbers. Lewis’ insight into the sales is important. He says one customer bought “back-to-work” kits for employees, filled with masks, temperature gauges and hand sanitizer. This is the new normal, and Fastenal is set to win.

More companies will ramp orders of safety equipment as they bring employees back to work, and similar kits will be making the rounds at all sorts of factories. Plus, once those factories reopen, sales of Fastenal’s other products should gradually return to normal.


5 Streaming Stocks to Buy as Social Distancing Continues

[Tuesday, May 12, 1:26 p.m.]
Contributed by Sarah Smith

Americans are entering a new normal, and they have an intense fear of germs.

That fact, along with a series of recent reports, bodes well for streaming stocks. Consumers ramped up their TV watching early on, but as they continue to stay at home, their new streaming accounts and favorite shows won’t disappear.

Plus, cord-cutting trends are only accelerating. Research firm MoffettNathanson reported that as pay TV subscriptions fell by 1.8 million in the first quarter, the state of cable TV returned to levels not seen since 1995. Clearly, as consumers up their TV time, they’re not choosing new cable packages.

Granted, MoffettNathanson’s report also includes businesses and restaurants that have canceled cable subscriptions. But other reporting from Axios’ Sara Fischer backs up the case for streaming stocks. She writes that traditional TV companies are also struggling to move forward with the fall season. It’s hard for networks to sell marketers if they don’t know what shows they can realistically produce.

On the other hand, streaming platforms benefit from deep archives of fan-favorite shows. With this in mind, consider streaming stocks a great way to play a phased economy reopening. That’s one of the reasons InvestorPlace Markets Analyst Luke Lango is so bullish on the space. He recently wrote that the novel coronavirus is accelerating the shift from traditional TV to streaming TV at record pace.

Here are five names he recommended at the end of April:

  • Netflix (NASDAQ:NFLX)
  • Disney (NYSE:DIS)
  • Amazon (NASDAQ:AMZN)
  • AT&T (NYSE:T)
  • Roku (NASDAQ:ROKU)


Novavax Stock Soars 60% on Vaccine Funding

[Tuesday, May 12, 12:45 p.m.]
Contributed by Sarah Smith

Novavax (NASDAQ:NVAX) got up on the right side of the bed this morning. In an early press release, the vaccine specialist announced it had received an additional $384 million from the Coalition for Epidemic Preparedness Innovations (CEPI). This money will help the company in its fight to develop a novel coronavirus vaccine. Earlier in 2020, it received $4 million from the same group.

Boy, investors like what they see. NVAX stock is up 68% in intraday trading, surpassing $40 per share. Although the funding itself is exciting, it’s likely the market is cheering the company’s plan to ramp toward “100 million doses” by the end of 2020.

According to the press release, the funding will allow early stage clinical trials to begin in Australia. Top-line results from Phase I studies should be ready in July. As previously mentioned, another portion of the money will go toward scaling up manufacturing capacity in 2020 and 2021.

Barron’s Josh Nathan-Kazis adds in some important context. He writes that Novavax is relatively far along in its studies for a coronavirus vaccine. At the same time, it faces fierce competition from more well-established companies. Novavax has no approved products on the market, although it is currently developing a vaccine for the common flu.

Shares are up over 800% so far for 2020, and analysts have a 12-month price target just over $42. After today’s move, that doesn’t imply very much upside.

However, it’s obvious investors will reward any company that brings a successful vaccine to market. With that in mind, don’t discount the bullish opportunity in NVAX stock. Plus, a vaccine will open the doors to a truly safe reopening, and perhaps a return to the pre-pandemic way of life.


Wedbush: Buy Apple Stock as iPhone 12 Draws Near

[Tuesday, May 12, 12:08 p.m.]
Contributed by Sarah Smith

Sure, “fears for a Nightmare on Elm Street” quarter influenced Apple’s (NASDAQ:AAPL) March results. But at the same time, Wedbush analyst Daniel Ives sees the company’s service business as “Teflon-like.” That’s a pretty nice comparison.

In a new note to clients, Ives turned up the heat on Apple. He gave shares an “outperform” rating and bumped his price target from $335 to $350. With a current share price near $318, that implies 10% of upside.

So what happened to turn Apple from a nightmare to a stock to buy? According to Ives, the thesis revolves around the iPhone 12. The analyst writes that approximately 350 million iPhones are in the company’s upgrade window, and supply chain experts in Asia are confident about iPhone momentum in 2020 and 2021.

But this forecast doesn’t even take into consideration a fall 2020 launch of the new phones. Ives writes that his firm sees a 10%-15% chance Apple releases the phones on schedule. A $350 price target is pretty comforting, especially given that outlook.

InvestorPlace Markets Analyst Luke Lango agrees. He wrote Friday that Apple is one of the best ways to invest in 5G, as consumers will need 5G devices to benefit from the trend. With or without new models in 2020, it’s nice to know analysts are still bullish on AAPL shares. Whenever the iPhone 12 debuts, be ready for a rally.


Is Jeff Bezos’ Movie Theater Move a Chance for Bulls?

[Tuesday, May 12, 10:55 a.m.]
Contributed by Sarah Smith

Rumors swirled faster yesterday in the investing world than in lines for a Marvel movie premier. That’s because the United Kingdom’s Daily Mail reported on a potential acquisition of AMC Entertainment (NYSE:AMC) by Amazon (NASDAQ:AMZN).

The former company is a shell of its former self. Movie theaters remain closed in many states even as phase-one reopening plans go into motion. Plus, movie studios have had to delay production work, and therefore big release dates. These last few weeks have been an absolute nightmare for the industry.

But the latter company is a true winner, even amid the novel coronavirus. It seems like nothing can stop Amazon, and it allegedly wants to up its stake in the entertainment world. InvestorPlace’s Will Ashworth questions just how comfortable consumers will be if Bezos successfully extends his reach.

Sure, the rumors raise a handful of ethical questions. But yesterday investors seemed to like the news as AMC stock shot up 30%. It’s back on the move today, up almost 7% in intraday trading.

So, is a huge opportunity for investors, or is it too good to be true? Ashworth isn’t confident Amazon will come to AMC’s rescue. He also isn’t confident that AMC insiders would even approve such a deal.

Similarly, InvestorPlace Markets Analyst Luke Lango thinks it’s not worth chasing AMC stock here. But, he does see opportunity. He writes that Amazon should “absolutely” buy AMC. If it does, expect the deal to add long-term growth tailwinds to an already impressive company.

In the meantime, keep your eyes on the headlines. Any official acknowledgement of the deal could change things.


7 Dividend Stocks to Buy if You’re Searching for Income

[Tuesday, May 12, 10:23 a.m.]
Contributed by Sarah Smith

This year has no doubt been a rough one for dividend investors. We’ve reported in this blog on the trials many companies face, choosing to slash or suspend dividends in order to better survive the pandemic.

In short, income investing looks bleak. Even Disney (NYSE:DIS) made the move to halt its dividend for the first half of 2020. If Mickey Mouse can’t deliver, then what company can? Well, InvestorPlace’s Ian Bezek has the answer.

Bezek doesn’t disagree that dividend stocks look rough now. But he does have some advice — look for simply the best blue-chip stocks that have solid histories of dividend payouts. These companies are most likely to maintain their dividends even in the midst of chaos.

Phew, that’s reassuring. Here are the seven dividend stocks he’s recommending now:

  • Johnson & Johnson (NYSE:JNJ)
  • Public Storage (NYSE:PSA)
  • General Dynamics (NYSE:GD)
  • PepsiCo (NASDAQ:PEP)
  • Qualcomm (NASDAQ:QCOM)
  • Colgate-Palmolive (NYSE:CL)
  • Duke Energy (NYSE:DUK)


Stocks Open Higher Despite Fauci’s Virus Warnings

[Tuesday, May 12, 9:31 a.m.]
Contributed by Sarah Smith

Dr. Anthony Fauci, the United States’ top infectious disease expert, will testify today as states continue reopening. He warns that a premature move could cause “needless suffering and death.”

But Fauci is at odds with President Donald Trump and the broader market sentiment. As states reopen, businesses reopen. Furloughed employees return to work. It sounds so simple, right?

On Tuesday morning, it appears so. The S&P 500Dow Jones Industrial Average and the Nasdaq Composite are all opening in the green.

  • The S&P 500 opened higher by 0.37%
  • The Dow Jones Industrial Average opened higher by 0.46%
  • The Nasdaq Composite opened higher by 0.78%

Buy Carnival Stock As Consumers Come Cruising Back

[Monday, May 11, 4:40 p.m.]
Contributed by Sarah Smith

Over the last few weeks, this blog has provided investors several reasons to be bullish on Carnival (NYSE:CCL) stock. We’ve looked at insider buying and the company’s plan to return to cruising this summer. Now, InvestorPlace’s Bret Kenwell has an even better reason to buy shares.

It turns out that consumers really are ready to start cruising again. In the three-day period after Carnival announced its summer plans, bookings rose 600% compared to the previous three-day period. How’s that for pent-up demand?

Granted, Carnival isn’t reopening all ports at once. It currently is eyeing summer departures from Florida and Texas, but that’s better than nothing.

As Kenwell writes, cruises won’t look the same. Carnival and its peers need approval from the Centers for Disease Control and Prevention. If they acquire that, they’ll also be looking at some new health guidelines. He says travelers should anticipate health screenings, no self-serve buffets and restricted occupancy in some areas. Passengers may have to provide medical notes proving they’re not at increased risk of contracting the novel coronavirus.

Still need some convincing? InvestorPlace’s Ian Cooper wrote that now is the perfect time to buy CCL shares. He’s confident that 2021 will see renewed momentum. Plus, he likes votes of confidence from Wall Street. UBS analyst Robin Farley says Carnival is the strongest in its sector.


Stocks Struggle Monday as Virus Uncertainty Reigns

[Monday, May 11, 4:01 p.m.]
Contributed by Sarah Smith

Boris Johnson is pushing for businesses to reopen in the United Kingdom. The United States continues to see a wave of phased reopenings. But South Korea just saw a spike in new novel coronavirus cases, as did China’s Wuhan, the origin of the outbreak.

Many in the U.S. are still waiting for their $1,200 stimulus checks. Democrats and Republicans are bickering over a fourth wave of stimulus payments — and representatives of the former party are hoping to aid hard-hit states.

Elsewhere in the pandemic-driven investing world, attention is on companies like Quidel (NASDAQ:QDEL), set to ramp production of new test kits. Tesla (NASDAQ:TSLA) CEO Elon Musk is threatening to move the company unless his California plant is allowed to reopen.

With all this in mind, the S&P 500Dow Jones Industrial Average and the Nasdaq Composite are in rocky territory at the start of the week.

  • The S&P 500 closed higher by 0.01%
  • The Dow Jones Industrial Average closed lower by 0.45%
  • The Nasdaq Composite closed higher by 0.78%

Is It Time to Start Buying Car Stocks?

[Monday, May 11, 3:45 p.m.]
Contributed by Sarah Smith

New reporting from The New York Times shows the light at the end of the tunnel may be getting closer. According to a Monday report from AutoNation (NYSE:AN), car sales began to rebound in April. CEO Mike Jackson said that the “automotive recovery is underway” as consumers remain eager to purchase new vehicles amid easing lockdowns.

No, that’s not exactly what many experts predicted. It seemed likely that car sales would keep falling. Unemployment figures are still on the rise, and consumer spending is hurting as a result. But there are other things working in favor of car sales.

For one, public transit is likely to lose even some loyal riders as employees return to their daily commutes. In early April, Axios’ Kim Hart wrote that public transit was on a “death spiral” as consumers worried about heightened infection risk. After 9/11 rocked New York City, it took six years for subway ridership to return to pre-crisis levels.

Jackson agrees that this growing fear of public transit is partially responsible for the rebound in car sales. At the end of April, sales were off by only 20%. At the start of that same month, they were off by 50%.

Shares of AN stock are up almost 4% in intraday trading, in what has otherwise been a rough day for stocks. On a similar note, Ford (NYSE:F), General Motors (NYSE:GM), Toyota (NYSE:TM) and Fiat Chrysler (NYSE:FCAU) are planning for near-term returns to production. California-based Tesla (NASDAQ:TSLA) is finding some high-ranking support in its push to reopen early.

Bullish investors should keep a close on eye on AutoNation and this group of automakers. As states reopen, we should get more data on public transit use. If consumers delay their return to subways and bus systems, car sales could spike.


Bullish on Cryptocurrencies? Here’s a New Way to Invest.

[Monday, May 11, 2:57 p.m.]
Contributed by Sarah Smith

Today is a big day in the cryptocurrency world. After lots of waiting, it’s finally the day of bitcoin’s (CCC:BTC) halvening, or halving. This event has had InvestorPlace analyst Matt McCall pounding the table for weeks. Why? If demand for bitcoin is high at the time of the halving, prices could soar.

But there’s another reason for crypto bulls to celebrate today. According to an early morning press release, investors can now trade physically delivered futures contracts for ether (CCC:ETH). This news makes Chicago’s ErisX the first U.S.-based exchange to allow such trades.

So what does this all mean? Ether refers to the tokens behind ethereum, a specific use of blockchain technology. Ether tokens enable operations on the ethereum blockchain platform.

Bitcoin is certainly the most well-known crypto, but many factors, including the novel coronavirus, have sparked a growing interest in other cryptocurrencies. That’s why ErisX has been pushing for a license to offer more regulated investment products. Previously, the exchange operated a live spot market for ether and other digital currencies.

Now, individual and institutional investors can participate via physically delivered futures contracts. When these contracts expire, investors will actually receive ether tokens, and can use these contracts to build a position in the currency. ErisX has a similar offering for bitcoin futures.

The biggest takeaway is that now investors have direct access to ether through traditional commodities markets. Another popular investment option has been the Grayscale Ethereum Trust (OTCMKTS:ETHE) which tracks the price movement of ether, but does not lead to ownership of tokens.


3 Airline Stocks to Buy That Will Survive the Turbulence

[Monday, May 11, 2:09 p.m.]
Contributed by Sarah Smith

When Warren Buffett of Berkshire Hathaway (NYSE:BRK.A, NYSE:BRK.B) announced he was selling his stake in several major airlines, investors panicked. The Oracle of Omaha is a legend. He can practically see the future, and he sees value even in hard-hit sectors.

What does it mean when he doesn’t see rebound value in the airlines? According to InvestorPlace’s  David Moadel, it’s not exactly the red flag many investors fear.

In fact, Moadel thinks that individual investors shouldn’t follow in Buffett’s footsteps. He thinks three of the major airlines are actually ready to fly high once the novel coronavirus eases.

Here are the stocks he’s recommending now:

  • Delta Air Lines (NYSE:DAL)
  • American Airlines (NASDAQ:AAL)
  • United Airlines (NASDAQ:UAL)

Quidel Stock Looks to Be Monday’s Coronavirus Winner

[Monday, May 11, 1:19 p.m.]
Contributed by Sarah Smith

Today California-based Quidel (NASDAQ:QDEL) is looking to go from zero to hero. Yep, you guessed it. The daily victory comes on news related to the novel coronavirus.

Over the weekend, the company received emergency-use approval from the U.S. Food and Drug Administration for a new type of test. This antigen test detects proteins associated with the virus, requires just a nasal swab and generates results within minutes.

Shares of QDEL stock are up 30% in intraday trading as a result.

There’s a lot to like here. One positive is the quick turnaround. Other tests have longer wait times, although offerings from Abbott Laboratories (NYSE:ABT) feature 5-minute and 15-minute results. The faster people get their results, the sooner they can self-isolate or get the treatment they need.

Quidel’s test is also the first antigen test to receive such approval. Other tests look for either antibodies or genetic material associated with the virus. Although antibody testing has become a hot topic, critics point to its flaws. Many of the marketed tests generate a significant amount of false-positive results.

According to NPR’s Jason Slotkin these antigen tests will also be cheaper and more accessible. One flaw is that they are not as sensitive (meaning they can trigger false-negative results) as the harder-to-come-by PCR tests that look for the virus’ genetic material.

Shoving aside scientific details, investors are happy. Quidel’s high-flying shares are likely to stay hot as states ramp up testing in efforts to safely reopen.


Buy Berkshire Hathaway Stock Now at a Discount Price

[Monday, May 11, 12:12 p.m.]
Contributed by Sarah Smith

Warren Buffett made waves at his annual meeting for Berkshire Hathaway (NYSE:BRK.A, NYSE:BRK.B). As we reported last week in this blog, some investors took his commentary to be a sign of distress. Remember, it’s not that easy for someone with more than $100 billion in cash to find meaningful value in the stock market.

However, individual investors can now find value in Berkshire Hathaway stock. According to Barron’s Andrew Bary, UBS analyst Brian Meredith has a “buy” rating on BRK.B stock. His 12-month price target of $233 is equivalent to $349,500 on BRK.A shares. That’s over $100,000 of upside.

So, why buy now? Berkshire’s book value is falling, representing a chance to purchase shares at a discount. It now trades at about 1.1 times book — down from a recent average of 1.4 times.

Yes, it’s important to note that Buffett doesn’t like focusing on the company’s book value. He’s long said that it doesn’t accurately reflect the underlying values of his businesses — he thinks Berkshire’s intrinsic value is much higher. Despite Buffett’s preferences, the book value is hard to ignore now.

InvestorPlace’s Wayne Duggan agrees, citing Whitney Tilson in his argument. Tilson sees Berkshire Hathaway as the “best retirement stock in the market.” With a lower-than-average price-book ratio and Tilson’s glowing endorsement, Berkshire shares look too good to pass up.


Bill Ackman Is Hot on Restaurant Brands International Stock

[Monday, May 11, 11:02 a.m.]
Contributed by Sarah Smith

Bill Ackman, the famed investor behind Pershing Square, is turning up the heat on Restaurant Brands International (NYSE:QSR). His firm has held a 5% stake since 2012, but a recent move has Pershing Square upping its stake to 7% — and filing U.S. Securities and Exchange Commission form 13D signaling activist intent.

According to CNBC’s Kenneth Squire, Restaurant Brands International is a typical investment for Ackman. It offers predictable growth and solid cash flows. Plus, since its Burger King, Tim Hortons and Popeyes brands operate with franchise models, it has very low capital expenditures.

This means that while other restaurants face a long road to recovery, QSR stock should bounce back with greater ease. As InvestorPlace’s Dana Blankenhorn wrote in early April, its franchisees are dealing with the brunt of the novel coronavirus. Yes, shareholders face a year-to-date loss of 20%. But Blankenhorn believes this is an opportunity to pick up more shares.

TipRank’s Maya Sasson agrees. She wrote in late April that with extremely well-known brands, QSR stock is ready for double-digit growth by the end of 2020.


Stocks Open Lower as States Take the Reopening Plunge

[Monday, May 11, 9:31 a.m.]
Contributed by Sarah Smith

Wait, what? Last week, it seemed like all Wall Street wanted was for more states and businesses to reopen. Now, though, headlines proclaim that investor “jitters” are behind Monday morning’s gloomy stock market open.

Public health officials continue to warn of the risks associated with premature reopening, and South Korea just reported a spike in novel coronavirus cases. As is the new normal, there’s just too much going on to put everything nicely in balance.

As states continue to push forward with phase-one reopenings, there will be a lot to watch. For now, the S&P 500Dow Jones Industrial Average and the Nasdaq Composite are all in the red.

  • The S&P 500 opened lower by 0.79%
  • The Dow Jones Industrial Average opened lower by 0.87%
  • The Nasdaq Composite opened lower by 0.65%

Disney Stock Bulls See More Reasons to Buy

[Friday, May 7, 4:37 p.m.]
Contributed by Jessica Loder

In Bret Kenwell’s stock market wrap-up today, he put the spotlight on Disney (NYSE:DIS). The headlines have been pretty rough for DIS stock lately, but things seem to be taking a turn for the better.

Investors and fans alike had been worried that even once things began to reopen, theme parks and major sporting events – places known for massive crowds — might not pick up where they left off. Would the visitors be too worried about Covid-19 to want to brave the crowds, even with precautions?

But then Shanghai Disney started selling tickets to their reopening on May 11, and those tickets sold out “in minutes.” Sure it’s opening at 30% capacity, but still – it sold out in minutes. Apparently, there is plenty of demand, and that bodes well for when the rest of Disney’s theme parks reopen.

Not only that, but while the big-name locations are closed until further notice, on May 20 some of the stores are opening in Disney Springs, a shopping area at Walt Disney World.

Rosenblatt sees these moves as positives, as earlier openings mean more revenue. Analyst Bernie McTernan wrote “If the timeline for reopening Downtown Disney in Shanghai and the Shanghai Disneyland is similar for Disney Springs and Disney World it suggests Disney World would reopen July 22nd, 41 days ahead of our current forecast.”


Flip Open the Paper and Buy New York Times Stock

[Friday, May 8, 4:16 p.m.]
Contributed by Sarah Smith

Investing in a newspaper, in this economy? That seems a bit outrageous. But according to new reporting from The Wall Street JournalNew York Times (NYSE:NYT) didn’t have that bad of a first quarter.

In fact, the company reported its biggest quarterly increase in digital subscriptions ever, which also helped to push up revenue. The New York Times gained 587,000 new digital subscribers, likely as consumers race to find accurate information about the novel coronavirus.

What is gloomy is the company’s outlook for the current quarter — with predictions for advertising revenue to fall as much as 55%. This problem by no means is unique to The New York Times. Ad-dependent companies all through the investing ecosystem are hurting.

So what does this mean? Well, the paper is attracting new subscribers when it matters most, even though consumer spending is dropping. Plus, it’s likely many investors will price in falling ad revenue in advance. When ad spending rebounds, NYT stock should benefit along with its peers.

But there’s an even more bullish case to be made here. After the report, CFRA analyst Tuna Amobi upgraded shares to a “buy” rating with a $38 price target. It’s not drastic, but it is a good sign.

InvestorPlace’s Josh Enomoto has been bullish on NYT stock since January 2020 — and his catalyst goes beyond the pandemic. As many investing experts predict that President Donald Trump will retake the White House in November, Enomoto thinks The New York Times will see heightened readership as the election approaches. It’s no secret that Trump and the press don’t always get along, which should mean more drama, more subscribers and more share price returns for investors.


Deutsche Bank: General Motors Is Wall Street’s New Darling

[Friday, May 8, 3:36 p.m.]
Contributed by Sarah Smith

Until Wednesday, the only good news in the automotive world seemed to be the birth of Tesla (NASDAQ:TSLA) CEO Elon Musk’s son. That all changed when General Motors (NYSE:GM) reported first-quarter results that had the analyst community cheering.

Granted, it’s a rough world for traditional carmakers. As we’ve previously reported in this blog, General Motors and its competitors — Ford (NYSE:F) and Toyota (NYSE:TM) — have seen sales slump in a big way as the novel coronavirus impacts consumer spending.

Regardless, Wednesday’s earnings report had GM stock up 3%. That’s because adjusted earnings per share of 62 cents seriously beat expectations for 33 cents. General Motors also beat on revenue expectations.

This surprise had Deutsche Bank analyst Emmanuel Rosner “re-upgrade” GM stock to a “buy” rating, just a month after downgrading it to a “hold.” Although shares are still down almost 40% for the year, Rosner thinks they’ve priced in any more bad news. He also interprets the first-quarter results as a sign that cost-cutting measures are working in General Motor’s favor.

From Deutsche Bank’s Emmanuel Rosner:

“GM’s strong [first-quarter] performance and forward-looking outlook … demonstrate the benefit from its proactive actions to transform the business, right size its costs and boost profitability.”

Here’s one more fun note. According to TipRanks, 80% of analysts covering GM stock think it’s a buy now. The average 12-month price target is $31.11, implying almost 40% of upside.


4 Top Gold Stocks to Buy Now

[Friday, May 8, 1:22 p.m.]
Contributed by Sarah Smith

Not too long ago, Bank of America analyst Michael Widmer set an 18-month price target of $3,000 on gold. With that hike he had one catchy message: “The Fed can’t print gold.”

Widmer’s words likely resonate with a lot of investors. As we’ve previously reported in this blog, the Federal Reserve’s unprecedented actions to fight the economic effects of the novel coronavirus have some worried about inflation after the pandemic.

And on Thursday, famed investor Paul Tudor Jones made headlines when he admitted to purchasing bitcoin as a hedge against inflation. Clearly, inflation risk is top of mind.

But gold is the original hedge. One chief executive in the space is calling it a “self-funded insurance policy” as demand for the shiny metal climbs. That’s why InvestorPlace’s Chris Markoch rounded up four gold stocks for investors to consider now. Just as with other hot trends, Markoch cautions against buying into the hype. His recommendations are not speculative — they’re quality plays.

Here are the four stocks he’s recommending now:

  • Barrick Gold (NYSE:GOLD)
  • Newmont Corporation (NYSE:NEM)
  • Wheaton Precious Metals (NYSE:WPM)
  • Vectors Gold Miners ETF (NYSEARCA:GDX)

It’s Time to Buy Some Small-Cap Stocks

[Friday, May 8, 12:35 p.m.]
Contributed by Sarah Smith

The novel coronavirus has shed light on several different stock buying strategies. Many experts are recommending that investors buying solid large-cap stocks at discount prices. For example, before the market rebound, leading names like Facebook (NASDAQ:FB) were at crazy low prices. Unfortunately, other investors are staying out of the stock market entirely and focusing on cash.

According to the American Association of Individual Investors, regardless of your strategy, it’s important not to forget small-cap stocks when making pandemic purchases. Why? These smaller names tend to outperform their larger peers after extreme market action.

This phenomenon is known as reversion to the mean. As AAII Journal editor Charles Rotblut writes, reversion to the mean is like a rubber band. When stretched, it snaps back, and sometimes it snaps back fiercely. Small-cap stocks have been stretched to record-cheap prices. If they snap “fiercely” higher, you don’t want to miss out.

So, where should you start? InvestorPlace Markets Analyst Luke Lango has 10 recommendations:

  • Cardlytics (NASDAQ:CDLX)
  • Inseego (NASDAQ:INSG)
  • Nio (NYSE:NIO)
  • Plug Power (NASDAQ:PLUG)
  • Stitch Fix (NASDAQ:SFIX)
  • Tabula Rasa Healthcare (NASDAQ:TRHC)
  • Health Catalyst (NASDAQ:HCAT)
  • InMode (NASDAQ:INMD)
  • LivePerson (NASDAQ:LPSN)
  • Maxar Technologies (NYSE:MAXR)

2 Unconventional Airline Stocks to Buy Now

[Friday, May 8, 11:27 a.m.]
Contributed by Sarah Smith

In just a few weeks, the novel coronavirus decimated air travel. International borders were closed, airlines stopped serving major hubs and passengers simply stopped flying. But as CNBC’s Leslie Josephs writes, much of the conversation has focused on passenger airlines.

Now, big names like Delta Air Lines (NYSE:DAL), American Airlines (NASDAQ:AAL) and United Airlines (NASDAQ:UAL) are once in again in the news as they ramp up cargo-only flights. Some investors like what they see, and think this pivot shows their comeback potential.

Josephs points out two other airline stocks that aren’t getting as much love — but they really deserve it. Cargo operator Atlas Air Worldwide Holdings (NASDAQ:AAWW) is up 40% for the year. That’s way better than the passenger carriers. Shares of Air Transport Services Group (NASDAQ:ATSG) are down for the year, but its revenue is way up.

It’s certainly not a bad idea for the traditional passenger carriers to break into the cargo space, but Atlas and ATSG have just been doing it longer. Plus, AAWW and ATSG benefit from partnerships with Amazon (NASDAQ:AMZN) — they’re both contracted to fly for the e-commerce giant.

With that in mind, these unconventional airline stocks deserve a second look. If anything, the pandemic is accelerating e-commerce, and that trend isn’t likely to reverse.


3 Stocks to Buy That Are Long-Term Coronavirus Winners

[Friday, May 8, 10:50 a.m.]
Contributed by Sarah Smith

Investors have seriously profited from stocks the novel coronavirus is making more relevant. Clorox (NYSE:CLX), Alpha Pro Tech (NYSEMKT:APT) and Costco (NASDAQ:COST) are all great buys while consumers focus on bulk grocery orders, face masks and disinfecting products.

But in an interview with Investor’s Business Daily, Andrew Horowitz of “The Disciplined Investor” highlighted three stocks investors should be looking to buy now. These move beyond the first phase of the pandemic — focusing instead on the crisis’ long-term impacts.

For example, one stock he recommends is a play on funeral and cremation services. Another company he likes produces high-tech temperature scanners. As states move to reopen, all sorts of venues are likely to implement some sort of temperature check. Earlier in May, investors learned that Simon Property Group (NYSE:SPG) would begin reopening its mall properties with optional temperature checks for shoppers, and mandatory checks for employees.

So, without further ado, here are Horowitz’s long-term coronavirus winners:

  • Flir Systems (NASDAQ:FLIR)
  • Service Corporation International (NYSE:SCI)
  • Veeva Systems (NYSE:VEEV)

Stocks Trying to End the Week on a High Note

[Friday, May 8, 9:31 a.m.]
Contributed by Jessica Loder

The Nasdaq moved back into the green on the year yesterday, and last night the U.S. federal government signaled that a new trade war with China may be off the table. Traders seem to be taking that optimism into Friday.

The one big sour note is the April unemployment report, released at 8:30 this morning. The report included a loss of 20.5 million jobs in April, and an unemployment rate of 14.7%. But the plummeting employment rate isn’t exactly new, and the troubling numbers may have already been priced in.

Whatever the reason, stocks are in the green Friday morning. The S&P 500, Dow Jones Industrial Average and the Nasdaq Composite all opened up for the day.

  • The S&P 500 opened higher by 1.06%
  • The Dow Jones Industrial Average opened higher by 1.32%
  • The Nasdaq Composite opened higher by 0.7%

The Best Thing Happening During These ‘Worst of Times’

[Thursday, May 7, 4:55 p.m.]
Contributed by Andrew Taylor

During times of great volatility, investors often cling to what they’re familiar with … including the stocks of companies they know best.

Fear and conventional wisdom push people to the biggest brands.

But what if I told you that America’s top stock picker — a man with 40 recommendations that have gained at least 1,000% in his career — believes that America’s most popular brand is a “must sell” right now?

That’s exactly what Eric Fry is saying

This giant of the past was doomed with or without the fear of a pandemic. Eric believes it’s one of 25 big-name stocks that are going to experience hard times, even if a coronavirus cure is found tomorrow.

And, remember, Eric is the legendary trader that accurately predicted the collapse of more than 70 stocks. That includes Cisco (fell 75% in a year after his prediction), Tyco (fell 74% in the year after his prediction) and Countrywide Financial (fell 87% in the two years after his prediction).

Instead, Eric believes anyone with money in the market should focus on four companies that are in position right now to help people capture huge market gains.

You probably haven’t heard of a single one of these firms…

But you will.

Get the facts for yourself and be one of the first to learn more about the four stocks you should buy right now … as well as the 25 companies you should sell immediately, on our website, here.

Tune in to this video presentation now, while it is still available, and Eric will reveal what he believes will be his next 1,000% winner. The name, the ticker symbol and why it’s such a screaming buy — it’s all in Eric’s presentation and FREE to view. Just keep in mind, this valuable information won’t be up on our website forever.


Fastly and Twilio Are Set to Be Coronavirus Winners

[Thursday, May 7, 4:42 p.m.]
Contributed by Sarah Smith

InvestorPlace’s Bret Kenwell highlighted two serious winners in his daily column today. Twilio (NYSE:TWLO), a cloud communications platform, saw its shares close higher by 40%. That’s largely thanks to its stellar second-quarter guidance.

Analysts were calling for estimates of $323.4 million, but Twilio’s management is changing the game. They expect revenue between $365 million and $370 million — remember, most companies are reducing or withdrawing guidance completely.

Thursday’s second winner was cloud computing services provider Fastly (NYSE:FSLY). Shares similarly skyrocketed, closing higher by 46%. After the company hiked its full-year outlook, Kenwell writes it’s refreshing to see that the novel coronavirus isn’t hurting all companies.

A word of caution about chasing the rally here: InvestorPlace Markets Analyst Luke Lango sees a 2024 price target of $140 for Twilio shares. After today, they’re at $170. With this in mind, follow InvestorPlace analyst Matt McCall’s advice and pick up TWLO on the next dip.


Stocks Close Higher Thursday Ahead of Payroll Report

[Thursday, May 7, 4:01 p.m.]
Contributed by Sarah Smith

As we near the end of the week, it’s time for a little déjà vu. What does that mean? Well, it’s yet another Thursday marked by a grim economic report. This morning, we learned that another 3.2 million Americans filed for unemployment benefits, and the major indices don’t seem to care.

Also, investors once again find themselves in a predicament ahead of the U.S. Department of Labor’s monthly non-farm payrolls report. St. Louis Federal Reserve President James Bullard said this report could be one of the worst ever. That’s comforting!

At the same time, this weekend will mark the beginning of several states’ reopening plans. On Friday, 85% of Starbucks’ (NASDAQ:SBUX) stores should be open, and it will be a little easier for consumers to get their daily coffee fix.

In other words, there’s a cognitive dissonance in the market. At market close Thursday, the S&P 500Dow Jones Industrial Average and the Nasdaq Composite were well in the green. Will that hold tomorrow morning?

  • The S&P 500 closed higher by 1.15%
  • The Dow Jones Industrial Average closed higher by 0.89%
  • The Nasdaq Composite closed higher by 1.41%

7 Cryptocurrencies to Buy for the Bitcoin Halvening

[Thursday, May 7, 3:34 p.m.]
Contributed by Sarah Smith

Today, famed investor Paul Tudor Jones made headlines when he announced he was buying bitcoin. According to Bloomberg’s Erik Schatzker, this makes him one of the first big names to do so. And Schatzker’s argument is pretty convincing — he sees cryptos as similar to gold in the 1970s, a great hedge against inflation.

As the Federal Reserve has stepped up its role to fight the economic effects of the novel coronavirus, many experts are worried what unprecedented central bank actions could mean for inflation. That’s why bitcoin — and smaller cryptocurrencies known as altcoins — have been gaining a lot of traction.

Cornell University’s William Cong told InvestorPlace that one of the biggest attractions of cryptocurrencies is that they are decentralized — they’re not linked to the Fed. From Cong:

“Existing currency valuation models do not quite take into consideration decentralization — a potentially distinguishing feature of cryptocurrencies.”

But this decentralization is not the only reason cryptos are hot right now. Bitcoin’s next halvening is just around the corner, and prices have been known to skyrocket after these events. That’s why InvestorPlace analyst Matt McCall is gearing up to share a new crypto recommendation in less than 24 hours.

It’s also why InvestorPlace Markets Analyst Luke Lango is bullish on cryptocurrencies. Ahead of the halvening, he’s recommending that investors buy these seven coins:

  • Bitcoin (CCC:BTC)
  • Zcash (CCC:ZEC)
  • Ripple (CCC:XEC)
  • Basic Attention Token (CCC:BAT)
  • Chainlink (CCC:LINK)
  • Synthetix Network Token (CCC:SNX)
  • DxChain Token (CCC:DX)


3 Stocks to Buy for a Long-Lasting Bear Market

[Thursday, May 7, 3:06 p.m.]
Contributed by Sarah Smith

Each week, some pretty staggering economic figures have hit the market. Just this morning investors learned that another 3.2 million Americans filed for unemployment benefits. A few days prior, a new report from ADP shows that 20.2 million private jobs were lost in the month of April.

With that in mind, those calling for a long-lasting bear market, like InvestorPlace’s Laura Hoy, don’t seem irrational. An important note is that Hoy isn’t cashing out — she’s recommending stocks best fit to weather tough times.

InvestorPlace also spoke with Scott Baier, Clemson University’s economics department chair, about what economic recovery will look like. He sees a lot riding on the second quarter.

“The keys to the market in Q2 will depend on the progress that is made in our ability to respond to the health threats posed by COVID-19. If [we] are successful at flattening the curve and if state and federal governments have succeeded in making progress the market should begin to bounce back. Similarly, if the fiscal and monetary policies are able to provide support for business to remain open and retain their employees, the market is likely to bounce back in Q2.”

Taking Baier’s words to heart, Hoy says that investors should be looking now for stocks that would benefit from economic recovery, but that also could sustain a longer bear market.

Here are the names on her list:

  • CVS Health (NYSE:CVS)
  • Dominion Energy (NYSE:D)
  • 3M (NYSE:MMM)

Bernstein: 4 Better Work-From-Home Stocks to Buy

[Thursday, May 7, 2:42 p.m.]
Contributed by Sarah Smith

Bernstein analysts aren’t strangers to the fact that Zoom Video Communications (NASDAQ:ZM) has been a popular pandemic play. But they also know that many investors missed out on the first wave of work-from-home stocks.

Today, a new note to clients brings some good news. As companies like Capital One (NYSE:COF) and Facebook (NASDAQ:FB) plan to keep most employees at home for several more months, the remote work trend isn’t going anywhere.

So where should investors look? Analysts Zane Chrane and Mark Moerdler are recommending “secondary beneficiaries” to Zoom’s surge. For instance, companies that provide support to its video conferencing service.

Here are four work-from-home stocks they’re recommending now (subscription required):

  • Equinix (NASDAQ:EQIX)
  • Amazon (NASDAQ:AMZN)
  • Oracle (NYSE:ORCL)
  • Microsoft (NASDAQ:MSFT)

2 Mobile Gaming Stocks to Buy Now

[Thursday, May 7, 2:30 p.m.]
Contributed by Sarah Smith

We’ve written often in this blog about video game stocks, but for good reason. Microsoft (NASDAQ:MSFT) and Sony (NYSE:SNE) both plan to launch new consoles in 2020, and beyond that, the novel coronavirus is rapidly increasing the popularity of video games.

A perfect piece of evidence is Nintendo (OTCMKTS:NTDOY). Its Switch console is flying off shelves — almost impossible to find. Much of that demand is thanks to the new Animal Crossing: New Horizons, released just in time for stay-at-home orders.

But, yesterday’s earnings report from Zynga (NASDAQ:ZNGA) is proof that demand for mobile gaming is just as high. Remember Words With Friends and Farmville? Apparently many consumers still do. Zynga CEO Frank Gibeau told Axios that the pandemic is driving consumers back to familiar games.

On that note, Zynga had a stellar earnings report, beating its own estimates. According to Barron’s Eric Savitz, Zynga predicted revenue of $385 million. Instead, it reported $404 million — up a whopping 42% year-over-year. No wonder many InvestorPlace writers, including analyst Matt McCall, have been pounding the table on ZNGA stock.

But there’s a second winner elsewhere in the mobile gaming world. InvestorPlace’s Josh Enomoto recently recommended Glu Mobile (NASDAQ:GLUU), the maker of branded games like one for Keeping Up With the Kardashians. Enomoto says the biggest appeal of Glu’s game is that they’re cheaper than consoles, and the games associated with consoles.

While it seems like the entire industry is hot, don’t count out mobile gaming stocks now.


Is There Still Time to Buy Moderna Stock?

[Thursday, May 7, 2:10 p.m.]
Contributed by Sarah Smith

Another day, another pharmaceutical darling. Today it’s shares of Moderna (NASDAQ:MRNA) that are shooting higher in the market — to the tune of 10.5%.

That’s because the company is testing a vaccine candidate for the novel coronavirus, and once again it’s upping the ante. According to reporting from BioPharma Dive’s Ned Pagliarulo, Moderna already had an “exceptionally ambitious clinical development plan” for its candidate.

On Thursday, though, Moderna released even more ambitious news. As the vaccine candidate works through Phase 1 trials, Moderna is prepping to launch late-stage trials by this summer. As Pagliarulo highlights, just 10 days ago Moderna said it would start those same trials in the fall.

Investors love the ambition. Even without conclusive data, Moderna is ramping up production of the candidate. Consumers, many afraid of participating in a reopened world without a vaccine, are waiting with bated breath.

But MRNA stock has already had a crazy 2020. Shares hit a low just below $18 and climbed as high as $56. Counting Thursday’s intraday rally, they’re resting near $54 now. Can they go higher, or is it too late for new investors to get in on the action?

InvestorPlace’s Ian Cooper says there’s still more room to run, which is why he’s recommending Moderna stock now. He says unprecedented demand for a coronavirus vaccine and the confidence a successful treatment will bring to the market give shares “plenty” of upside potential.


My Newest Crypto Pick Is Live in 24 Hours

[Thursday, May 7, 1:35 p.m.]
Contributed by Matt McCall

We are down to just 24 hours.

That’s when I’m releasing my newest cryptocurrency buy recommendation.

You don’t want to be late to position yourself.

The cryptocurrency Halvening event is set to occur just one week from now.

The last time this event occurred, little-known cryptocurrencies saw extraordinary gains, like…

  • Reddcoin, which grew 72,400%.
  • Neo, which rose 134,453%.
  • And Ripple, which shot up 43,448%.

History has shown the biggest gains in crypto investing goes to those who move earliest.

That’s why I’m urging you to go over my buy recommendation the moment it goes live. That’s less than 24 hours from now.

The best part about crypto investing is that a small stake, just $500 to $1,000, can potentially grow into five or six figures if invested correctly. My newest buy recommendation tomorrow can help kickstart your crypto investing journey.

If you want to be one of the first to receive my newest crypto buy recommendation and research…

Claim your spot here.


Starbucks Stock Is a Buy as Coffee Cravings Intensify

[Thursday, May 7, 1:25 p.m.]
Contributed by Sarah Smith

Many consumers (myself included) miss the experience of picking up an iced caramel macchiato from Starbucks (NASDAQ:SBUX). No, iced coffee drinks are not by any means essential. But Starbucks and its peer coffee chains are a symbol of American culture. In particular, Starbucks is a brand deeply embedded in daily life.

That’s why InvestorPlace analyst Matt McCall thinks Starbucks is among the strongest restaurant stocks. Customers are intensely loyal to the Seattle-based chain. Today, he wrote that while SBUX stock has been hit hard by the novel coronavirus — like all other food names — it’s used this time to pivot.

As The Washington Post reported Tuesday, Starbucks is set to reopen 85% of its stores by tomorrow with mobile ordering, contactless payment and curbside pick-up options. Previously, many stores without drive-thru windows were closed.

These reopenings, and Starbucks’ quick pivot to safer service, is a testament to its strength. As McCall writes, that should make SBUX stock a buy now.

Shares are up 3.5% in intraday trading.


Buy Peloton Stock as Consumers Panic Buy Peloton Bikes

[Thursday, May 7, 1:10 p.m.]
Contributed by Sarah Smith

In perhaps a sign of these bizarre times, consumers are panic buying Peloton (NASDAQ:PTON) bikes. Yes, these bikes come with a $2,000-plus price tag. But they also represent a certain quality — and a luxury brand — for athletes unable to hit the gym.

After its 2019 initial public offering, many investors scoffed at Peloton. Who was buying luxury bikes? To make matters worse, a poorly planned holiday commercial spurred widespread outrage. Now, though, it looks like Peloton is making a comeback.

As reported by the team at Morning Brew, Peloton’s revenue climbed 66% and hit $525 million. That definitely beat analyst expectations. On top of that, it added 1.1 million users to its digital fitness platform, where it offers virtual classes alongside its equipment.

InvestorPlace’s Chris Markoch has long been rallying behind fitness stocks for our new at-home world. In early April he listed PTON shares as some of the top names to buy. At the time, Markoch argued that social distancing was forcing people to change their habits — and more consumers were choosing to get fit with Peloton.

Even once social distancing ends, many fitness buffs will see gyms as scary germ factories. That should bode well for Peloton’s continued success in 2020 and beyond.

One thing to watch: As Morning Brew highlights, Peloton has halted deliveries of its treadmill. This product typically retails for $4,295 and is too big for safer delivery options the company is using for its signature bike. Will a return of treadmill sales further boost PTON?


10 AI Stocks to Buy for Solid Income Now

[Thursday, May 7, 11:35 a.m.]
Contributed by Sarah Smith

Yes, our world currently revolves around toilet paper, face masks and all sorts of disinfecting products. But beneath the surface, megatrends in tech like 5G and artificial intelligence are still evolving. In fact, after the pandemic, we will rely on these new technologies for innovations in critical areas like healthcare and communications.

But recognizing the hype in these technologies poses a risk to investors. Not all companies engaging with AI are stocks you want in your portfolio. So then how do you sort through the noise to profit?

InvestorPlace analyst Neil George is all about finding solid, profitable opportunities. Within the 5G space, he looks at software companies, data center companies and even a finance company at the heart of Silicon Valley startups.

Here are the 10 AI stocks he’s recommending now:

  • Vanguard Information Technology ETF (NYSEARCA:VGT)
  • AT&T (NYSE:T)
  • Verizon (NYSE:VZ)
  • Samsung (OTCMKTS:SSNLF)
  • Ericsson (NASDAQ:ERIC)
  • Microsoft (NASDAQ:MSFT)
  • Digital Realty Trust (NYSE:DLR)
  • Corporate Office Properties (NYSE:OFC)
  • Hercules Capital (NYSE:HTGC)
  • Amazon (NASDAQ:AMZN)


Stocks Open Higher Despite Unemployment Figure

[Thursday, May 7, 9:31 a.m.]
Contributed by Sarah Smith

Another 3.17 million Americans filed for unemployment benefits, more than analysts expected from Thursday’s report. However, it seems that investors are mostly shrugging off this weekly gloom.

It’s safe to say the major indices are — stocks are well in the green Thursday morning. The S&P 500, Dow Jones Industrial Average and the Nasdaq Composite all opened up for the day. Plus, with this morning’s open, the Nasdaq Composite has erased its 2020 loss.

  • The S&P 500 opened higher by 1.33%
  • The Dow Jones Industrial Average opened higher by 1.12%
  • The Nasdaq Composite opened higher by 1.35%

Nio Stock Soars on April Delivery Figures

[Wednesday, May 6, 4:38 p.m.]
Contributed by Sarah Smith

There’s a particular type of optimistic investor that loves Chinese electric vehicle maker Nio (NYSE:NIO). The company represents massive potential — but it hasn’t had an easy journey. It has faced cash crunches, high levels of criticism and a lot of market doubt. Shares rest now just above $3.60.

But part of its struggle has been universal. In the first quarter, car sales were deeply impacted as the novel coronavirus kept people inside. That’s why the company’s April results had Nio stock gain 10.4% in the stock market today.

As InvestorPlace’s Bret Kenwell wrote in his daily column, the company delivered 3,155 vehicles in April. That’s up more than 100% from March. And, it’s also a great testament to China’s economic recovery.

According to TipRanks, Nio stock has been racking up hold and sell ratings. But today’s report could be just what the company needs to gain new investor favor. Bank of America analyst Ming-Hsun Lee gave it a “buy” rating today and a $5 price target. That alone gave investors hope.

So, is it a buy now? InvestorPlace Markets Analyst Luke Lango thinks so. He wrote Monday that Nio has the potential for “HUGE” gains. That’s because he sees the electric vehicle market, especially in China, set for a massive boom.


Stocks Reverse Course Wednesday, Shedding Gains

[Wednesday, May 6, 4:01 p.m.]
Contributed by Sarah Smith

Earlier this morning, bulls seemed set to have a good day. More and more states are jumping on board the reopening bandwagon, and nations around the world are doing the same. But with the exception of the Nasdaq Composite, stocks shed their gains over the course of the day.

Investors have a lot to consider, including the health risks associated with reopening. Retailers are struggling with bankruptcy and further stimulus funding seems far away. Perhaps it’s not all that surprising the S&P 500 and Dow Jones Industrial Average couldn’t stay in the green.

  • The S&P 500 closed lower by 0.7%
  • The Dow Jones Industrial Average closed lower by 0.91%
  • The Nasdaq Composite closed higher by 0.51%

3 Solar Stocks to Buy as Renewable Energy Regains Interest

[Wednesday, May 6, 3:47 p.m.]
Contributed by Sarah Smith

When InvestorPlace’s Larry Ramer recommended three top solar stocks in February 2020, he likely had no idea the novel coronavirus was about to sweep the world. It’s also likely that he didn’t predict the ensuing pandemic would throw Russia into an oil price war with Saudi Arabia. But boy, this year has been a doozy.

In March and April, renewable energy seemed doomed. With crude oil at rock-bottom prices, there just was less appeal for alternate sources. As Bloomberg’s Anthony Di Paola writes, cheap crude used to deter investments in renewable energy, particularly in nations dependent on oil sales.

But May 2020 is showing that things are changing. Di Paola writes that countries in the Middle East are surprisingly moving forward with renewable energy projects. Saudi Arabia is pushing to drastically up its renewable capacity by 2030, and in April took the next steps in selecting solar projects.

In the United Arab Emirates, Abu Dhabi and Dubai are moving forward with building solar plants after receiving “record-low” bids. So, it seems like solar power is still hot.

For investors who want to get ahead of the rebound, here are Ramer’s three picks:

  • JinkoSolar (NYSE:JKS)
  • SunPower (NASDAQ:SPWR)
  • Daqo New Energy (NYSE:DQ)

On another positive note, shares of all three companies are climbing in the stock market today.


Did Disney Stock Just Start Its Comeback Story?

[Wednesday, May 6, 3:22 p.m.]
Contributed by Sarah Smith

In many ways, Disney’s (NYSE:DIS) earnings report was a disaster for the company. It reported a 58% drop in operating income for its parks and cruises segment — one of its most iconic. Overall, Disney’s earnings per share came in at 60 cents, missing expectations for 89 cents. And it’s suspending its dividend for the first half of the year.

That’s all bad news. But there’s a silver lining boosting DIS stock in the market today.

CNBC’s Jessica Bursztynsky writes that its Disney+ streaming service now has 54.1 million subscribers. That’s up from 33.5 million at the end of March.

Yes, the streaming service certainly isn’t driving the bulk of Disney’s revenue. And yes, critics are right in saying Disney is fundamentally associated with Cinderella’s castle, not a living room couch. But the quick success of Disney+ highlights the power of the company, and what InvestorPlace’s Chris Markoch sees as the crux of its comeback story.

Even as a serious bull, Markoch isn’t denying that Disney faces some serious challenges. However, he’s confident that at least a handful of curious consumers will return to Florida and California parks as soon as they reopen. That’s why he says with some faith, trust, pixie dust and hand sanitizer, DIS stock is a buy right now.

Here’s a final note: Disneyland’s Shanghai location will begin reopening May 11. Investors should keep a close eye on that process.


Here’s the Bull Case From Warren Buffett’s Annual Meeting

[Wednesday, May 6, 2:48 p.m.]
Contributed by Sarah Smith

If you’ve checked the financial news in the last few days, you’ve likely seen some doom-and-gloom headlines about Warren Buffett’s annual Berkshire Hathaway (NYSE:BRK.A, NYSE:BRK.B) meeting. Some investors are focusing on a “tone shift.” Buffett is known for being incredibly pro-America and incredibly optimistic. But this time around he isn’t buying stocks.

InvestorPlace’s Dana Blankenhorn wrote today that Buffett’s cash hoarding is representative of deeper economic troubles in America. The Federal Reserve has stepped in to save demand, but Americans aren’t spending money. Frankly, Blankenhorn writes, many don’t have money to spend.

Buffett also sold airline stocks — some of his more noteworthy investments. He also is hinting at another market correction, with what InvestorPlace’s Will Ashworth describes as a less-confident approach than during the Great Recession.

If the Oracle of Omaha isn’t buying, isn’t that a terrible sign? While there are certainly problems in today’s market, including the income inequality Blankenhorn highlights, Buffett’s virtual meeting wasn’t a destruction of the bull case.

In fact, Ashworth writes that many of Berkshire Hathaway’s businesses are doing well. Some are even increasing headcounts in the midst of a pandemic, which is a comforting sign of their health.

From a sentiment perspective, Buffett isn’t suddenly betting against America. He’s merely cautioning investors that it’s impossible to predict tomorrow, or even next month, as the novel coronavirus continues to affect the world.

Beyond that, Buffett needs what you could call an elephant-sized deal to profit. He has $125 billion to work with — throwing money into the market better be worth his time.

So what’s the takeaway? The 89-year-old Buffett is being cautious, and he’s looking for better values to step in and buy. That doesn’t mean it’s time to cash out, because you certainly won’t end up with his $125 billion cash pile. You’re better sticking it out in the market.


3 Teleconferencing Stocks to Buy Now

[Wednesday, May 6, 2:06 p.m.]
Contributed by Sarah Smith

Yesterday, we reported that Capital One (NYSE:COF) will keep the majority of its employees working from home until September. To many experts, that’s far from an irrational move.

Even Berkshire Hathaway’s (NYSE:BRK.A, NYSE:BRK.B) Warren Buffett is speaking up about remote work. According to InvestorPlace’s Ian Cooper, the Oracle of Omaha sees the pandemic making permanent changes to office life.

In other words, many Americans who began working from home because of the novel coronavirus will not return to traditional offices just because lockdown protocols are lifting.

Tech stocks that play into telework — and specifically teleconferencing — have been some of this year’s biggest winners. But should you throw your money behind any old videoconferencing name?

Cooper doesn’t think so. Instead, he sees these three stocks as the top plays in the space now:

  • Zoom Video Communications (NASDAQ:ZM)
  • Slack Technologies (NYSE:WORK)
  • RingCentral (NYSE:RNG)

The Buzz Behind Bitcoin’s Price Surge

[Wednesday, May 6, 12:55 p.m.]
Contributed by Nicholas Stern

Bitcoin is hovering around $9,200 at the moment. It’s up over 11% in the past week and over 30% in the past month.

There’s a buzz in the air, and many in the industry are pointing to bitcoin’s halving as one reason generating the recent excitement and price action.

Indeed, searches for “bitcoin halving” on Google have increased exponentially in recent weeks.

Source: InvestorPlace

More and more people are clamoring to figure out what’s behind this change to bitcoin’s mining reward and why it could lead to higher prices.

If you’re not familiar with the halving (or halvening), basically, it happens about every four years when the supply of new bitcoin coming on the market gets cut in half. The idea is if the supply drops at a time when demand is likely to increase, prices can skyrocket. Well, that day is coming quick!

Investors who know their stuff about bitcoin, like InvestorPlace analyst Matt McCall, have been talking about it for months. Matt recently held a special event that gives folks what they need to know right now to take advantage of this historic opportunity.

The most important thing to remember at this point is that while the halving is just days away, it’s not too late.

According to CoinDesk, recent research by asset manager Bitwise shows that a portfolio balanced with bitcoin can add value, even when prices are historically high.

The research shows a traditional portfolio of 60% stocks and 40% bonds that made room for 2.5% in bitcoin in January 2014 would have increased returns from 26% to nearly 45% by March 31, 2020.

Returns still increased even when bitcoin was added at its to-date all-time high of $20,000 in December 2017, and then saw a substantial pullback.

The bottom line is that while bitcoin is volatile, it’s also not tightly correlated to other assets. That gives bitcoin a leg up for investors seeking to more profitably balance risk and reward in their portfolios.

But that’s not all.

See, while bitcoin’s rise has been impressive, many of the other crypto assets known as altcoins have been doing much better. Altcoins are really where the action’s at these days.

Matt lays out what’s going on with altcoins as the halving approaches, and why their rise should quickly surpass bitcoin’s. Check it out.


UBS: Hiding in Cash Is Not the Answer

[Wednesday, May 6, 12:11 p.m.]
Contributed by Sarah Smith

In a new note to clients, UBS warned that “sitting in cash is not the answer.” What prompted such an announcement? Well, in the last eight weeks, investors have been piling into money market funds, a specific type of mutual fund that primarily holds cash and other highly liquid assets.

Plus, in the same time period, the amount of cash on the sidelines has leapt $1 trillion to a total of $4.7 trillion. During the entire 2008 financial crisis, that figure increased by less than $500 billion.

It’s clear that the stock market just seems too volatile some days. But one of the biggest takeaways from the Great Recession is that investors who got out of the market and stayed out are some of this decade’s biggest financial losers. That’s why it’s important to park your cash somewhere it will make you money.

So where should you park it? UBS recommends using the novel coronavirus as an opportunity to selectively buy cyclical stocks, defensive stocks and other long-term winners. According to the analysts, this strategy helps minimize risk and volatility while still putting your money to work.

The firm also recommends stocks that are set to benefit from Covid-19, like plays in telemedicine and health tech, fintech, e-commerce, automation and the so-called food revolution.


Look to the Supply Chain for the Next Stocks to Buy

[Wednesday, May 6, 11:40 a.m.]
Contributed by Sarah Smith

The world changed in March 2020, and so did the stock market. Names that were solid in January looked laughable. Stocks that no one was thinking about like Clorox (NYSE:CLX) and Allied Healthcare Products (NASDAQ:AHPI) suddenly were flying high.

Behind this shake up was the global supply chain. Clorox products were hot because of their disinfectant power, but also because Clorox wipes were impossible to find. Allied Healthcare Products gained popularity as consumers — and healthcare professionals — struggled to find personal protective equipment (PPE).

Now, it seems that those areas of the supply chain are starting to settle into a new normal. But GOBankingRates’ Gabrielle Olya writes that it’s time to prepare for the next phase of panic buying. With that will come new hot stocks. Here are the categories she thinks will be in high demand soon:

  • Laptop exports have decreased, and more Americans are working from home. InvestorPlace’s Tom Taulli writes that Microsoft (NASDAQ:MSFT) is a great stock to buy thanks to its Surface laptops.
  • Generic drug exports are also at risk thanks to stay-at-home orders in India. InvestorPlace’s Josh Enomoto wrote that Teva Pharmaceuticals (NYSE:TEVA) is a top healthcare play now as consumers begin stocking up on generic and over-the-counter drugs.
  • Apple (NASDAQ:AAPL) already warned shareholders that its iPhone supply chain may face disruptions. InvestorPlace analyst Louis Navellier sees innovation pushing AAPL shares higher for years to come.
  • Are you picking up a bad habit in quarantine? Unfortunately, a vape shortage is just around the corner, writes Olya. That’s because China is a lead manufacturer of vaping products. Want to profit from this trend? Look to Turning Point Brands (NYSE:TPB), another pick from Josh Enomoto.
  • The next thing flying off the shelves is likely to be cans of diet soda. Coca-Cola (NYSE:KO) in particular makes its low-calorie options in China. But InvestorPlace’s Dana Blankenhorn is confident that KO shares — and the company’s dividend — will survive the pandemic.


Ariel Investments Is Buying Iconic Stocks on the Dip

[Wednesday, May 6, 10:42 a.m.]
Contributed by Sarah Smith

When everything in the market seems upside down, it’s nice to know what the experts are doing. It’s also nice to get a sense for what the experts are thinking.

According to John Rogers, the co-CEO and chief investment officer at Ariel Investments, there’s no doubt that the pandemic-driven downturn is “stunning” and “wrenching.” But he’s not panicking. That should help calm individual investors’ nerves.

Like other famous value investors, Rogers is looking for discounts in hard-hit, iconic brands. On his buy list are Madison Square Garden Entertainment (NYSE:MSGE), Vail Resorts (NYSE:MTN) and Royal Caribbean (NYSE:RCL).

It’s good to know Rogers is looking for stocks to buy now. But, he does have a word of caution. He says as concerns about a second wave of the novel coronavirus swirl, the return to normal may be slower than expected.


Stocks Open Higher Wednesday

[Wednesday, May 6, 9:31 a.m.]
Contributed by Sarah Smith

Investors are really clamoring for states to reopen — and they’re driving the market higher on Wednesday morning. By the end of this week, several states will have started to lift lockdown measures.

As the market prices in higher levels of consumer spending and reopened businesses, will Wednesday see major gains? I guess we’ll have to wait and see.

With that in mind, the S&P 500Dow Jones Industrial Average and the Nasdaq Composite are all opening in the green.

  • The S&P 500 opened higher by 0.56%
  • The Dow Jones Industrial Average opened higher by 0.53%
  • The Nasdaq Composite opened higher by 0.73%

Learn More About Chegg Before it Goes to $200

[Wednesday, May 6, 8:41 a.m.]
Contributed by Jessica Loder

As more and more people are stuck home, their thoughts turn toward learning something new. And InvestorPlace Markets Analyst Luke Lango sees that as just one of many reasons Chegg (NYSE:CHGG) could be going to $200.

“It increasingly appears that Chegg is taking over the education world,” wrote Lango. “… over the past few years, Chegg has created a strong but niche on-demand connected learning platform which some, but not many, high school and college students use.”

And the proof is in the pudding — or in this case, the earnings report. Not only was its revenue up 35% for the first quarter, but its subscriber numbers were up by about the same. And with social distancing and closed schools still the order of the day for much of the U.S. (historically Chegg’s biggest market), more people may find their way to one of the company’s programs in Q2.

Now, that tailwind won’t last forever. Eventually we’ll get back to some semblance of normal, and many students will go back to learning in a physical school. But Lango sees the company enjoying a higher profile going forward that will lead to more growth. “Thanks to Covid-19, students and academic institutions across the world are pivoting towards online learning platforms. Those platforms have a lot to offer. Consequently, even once physical school resumes, many of those students and institutions will continue to use online learning tools as necessary supplements.”

Chegg would have to do a lot right to get to that $200 target, but it’s already well on its way.


Stocks Close Slightly Higher Tuesday After Cutting Gains

[Tuesday, May 5, 4:01 p.m.]
Contributed by Sarah Smith

Is the White House phasing out its highly watched virus task force? Will meat shortages destroy the U.S. food supply chain? And what did Tesla (NASDAQ:TSLA) CEO Elon Musk really name his son?

Boy, those are some big questions. In all seriousness, the S&P 500Dow Jones Industrial Average and the Nasdaq Composite all closed the day in the green. But they shed gains in the last hour of trading, perhaps as headlines became too overwhelming.

There’s a lot to watch in the market these days, particularly as states continue the push to reopen. Don’t blink, you could miss a massive move.

  • The S&P 500 closed higher by 0.9%
  • The Dow Jones Industrial Average closed higher by 0.56%
  • The Nasdaq Composite closed higher by 1.13%

3 Stocks to Buy With Big Risks and Big Rewards

[Tuesday, May 5, 3:47 p.m.]
Contributed by Sarah Smith

With all the uncertainty in the market — and in the broader world — now may seem like the perfect time to sit back, bite your nails and count your cash. But InvestorPlace’s David Moadel has a different idea.

On Tuesday, he shared an argument for taking some big risks in the face of the pandemic. Why? Big risks often mean big potential rewards.

Don’t worry. He’s not recommending stocks from unproven companies. Instead, he’s looking at stocks that have long histories and represent hard-hit industries. Here’s Moadel’s list:

  • Las Vegas Sands (NYSE:LVS)
  • Chipotle Mexican Grill (NYSE:CMG)
  • Simon Property Group (NYSE:SPG)

Wells Fargo: 3 Food Stocks to Put in Your Shopping Cart

[Tuesday, May 5, 3:25 p.m.]
Contributed by Sarah Smith

We’ve written that hygiene habits are likely to change for good, and trends like telework and telemedicine will stick around — and accelerate. But Wells Fargo analysts are also honing in on another trend gaining permanence thanks to the novel coronavirus.

Before the pandemic, consumers were prone to eating out. Now, forced to eat at home more often, certain food stocks are seeing sales spike. Wells Fargo doesn’t think that trend will immediately reverse.

Here are three food stocks to put in your cart now (subscription required):

  • Mondelez (NASDAQ:MDLZ)
  • Nomad Foods (NYSE:NOMD)
  • Simply Good Foods (NASDAQ:SMPL)

3 Telework Stocks to Buy as Companies Stay Remote

[Tuesday, May 5, 3:00 p.m.]
Contributed by Sarah Smith

On Tuesday afternoon, Capital One (NYSE:COF) announced that the majority of its almost 50,000 employees would continue working from home through September. Shares are lagging the market on an otherwise up day.

Investors shouldn’t be surprised by the news. Axios’ Erica Pandey writes that remote work is sticking — more than 50% of American employees are now working from home. That’s up from just 4% before the pandemic.

For some businesses, that’s bad news. As we’ve previously reported, office spaces are likely to change permanently, and continued remote work could harm companies that benefit from urbanization (like luxury apartment REITs). Instead of fretting, though, look for ways to profit from the new normal.

InvestorPlace spoke with Vidyanand Choudhary, a professor and senior associate dean of information systems at the University of California’s Irvine campus. Here’s what he says:

“The need for social distancing and therefore some type of telework will continue for the next year or two. As such, it may lead to a culture shift where working from home becomes the new normal. Longer term, working from home may become more acceptable even after the end of this crisis.”

So what stocks should you buy to benefit from this culture shift? InvestorPlace’s Chris Markoch has a few ideas. He’s recommending Cisco (NASDAQ:CSCO), Zoom Video Communications (NASDAQ:ZM) and Microsoft (NASDAQ:MSFT) as the top stocks to buy for remote work. InvestorPlace’s Tom Taulli agrees. He just wrote that MSFT stock will continue to benefit from teleworking momentum.


Pfizer and BioNTech Stock Are Rocketing Higher Tuesday

[Tuesday, May 5, 2:21 p.m.]
Contributed by Sarah Smith

Who would have guessed in January that the whole market would be so excited about a potential vaccine? It’s clear things are just radically different. On Tuesday, Pfizer (NYSE:PFE) and BioNTech (NASDAQ:BNTX) are taking their turn in the spotlight.

This rally comes after the duo announced they had given their first U.S. volunteers a dose of a novel coronavirus vaccine candidate.

According to BioPharma Dive’s Jonathan Gardner, the companies have already completed dosing in a German study. Now, they will run a U.S. trial across four sites, testing the vaccine to determine if it’s safe and if it can stimulate an immune response to the virus.

Data from the trials will be ready in late May or June. As Gardner writes, Pfizer is preparing to deliver “millions of doses” by the end of 2020. Boy, that’s exciting. PFE stock is up 3% and BNTX stock is up almost 8% in intraday trading.

InvestorPlace’s Todd Shriber is bullish on Pfizer stock for many reasons — he sees it as a long-term investment with potential beyond the coronavirus. That’s why he wrote at the end of April that its drug pipeline and cash balance make it a compelling buy right now.


9 Online Retail Stocks to Buy as Social Distancing Continues

[Tuesday, May 5, 2:14 p.m.]
Contributed by Sarah Smith

States are reopening, but that doesn’t mean everything is returning to normal. Americans have learned a lot about hygiene and viruses over the last few weeks, and those lessons will stick. Plus, the earliest phases of reopening require strict adherence to social distancing guidelines.

So what does that mean for the economy? As InvestorPlace’s Josh Enomoto writes, it means that some retailers will see the novel coronavirus as a catastrophe. Others will see it as a massive opportunity. InvestorPlace spoke with Thomas Gilbert, an associate professor of finance and business economics at the University of Washington’s Michael G. Foster School of Business. From Gilbert:

“My sense is that innovation is increasing and will increase rapidly in all domains touching ‘remote, distance, cyber, virtual, artificial, automated, etc.’ Online retailing was only 10% of total retailing prior to the virus and I would not be surprised if the new normal will be far far higher, like 50%.”

With that in mind, investors need to find the companies set to benefit from this lasting shift to online retailing. Here are nine online retail stocks Enomoto is watching now:

  • Amazon (NASDAQ:AMZN)
  • Wayfair (NYSE:W)
  • Etsy (NASDAQ:ETSY)
  • Shopify (NYSE:SHOP)
  • Home Depot (NYSE:HD)
  • Kroger (NYSE:KR)
  • Target (NYSE:TGT)
  • Best Buy (NYSE:BBY)
  • Domino’s Pizza (NYSE:DPZ)


5G Stocks Lead the Market Charge Tuesday

[Tuesday, May 5, 11:51 a.m.]
Contributed by Sarah Smith

President Donald Trump long ago waged a war against China’s Huawei, a company otherwise set to dominate the 5G rollout. Now, thanks to the novel coronavirus, that war is once again front and center. There are two emerging ways to play this anti-Huawei sentiment.

First, some big tech names made even bigger news this morning. With support from the federal government, 30 firms launched the Open RAN Policy Coalition.

According to Axios’ Margaret Harding McGill, the coalition supports a software-driven approach to 5G. In other words, these companies would like to see 5G move away from network hardware. Why? This avoids trapping countries between Huawei and more expensive options, like Nokia (NYSE:NOK) and Ericsson (NASDAQ:ERIC).

So who’s leading the coalition? Big names like International Business Machines (NYSE:IBM), Amazon (NASDAQ:AMZN) and AT&T (NYSE:T) unsurprisingly are involved. Dish Network (NASDAQ:DISH) is set to build a new nationwide wireless network, bringing the smaller company also to the front of the race.

OK, so what’s the other play?

InvestorPlace’s Ian Bezek wrote this morning that he, too, thinks the future of 5G includes a shift away from Huawei. But he likes ERIC stock. According to Harding McGill, Bezek isn’t alone. U.S. Attorney General William Barr supports Ericcson and Nokia.

Regardless of what plan wins, 5G stocks are sure to be hot. They represent a big tech investment in a post-pandemic world.


Wayfair Stock Is an Unlikely Coronavirus Winner

[Tuesday, May 5, 11:25 a.m.]
Contributed by Sarah Smith

I’ve spent an unprecedented amount of time at home, and I’ve become quite familiar with what I don’t like about my apartment. In other words, my to-do list is loaded with small cleaning and organizational tasks. Oh, and I’m looking to buy some nightstands.

Apparently, I’m not alone. As CNBC’s Lauren Thomas reported this morning, Wayfair’s (NYSE:W) first-quarter sales were up 20% year-over-year. According to CEO Niraj Shah, consumers are “disproportionately” investing in home improvement while states remain in lockdown.

That all sounds good. But InvestorPlace analyst Matt McCall added some shocking context to that first-quarter sales figure. Wayfair shares are up 700% from their March lows. That’s crazy. It’s obvious that investors who already got in are happy Tuesday. But is there a chance for new buyers to profit?

InvestorPlace Markets Analyst Luke Lango thinks so. He included Wayfair on a list of 15 tightly wound stocks with “pop” potential. According to Lango, as the company scales, huge revenue growth will translate to big profit growth. If you believe in the future of e-commerce, that sounds like a safe bet.

Plus, Wayfair is a pick in InvestorPlace.com’s Best Stocks for 2020 contest. Long before the pandemic hit, The Motley Fool’s Jason Moser identified it as a top company cashing in on future retail trends.

I can’t imagine ever going to a brick-and-mortar store to buy those nightstands I want. And the numbers show many consumers are in the same boat. Don’t miss out on this high-flying opportunity.


7 Tech Stocks to Buy to Profit from the Pandemic

[Tuesday, May 5, 10:11 a.m.]
Contributed by Sarah Smith

Investors have dumped everything — even solid tech stocks — during 2020’s market selloff. Why? The pandemic wrought by the novel coronavirus is hard to predict, and it’s having far-reaching effects.

InvestorPlace’s Ian Bezek has a wake-up call for investors. Tech stocks will be some of the best buys in the new world, and they’re also profiting right now. That’s why he thinks it’s time to start buying up shares.

Still not convinced? Look at how Zoom Video Communications (NASDAQ:ZM) became a hot stock seemingly overnight. Companies that react and thrive through the pandemic are ones you want to hold for the long run.

Here are the seven tech stocks Bezek is watching now:

  • Ericcson (NASDAQ:ERIC)
  • Palo Alto Networks (NYSE:PANW)
  • Facebook (NASDAQ:FB)
  • Slack Technologies (NYSE:WORK)
  • Avalara (NYSE:AVLR)
  • Broadridge Financial Solutions (NYSE:BR)
  • Roper Technologies (NYSE:ROP)


Stocks Open Higher Tuesday as States Continue to Open

[Tuesday, May 5, 9:31 a.m.]
Contributed by Sarah Smith

It’s a rather conflicting time in the markets. Yes, states are continuing to reopen. Even hard-hit California will see lockdown restrictions begin easing this Friday, and states like Georgia and Florida are pushing for a true return to normal.

But experts are still sounding the alarm on the novel coronavirus. According to The New York Times, the U.S. is still seeing an increase of 25,000 new cases per day and 1,000 new deaths per day. President Donald Trump revised his outlook on the pandemic over the weekend, noting that 100,000 Americans could die.

As investors try to find balance, it appears that bulls are leading the way Tuesday morning. The S&P 500Dow Jones Industrial Average and the Nasdaq Composite are all opening well in the green.

  • The S&P 500 opened higher by 1.04%
  • The Dow Jones Industrial Average opened higher by 0.94%
  • The Nasdaq Composite opened higher by 1.08%

Goldman Sachs: ConocoPhillips Stock Is a ‘Conviction Buy’

[Monday, May 4, 4:43 p.m.]
Contributed by Sarah Smith

According to Goldman Sachs analysts, the embattled energy sector is clinging to some rays of hope yet. On Monday, Neil Mehta raised his price target on ConocoPhillips (NYSE:COP) to $51 and named it one of the firm’s “conviction” buys.

As InvestorPlace’s Bret Kenwell wrote in his daily column, Mehta believes that energy stocks are approaching the bottom. With that in mind, he thinks ConocoPhillips is the top energy play. Why? The Goldman Sachs analyst says that COP stock has underperformed relative to larger U.S. names. It’s also closely tied to Brent, the international benchmark for crude oil.

One thing to note — Chevron (NYSE:CVX) previously held this glorious title. According to Kenwell, Goldman Sachs still lists CVX as a “buy,” but it’s moving on to better things with COP stock.


Stocks Close Slightly Higher After Tough Trading

[Monday, May 4, 4:01 p.m.]
Contributed by Sarah Smith

Bulls are working hard to start this week on a strong foot. Stocks struggled most of Monday after opening down, but the major indices crept into the green at the end of the day.

There’s a lot ahead this week — including key earnings results and the non-farm payroll report. Investors are sure to get a closer look at exactly how the pandemic is affecting the economy, and how promises of reopening are turning things around.

With that in mind, the S&P 500Dow Jones Industrial Average and the Nasdaq Composite all closed in the green.

  • The S&P 500 closed higher by 0.42%
  • The Dow Jones Industrial Average closed higher by 0.11%
  • The Nasdaq Composite closed higher by 1.23%

3 Biotech Stocks to Buy for a Market Rebound

[Monday, May 4, 3:47 p.m.]
Contributed by Sarah Smith

It’s been a rough couple of days for investors. President Donald Trump rekindled trade tensions with China. Southern states — leading the push to reopen — are seeing increases in deaths and new cases of the novel coronavirus. All in all, uncertainty has returned to the market and stocks are in the red.

But according to TipRank’s Maya Sasson, biotech stocks are looking very attractive right now. That’s because the most-recent market downturn is creating better entry points in some top names.

Here are three cheap biotech stocks under $10 Sasson is watching now:

  • Aptinyx (NASDAQ:APTX)
  • Viking Therapeutics (NASDAQ:VKTX)
  • Mersana Therapeutics (NASDAQ:MRSN)

Afterpay Stock Is a Top Play on the Future of Retail

[Monday, May 4, 3:21 p.m.]
Contributed by Sarah Smith

If you spend even a fraction of the time I do online shopping, then you’re probably familiar with the “buy now, pay later” services from Afterpay (OTCMKTS:AFTPY). If not, then you’re probably familiar with its competitors Klarna and Sezzle. If you haven’t heard of any of those three, then perhaps I engage too heavily in retail therapy.

The short story is that Afterpay and its peers are racking up partnerships with retailers. Instead of paying $32 for a makeup product from Fenty Beauty, you can make four interest-free installments of $8 with Afterpay. While that might seem a tad unnecessary, the appeal is in higher-cost items.

And according to Retail Brew, the pandemic has brought renewed interest in buy now, pay later services. It’s hard to sell shoppers on $100 clothing during an economic crisis, but four installments of $25 is much easier to stomach.

Plus, more brands are embracing Afterpay. Just last week, popular lounge brand Richer Poorer — found at retailers like Urban Outfitters (NASDAQ:URBN) — partnered with Afterpay.

That’s a lot to like. But wait, there’s more. In news that has AFTPY stock climbing 13% in intraday trading, Tencent (OTCMKTS:TCEHY) disclosed a 5% stake in Afterpay. According to press releases, this relationship will bring fintech and online advertising services to the smaller firm.

It’s no secret that retail as we know it is dying. Afterpay stock is the perfect way to invest in the retail of tomorrow. Don’t discount this opportunity.


2 Stocks to Buy for the Return of Live Sports

[Monday, May 4, 2:52 p.m.]
Contributed by Sarah Smith

It’s been a sad couple of weeks for sports fans. In the past, a weekend would bring highly anticipated games — and lots of revenue for the underlying companies. Now, you’re lucky to find a marble race or a turtle derby on ESPN. How the mighty have fallen.

But many in the investing world are confident that live sports aren’t a thing of the past. In fact, Barron’s Nicholas Jasinski is placing his bet on two sports stocks to buy now.

According to Jasinski, Madison Square Garden Entertainment (NYSE:MSGE) and Madison Square Garden Sports (NYSE:MSGS) are top rebound plays. The former is centered around the Madison Square Garden arena. The latter is a play on the arena’s sports teams, the Knicks and the Rangers. It’s definitely an interesting situation.

So what makes MSGE and MSGS worthy investments? For one, an empty arena is still an arena. In other words, it represents valuable real estate. And now that the teams are separately valued from the arena, there’s a big catalyst — scarcity.

Each major sports league has a certain number of teams. That means there’s “scarcity value.” Jasinski writes that the Knicks and Rangers are worth $4.6 billion and $1.7 billion, respectively. MSGS then allows investors to get in on that big value.

Essentially, as Jasinski writes, these are plays on the economy reopening. And in my opinion, it seems pretty unlikely that marble races will be enough to satisfy consumers for years to come. Get ready for the (eventual) return of big league sports with MSGE and MSGS now.


Credit Suisse: 7 Gold Standard Stocks to Buy Now

[Monday, May 4, 1:50 p.m.]
Contributed by Sarah Smith

Investing in stocks that are safer than government bonds — typically considered among the safest investments — definitely sounds appealing. That’s why analysts at Credit Suisse are rounding up new “gold standard” stocks to buy now.

So what is the new gold standard? According to analyst Andrew Garthwaite, these stocks are comparable to the G7 countries in terms of creditworthiness. They also have higher dividend yields than sovereign bonds and have either “outperform” or “neutral” ratings.

Here are the seven names analysts are watching (subscription required):

  • Apple (NASDAQ:AAPL)
  • CME Group (NASDAQ:CME)
  • Johnson & Johnson (NYSE:JNJ)
  • Microsoft (NASDAQ:MSFT)
  • Procter & Gamble (NYSE:PG)
  • Visa (NYSE:V)
  • Walmart (NYSE:WMT)


6 New ‘Big Tech’ Contenders to Buy for the New World

[Monday, May 4, 1:36 p.m.]
Contributed by Sarah Smith

All eyes were on the Big Tech leaders — Alphabet (NASDAQ:GOOG, NASDAQ:GOOGL), Amazon (NASDAQ:AMZN), Apple (NASDAQ:AAPL), Microsoft (NASDAQ:MSFT) and Netflix  (NASDAQ:NFLX) — last week. This group’s first-quarter earnings moved the market, and drew crazy amounts of attention as a means for evaluating the pandemic’s damage.

But the team at Morning Brew thinks that these leaders are set to fall off their pedestals. A weekend edition of the newsletter suggests that this group will get disrupted “either by natural industry evolution or alien invasion.”

All joking aside, perhaps such a shake-up is a long time coming. But which companies would take their spots? And how will the novel coronavirus influence Big Tech hegemony?

Here are six publicly traded companies Morning Brew is watching:

  • Salesforce (NYSE:CRM)
  • Zoom Video Communications (NASDAQ:ZM)
  • Slack (NYSE:WORK)
  • PayPal (NASDAQ:PYPL)
  • Square (NYSE:SQ)
  • International Business Machines (NYSE:IBM)

There’s a bonus play, too. Private Epic Games — home to Fortnite — is also a pandemic winner. While you can’t invest through traditional marketsTencent (OTCMKTS:TCEHY) holds a 40% stake.


Carnival Announces Return of Cruises: Buy CCL Stock

[Monday, May 4, 12:35 p.m.]
Contributed by Andrew Taylor

Battered cruise ship operator Carnival (NYSE:CCL) announced today that it plans to resume limited cruise services on Aug. 1. Adventurous travelers will be able to book travel with Carnival Cruise Lines for ships departing from Galveston, Texas; Miami, Florida; and Port Canaveral, Florida starting that date.

Only by filling cabins will Carnival start driving revenue and recovery, so the announcement that the company will start setting sail is an important milestone in the company’s return.

Last week, in an article titled, “Carnival Will Trend Higher With Strong Liquidity,” InvestorPlace’s Faisal Humayun announced that, “I believe the stock has more upside from oversold levels.” Humayun does an elegant job describing why Carnival’s recent steps to shore up credit and liquidity make it a stock to buy. Having visibility into the return of active cruising before the end of the summer certainly supports that case.

Also last week, InvestorPlace Markets Analyst Luke Lango highlights Carnival as one of his 30 Consumer Stocks to Buy Once the Coronavirus Pandemic Passes.

Carnival stock is an intriguing possibility for the risk-loving investor with a tolerance for loss. Given that the company has now provided more visibility to the return of operations, investors seeking massive returns won’t have much longer to wait before getting in.


Buy Salesforce Stock for Its Economic Reopening Solutions

[Monday, May 4, 12:18 p.m.]
Contributed by Sarah Smith

As states begin reopening around the United States, Salesforce (NYSE:CRM) is positioning itself to be a winning company. On Monday, it released reopening-specific tools, including a new Work.com dashboard. This solution allows businesses to track readiness across various locations and monitor employee health. CRM stock is up 2.5% in intraday trading on the news.

From Salesforce President and COO Bret Taylor:

“Every company and community in the world is focusing on how to safely reopen and get to a new normal. With Work.com, we’re bringing together powerful new technology, our partners and network of experts to help organizations reopen and recover from this crisis while putting employee and visitor health and safety first.”

According to Axios’ Ina Fried, the solutions will cost between $5 and $50 per user. Salesforce is also offering contract tracing, shift management and other emergency response tools.

But as Fried writes, perhaps the most important — and most upside-generating — element of this announcement is that these tools make Salesforce a leader in pandemic-specific tech.

Companies like Zoom Video Communications (NASDAQ:ZM) and Slack (NYSE:WORK) have seen existing platforms benefit from new trends. But Salesforce’s Work.com goes beyond that — tackling the pandemic’s next phase.

So is it time to buy CRM stock? InvestorPlace Markets Analyst Luke Lango thinks so. He wrote in early April that Goldman Sachs was hot on the name. Lango thinks that companies learned a big lesson — it’s time to turn digital. That means Salesforce will benefit from increased IT spending and see a big rebound when the economy does recover.


$3 Crypto Could Jump After May 13

[Monday, May 4, 11:45 a.m.]
Contributed by Matt McCall

The last time bitcoin traded for $3 was nearly ten years ago.

The days of extraordinary 10,000% bitcoin gains in just a short time period are likely over.

But there’s a little-known crypto I’m extremely bullish about right now.

This cryptocurrency applies real-world applications to the world of blockchain, which makes its growth potential extraordinary.

It’s probably the most practical and beneficial blockchain token in existence today.

The best part is, you can invest in a single token for less than $4 right.

I believe this crypto will see serious gains from current price levels. That’s why I recently added it to my Ultimate Crypto model portfolio.

But you can’t delay if you want to position yourself.

The crypto Halvening event is set to take place just days from now, on May 13.

Cryptocurrencies have historically grown after the past two Halvening events in 2012 and 2016.

So don’t let this opportunity pass you by. Look over the full details of this $3 crypto before the Halvening occurs.

Click here to learn how you can find out the name and ticker symbol.


Don’t Blindly Buy Food Stocks, But Focus on Grocery Plays

[Monday, May 4, 11:18 a.m.]
Contributed by Sarah Smith

It’s no secret that grocery stores are hot right now. It also seems that more and more people are opting for curbside pick-up and grocery delivery options, as fears of the novel coronavirus climb. There’s finally data to back that up — and it makes grocery store stocks look even better.

According to Food Logistics, online grocery sales hit $5.3 billion in April, up 37% from the prior month. That’s huge, but perhaps not all that surprising. What it does mean is that grocery stores pivoting to in-demand options are set to be winners.

So which stocks should you buy? InvestorPlace’s Josh Enomoto has a few ideas. He recently listed Kroger (NYSE:KR) as one of his top food stocks to buy. Enomoto writes that as social distancing continues, Kroger is set to be a winner because of its easy delivery and pick-up options.

For the same reason, he likes Sprout Farmers Market (NASDAQ:SFM), a smaller chain.

Enomoto has one important caveat. He cautions investors against “blindly” buying food stocks just because they’re a hot idea. Instead, search out names with successful alternate sales options. These grocery stocks look to be certain winners in our new world.


Roche Stock Is Popping Higher on New Antibody Test

[Monday, May 4, 10:40 a.m.]
Contributed by Sarah Smith

Who doesn’t love good news about the novel coronavirus? On Monday, as uncertainty drags the broader market down, Roche (OTCMKTS:RHHBY) stock is climbing 3.2% in intraday trading.

Over the weekend, the Swiss company announced it had received U.S. Food and Drug Administration emergency approval for its antibody test. And boy, these tests are in high demand. Unlike tests for the virus itself, antibody tests can tell whether or not an individual has been exposed to the virus at all. In other words, they can tell if asymptomatic individuals have already contracted Covid-19.

Antibody tests seem to be the key to safely reopening the economy, and determining who has immunity. Roche, like test maker Abbott Laboratories (NYSE:ABT), is benefiting from positive results.

With that in mind, don’t discount the opportunity in Roche stock. The company has promised to make its antibody test available in early May, and to produce the tests in “the high double-digit millions” each month starting in June.


Stocks Sink Monday as Virus Uncertainty Returns

[Monday, May 4, 9:31 a.m.]
Contributed by Sarah Smith

Just how bad will the economic fallout from the novel coronavirus be? That question — and fears of the answer — is driving stocks down Monday morning. To be fair, stocks were already struggling Friday as President Donald Trump threatened to escalate trade tensions with China.

Oh, there’s some pessimism elsewhere in the investing world too. Investors carefully scrutinized Warren Buffett’s annual meeting for Berkshire Hathaway (NYSE:BRK.A, NYSE:BRK.B) stock holders over the weekend. What’s the result? While he reiterated his case for long-term optimism, some are reading between the lines. What will the near term look like?

With these questions circulating, the S&P 500Dow Jones Industrial Average and the Nasdaq Composite are all starting Monday in the red.

  • The S&P 500 opened lower by 0.71%
  • The Dow Jones Industrial Average opened lower by 0.97%
  • The Nasdaq Composite opened lower by 0.52%

JPMorgan: Apple Is One of the Top Stocks to Buy

[Friday, May 1, 4:32 p.m.]
Contributed by Sarah Smith

InvestorPlace’s Bret Kenwell reported in his daily column that investors had a rather neutral response to Apple’s (NASDAQ:AAPL) Thursday earnings report. Apple beat expectations for earnings and revenue, and its Services unit was once again a star. But the company’s future is just a little too uncertain.

However, that uncertainty isn’t stopping JPMorgan analyst Samik Chatterjee from being bullish on AAPL stock. On Friday, he named it one of the firm’s top stocks to buy and raised his price target from $335 to $350. He has an “overweight” rating on the stock.

So what’s there to like? Chatterjee cites higher-than-expected demand for the iPhone 11, improving revenue forecasts for 2020 and the company’s strong ties to work-from-home and online learning trends.

According to TipRanks, the average 12-month price target on AAPL stock is just over $320. That implies 10% upside from the current share price.


Dow Jones Drops 600 Points on Friday’s Mixed News

[Friday, May 1, 4:01 p.m.]
Contributed by Sarah Smith

Breaking news from President Donald Trump that the U.S. Food and Drug Administration approved Gilead Sciences’ (NASDAQ:GILD) remdesivir for emergency use wasn’t enough for stocks to close Friday in the green. Perhaps that’s because earlier news from Trump was still rocking the market. That’s right, going into pre-market trading, investors were fearing a return of the U.S.-China trade war.

Elsewhere in the investing world, the market was digesting earnings from Big Tech. States continue to reopen and retailers roll out new hygiene strategies. It seems Friday simply brought too many headlines after a solid month for stocks.

With all that in mind, the S&P 500Dow Jones Industrial Average and the Nasdaq Composite all ended the week on a sour note.

  • The S&P 500 closed lower by 2.79%
  • The Dow Jones Industrial Average closed lower by 2.53%
  • The Nasdaq Composite closed lower by 3.20%

Goldman Sachs Is Looking for Return-to-Work Stocks

[Friday, May 1, 3:47 p.m.]
Contributed by Sarah Smith

As states begin reopening, Goldman Sachs fund manager Katie Koch is hunting for companies ready to bounce. In this search, she’s moving past mega-cap tech stocks that have been stable in early 2020. Instead, she wants to find stocks that have been less “resilient” — meaning they will see more upside.

So where is she looking for these return-to-work plays? She’s focusing on companies with strong balance sheets, and names attached to growth opportunities.

Although she didn’t list any specific stocks, here are a few areas she’s watching:

  • As more Americans return to work, Koch is looking for childcare, catering and small business solutions providers, such as companies that specialize in payment solutions.
  • “Select” travel and restaurant stocks will benefit early on as the economy reopens. Look for standout companies in the hospitality space.
  • Koch says that one result of the pandemic is that more Americans are living life online. Because of that, she’s looking for stocks to buy that specialize in data gathering and 5G.

Stocks to Buy: Tesla Will Drive High Again on Fundamentals

[Friday, May 1, 2:35 p.m.]
Contributed by Sarah Smith

Not all Americans are content to binge-watch TV shows and make loaves of sourdough bread. On Friday, Tesla (NASDAQ:TSLA) CEO Elon Musk made it clear he was ready for stay-at-home orders to end — and quick. In a mid-day social media rampage, he discussed selling all of his homes, tweeted lyrics to the “Star Spangled Banner” and shared that girlfriend Grimes — whose baby is due Monday — is mad at him.

But in perhaps the most concerning post, he wrote “Tesla stock price is too high [in my opinion].” And it turns out a CEO’s opinion is pretty powerful. TSLA stock is down 9.1% in intraday trading.

So is it time for investors to ditch Tesla as the pandemic takes Musk to the brink? According to InvestorPlace Markets Analyst Luke Lango, no. Lango writes that investors need to see the forest through the trees. Musk’s antics are part of what makes TSLA such a high-interest stock.

Yes, it wasn’t the smartest move on the CEO’s part. But Lango is convinced the company’s fundamentals will keep driving it higher. His modeling even shows a 2020 price target above $800. At $710, shares are at an attractive discount now.


Is It Time to Buy Beaten-Down Macy’s Stock?

[Friday, May 1, 2:14 p.m.]
Contributed by Sarah Smith

The retail apocalypse is coming, and there will be many victims. InvestorPlace contributors have long listed Macy’s (NYSE:M) as one of the first to fall. With a current share price near $5.40 and a subpar e-commerce presence, there’s certainly a lot to critique.

But Friday’s Retail Brew newsletter offers some background to support a contrarian perspective. Is it perhaps time to start buying M stock? When mall operator Simon Property Group (NYSE:SPG) announced that it would begin reopening its properties, shares rebounded. Macy’s is now following in Simon Property’s footsteps.

On Tuesday, CEO Jeff Gennette said the company had no plan to reopen. On Thursday, the company pivoted, and announced plans to begin reopening almost 800 locations in the coming weeks. Shares are still down 7.6% in intraday trading.

It’s not clear that Macy’s will win — or even survive — the gloom in the retail sector. But Gennette’s plan shows the retailer is working toward victory. To start, Macy’s is downsizing. Its online sales were “better than expected” in March, which perhaps could bring an improved e-commerce experience to the department store.

All in all, it’s like too early to say if Macy’s is a stock to buy. But, investors shouldn’t count it out of the fight just yet.


Here’s a Reason to Be Bullish on Biotech Stocks

[Friday, May 1, 1:33 p.m.]
Contributed by Sarah Smith

As we’ve previously reported, biotech stocks are facing a key dilemma. Gilead Sciences (NASDAQ:GILD) is garnering much of the market’s attention with its standout drug remdesivir. Good news about remdesivir lifts the entire market, and bad news can bring it to its knees.

Not all companies are facing the same good fortune. Others that haven’t jumped into the novel coronavirus race are having to suspend trials and are seeing pharmaceutical sales drop. It’s hard to sell injectable cancer drugs when many cancer patients are delaying treatment.

Does this mean the biotech sector is one to avoid indefinitely?

New reporting from The New York Times highlights a key reason investors should still be bullish. According to Carl Zimmer, researchers are now studying existing drugs — not just antivirals — to see if they’re effective against Covid-19. A pre-print study cites compounds purchased from Sigma Labs  (NASDAQ:SGLB) and Thermo Fisher Scientific (NYSE:TMO). However, many of these compounds are manufactured by other pharmaceutical companies.

That means the broader biotech sector isn’t out of the race. While experts are hopeful about remdesivir, there may be other effective treatments. Keep an eye out for further study results and look for winners in the space.


Analysts Agree: JD.com Stock Is a Top Pandemic Buy

[Friday, May 1, 12:48 p.m.]
Contributed by Sarah Smith

Over the last two months, analysts have been jumping on board Beijing-based JD.com (NASDAQ:JD) with buy ratings and lofty price targets. Although some investors soured on Chinese stocks in the early days of the novel coronavirus, it’s clear things are changing.

E-commerce companies like JD and rival Alibaba (NYSE:BABA) are outperforming the broader market. Plus, China’s economy is leading the race to reopen. Perhaps that’s why so many analysts are yelling “buy.”

InvestorPlace Markets Analyst Luke Lango agrees with that sentiment. He writes that while decreased consumer spending weighed on JD stock, it’s clear retail sales are starting to rebound. That’s why he ranked it as one of the top five Chinese stocks to buy now.

Still not sure? There’s another major catalyst coming for JD shares. Axios’ Dan Primack wrote earlier this week that JD “confidentially” filed for a Hong Kong stock listing, following in Alibaba’s footsteps. If completed, the sale could raise $2 billion. That’s a big deal — particularly as it competes for market share with BABA and Amazon (NASDAQ:AMZN).

If you’re tempted, get in now. Lango said the company will be firing on all cylinders again before the end of 2020. You don’t want to miss out.


Walmart Stock: Buy Shares on New Grocery Delivery Service

[Friday, May 1, 12:07 p.m.]
Contributed by Sarah Smith

Everyone wants to stock up on groceries, but no one wants to face crowds — and germs — in stores. That’s why delivery services like Instacart and curb-side offerings from big grocery stores have gained so much popularity. Walmart (NYSE:WMT) stock has been one of the winners from this madness, but after a Thursday announcement it looks even more appealing.

The Verge’s Jay Peters reported that Walmart is launching Express Delivery, a service that will deliver groceries and other essential items in two hours or less. The big-box retailer has been piloting the service, and will ramp it up to 1,000 locations in early May. In the coming weeks, it will ramp further to 2,000 locations.

This seems like a dream. For $10, consumers can stay safe at home, order groceries and know they’ll be delivered with Walmart’s brand-name guarantee. No wonder WMT stock is in the green on an otherwise tough day of trading.

InvestorPlace’s Josh Enomoto is bullish on the name, too. He wrote Friday that unlike many specialty retailers, Walmart is likely to survive and thrive after the pandemic because it’s a one-stop shop.

As long as it performs well during the holiday quarter, Enomoto thinks it is one of the top 10 Dow Jones Industrial Average stocks to buy.


Buy Clorox Stock on Stellar Earnings

[Friday, May 1, 11:47 a.m.]
Contributed by Sarah Smith

Clorox (NYSE:CLX) stock has been a serious winner in 2020. Its products have been in high demand as Americans look to disinfectant every surface in sight. But analysts haven’t been hot on the name, pouring on sell and hold ratings ahead of its quarterly earnings report.

But boy did Clorox prove the bears wrong. As Barron’s Alexandra Scaggs wrote, sales increased 15% year-over-year, and earnings per share were up 31%. And unlike many other companies, Clorox actually increased its guidance for its fiscal year (which ends June 30). It expects annuals sales to grow between 4% and 6%.

On that news, CLX stock is up 4.5% in intraday trading.

So is it time to buy Clorox stock? InvestorPlace’s Josh Enomoto thinks so. He wrote this morning that it was one of the nine best dividend stocks to buy for all investors. Even if the pandemic eases in the near future and demand drops, Enomoto thinks a second wave of the virus will be a major catalyst.

From Enomoto:

“It’s possible that shares will come down as it appears we have reached the peak of this crisis. But according to infectious disease experts, it’s possible that a second wave of coronavirus could hit us. Therefore, CLX stock may have a longer upside pathway. That’s not great for our collective health but it’s potentially profitable news if you’re looking for dividend stocks to buy.”


3 Stocks Traders Can Seriously Profit from Right Now

[Friday, May 1, 11:19 a.m.]
Contributed by Sarah Smith

InvestorPlace’s Tyler Craig is looking to profit now. He’s found three stocks that, once winning, are now facing weakness. But he’s not despairing. Instead, he’s identified three bullish-leaning trades to make some serious money.

Here are the three stocks he’s looking at right now:

  • Walmart (NYSE:WMT)
  • Eli Lilly (NYSE:LLY)
  • Domino’s Pizza (NYSE:DPZ)

Moderna Stock Shoots Higher on Vaccine News

[Friday, May 1, 11:07 a.m.]
Contributed by Sarah Smith

Moderna (NASDAQ:MRNA) is looking to be Friday’s silver lining. Shares are shooting higher — to the tune of 5.8% — in intraday trading.

Why? Earlier in the morning, Moderna announced it reached a deal with Lonza (OTCMKTS:LZAGY) to accelerate manufacturing of its vaccine candidate for the novel coronavirus.

The experimental vaccine, mRNA-1273 is in early-stage clinical trials right now. But investors are excited at the potential — the deal would produce 1 billion doses a year.

So is it time to buy? InvestorPlace’s Ian Cooper thinks so. He wrote yesterday that MRNA stock was a top vaccine play. Cooper particularly likes that the company just received $483 million in federal funding. Shares are flirting with $50 now, but he thinks they could hit $55 again soon.


The Big Catalyst Behind Bitcoin’s Rise

[Friday, May 1, 10:25 a.m.]
Contributed by Nicholas Stern

We’re just days away from bitcoin’s halvening in May and the cryptocurrency markets are bouncing. In the past month, while the S&P 500 rose about 11%, bitcoin soared 44.5%.

There are a lot of explanations as to why people are jumping into cryptos at the moment, but nothing serves as a clearer catalyst than bitcoin’s halvening.

If you’re not familiar with the halvening, in a nutshell, it happens about every four years when the supply of new bitcoin coming on the market gets cut in half. If the supply drops at a time when demand is likely to increase, prices can soar.

Investors who know their stuff about bitcoin, like InvestorPlace analyst Matt McCall, have been talking about the halvening for months. Matt just held a special event that gives folks what they need to know right now to take advantage of this historic opportunity.

Wealthy investors looking to diversify their portfolios at a time of unprecedented volatility and money printing certainly aren’t waiting. The number of people building positions of 10,000 bitcoins or more for an expected price catapult has reached the highest level since Aug. 2, 2019, according to CoinDesk. For reference, 10,000 bitcoins are worth over $89 million at the moment.

Plus, there’s more activity on bitcoin’s network in general. An analysis by blockchain data firm Glassnode and @Unfolded found the bitcoin network has grown nearly 25% within the last year.

Folks’ awareness of bitcoin’s strengths as a scarce store of value, a sort of digital gold if you will, is growing. Only 21 million will ever be created.

That scarcity is behind a common metric used to value bitcoin known as stock-to-flow. It’s basically the ratio of the current bitcoin supply to the flow of new production, which again will drop in half in a matter of days.

Per Glassnode, bitcoin’s historic price has tracked the stock-to-flow ratio. It’s doing that right now. If the trend continues, we could see bitcoin surpassing $95,000 by mid-2021. That’d represent a 963% increase within a year or so.

And while bitcoin’s rise has been impressive, many of the other crypto assets known as altcoins have been doing much better. Altcoins are really where the action’s at these days.

Matt lays out what’s going on with altcoins in the run up to the halvening, and why their rise should quickly surpass bitcoin’s. Check it out.


7 Dividend Stocks to Buy for the Long Term

[Friday, May 1, 10:13 a.m.]
Contributed by Sarah Smith

InvestorPlace analyst Louis Navellier is still finding growth opportunities in the current market. Heck, he even found seven dividend stocks that still offer stable payouts.

He wrote Friday morning that we won’t see normalcy for quite some time, even after the economy reopens. That’s why he says it’s important to find long-term buys, not “sexy” stocks that are volatile along with the market.

Here are the seven top dividend stocks he’s recommending:

  • Easterly Government Properties (NYSE:DEA)
  • Frontline (NYSE:FRO)
  • Carlyle Group (NYSE:CG)
  • Unum Group (NYSE:UNM)
  • Huntsman (NYSE:HUN)
  • Dominion Energy (NYSE:D)
  • Xerox (NYSE:XRX)


Stocks Sink Friday Morning as Trump Threatens Tariffs

[Friday, May 1, 9:31 a.m.]
Contributed by Sarah Smith

Oh, the U.S.-China trade war. Remember when that was the sole driver of the market? Well, after a Thursday briefing, President Donald Trump is threatening new tariffs against China. Why? He says the novel coronavirus has “eclipsed” his phase-one trade deal in terms of priority.

Investors didn’t like that surprise. The S&P 500Dow Jones Industrial Average and the Nasdaq Composite are all sinking Friday, opening deep in the red.

  • The S&P 500 opened lower by 1.90%
  • The Dow Jones Industrial Average opened lower by 1.77%
  • The Nasdaq Composite opened lower by 0.28%

Stocks Fail to Rally After Thursday’s Jobless Report

[Thursday, April 30, 4:01 p.m.]
Contributed by Sarah Smith

This morning, investors learned that 3.8 million more Americans filed for unemployment benefits. As they processed that the pandemic-driven total now tops 30 million, stocks opened the day in the red.

Plus, news that novel coronavirus cases in the U.S. have surpassed 1 million isn’t helping matters. The S&P 500Dow Jones Industrial Average and the Nasdaq Composite all are closing down on Thursday.

  • The S&P 500 closed lower by 0.94%
  • The Dow Jones Industrial Average closed lower by 1.23%
  • The Nasdaq Composite closed lower by 0.28%

4 Food Stocks to Buy as At-Home Snacking Grows

[Thursday, April 30, 3:41 p.m.]
Contributed by Sarah Smith

According to The Food Institute, packaged food companies got a bit of a first-quarter surprise. As Americans continue to spend less on dining out, snack purchases are growing. Initially, many companies thought panic buying — what many called “hoarding” — would stop. But data shows that packs of Oreos and bags of Tostitos are flying off the shelves.

This elevated buying could have long-term impacts. PepsiCo (NASDAQ:PEP) CFO Hugh Johnston said that supply-chain levels could change for good, so that the company had more inventory on hand. He also thinks consumers are regaining loyalty toward bigger brands. That makes PEP stock look extra appealing now.

InvestorPlace’s Nicolas Chahine agrees. He wrote today that there’s clearly an “appetite” for Pepsi after its first-quarter earnings report.

So, what other big brands will benefit from snacking? Here are three more food stocks to watch:

  • Hershey (NYSE:HSY)
  • Mondelez (NASDAQ:MDLZ)
  • Coca-Cola (NYSE:KO)

AstraZeneca Stock Is Gaining on Coronavirus News

[Thursday, April 30, 3:15 p.m.]
Contributed by Sarah Smith

Gilead Sciences’ (NASDAQ:GILD) remdesivir has the market wrapped around its finger — or, its clinical trial results. Last week, it brought the market down when the World Health Organization leaked not-so-good data from suspended Chinese trials. Yesterday, remdesivir was a market cure. It broadly rallied stocks after a U.S. trial met its primary endpoint in treating patients with the novel coronavirus.

In the vaccine world, Inovio Pharmaceuticals (NASDAQ:INO) and Moderna (NASDAQ:MRNA) take most of the spotlight.

But BioPharma Dive’s Ben Fidler highlights that pandemic underdog AstraZeneca (NYSE:AZN) has a ton of potential. On Thursday, the pharmaceutical giant announced a partnership with Oxford University. Together, researchers will further work on a coronavirus vaccine.

As Fidler writes, the Oxford study started earlier than many others. It already began human testing, and could begin late-stage tests in mid-2020. That’s huge news.

And investors like what they are hearing. AZN stock is up 2.8% in intraday trading, on a day when the major indices are down.


Wall Street’s 20 Favorite Dividend Stocks to Buy

[Thursday, April 30, 2:47 p.m.]
Contributed by Sarah Smith

Wait, dividends are still a thing? Despite the far-reaching impacts of the novel coronavirus, some companies are still set to pay out quarterly dividends. And some companies have high-yield dividends — paying out more than the S&P 500’s 2% yield.

So which dividend stocks should be on your radar? According to CNBC and FactSet, here are 20 stocks Wall Street can’t seem to get enough of (subscription required).

  • Alexandria Real Estate Equities (NYSE:ARE)
  • AES (NYSE:AES)
  • Diamondback Energy (NASDAQ:FANG)
  • Prologis (NYSE:PLD)
  • NRG Energy (NYSE:NRG)
  • FirstEnergy (NYSE:FE)
  • Mondelez (NASDAQ:MDLZ)
  • Williams Companies (NYSE:WMB)
  • Baker Hughes (NYSE:BKR)
  • DuPont de Nemours (NYSE:DD)
  • Marathon Petroleum (NYSE:MPC)
  • Pioneer Natural Resources (NYSE:PXD)
  • Arthur J. Gallagher (NYSE:AJD)
  • Tyson Foods (NYSE:TSN)
  • BlackRock (NYSE:BLK)
  • Valero Energy (NYSE:VOL)
  • Chevron (NYSE:CVX)
  • Synchrony Financial (NYSE:SYF)
  • Weyerhaeuser Company (NYSE:WY)


3 Stocks Millennials Should Be Buying Right Now

[Thursday, April 30, 2:25 p.m.]
Contributed by Sarah Smith

Millennials are in a tricky spot right now. As Vice reported in early April, approximately one third of younger workers had lost their jobs. At the same time, many experts are saying that getting into the market during this coronavirus-driven dip will have life-changing economic impacts.

So how should younger investors view stocks right now? According to InvestorPlace’s Laura Hoy, millennials are going to have “the last laugh” in the stock market today. That’s because they have the most time to benefit from the market selloff.

But baby boomers — who likely have more stashed in retirement savings accounts — have less time to reap gains from post-pandemic rally. Hard-hit older investors will be forced to make stressful investment decisions.

So where should millennials start? Hoy has three recommendations:

  • Chevron (NYSE:CVX)
  • Ralph Lauren (NYSE:RL)
  • Alphabet (NASDAQ:GOOG, NASDAQ:GOOGL)

6 Healthcare Stocks to Buy as Biotech Soars

[Thursday, April 30, 1:50 p.m.]
Contributed by Sarah Smith

Biotech stocks are experiencing the novel coronavirus in many interesting ways. First-quarter earnings reports show that some drug sales are down, and companies are feeling the heat from clinical trial delays. But research firm CFRA is bullish on the broader healthcare sector.

Why? The firm’s analysts believe Covid-19 is strengthening the long-term picture. Companies are rushing to develop new drugs and vaccines, and many are embracing innovative technology. This should all pay off in the years after the pandemic.

With that in mind, here are six healthcare stocks CFRA is recommending now:

  • Owens & Minor (NYSE:OMI)
  • Quest Diagnostics (NYSE:DGX)
  • Amgen (NASDAQ:AMGN)
  • BioMarin Pharmaceutical (NASDAQ:BMRN)
  • Stryker (NYSE:SYK)
  • Boston Scientific (NYSE:BSX)


Morgan Stanley: Buy DraftKings Stock on Pent-Up Demand

[Thursday, April 30, 11:32 a.m.]
Contributed by Sarah Smith

It may seem odd to recommend a sports betting stock at a time when no live sports events are happening. But that’s exactly what Morgan Stanley analyst Thomas Allen did on Wednesday. He said his firm is going “all in” with DraftKings, which trades as a Diamond Eagle Acquisition Corporation (NASDAQ:DEAC).

Allen has an “overweight” rating on the stock and a $23 price target. Shares of DEAC are trading Thursday near $17.50.

So how does Allen explain his recommendation? Even though live sporting events are almost nonexistent, he sees the virtual NFL draft as a victory for sports betting. Shares spiked over the three-day event, as consumers showed “pent-up” demand for gambling opportunities.

From Allen, via CNBC (subscription required):

“In our view, DraftKings deserves a premium as an almost pure play on US sports betting and iGaming, in contrast to peers that either have brick-and-mortar or [international] regulatory risk.”

InvestorPlace’s Will Ashworth agrees. At the beginning of March, he wrote that recent IPO DraftKings was a top stock to buy as the market entered bear territory. If anyone can survive a sports betting world without live events, he argues it’s DraftKings.

The market seems to agree. Shares are up 2.2% in intraday trading.


8 Consumer Stocks to Buy with Strong Brands

[Thursday, April 30, 10:40 a.m.]
Contributed by Sarah Smith

You’re probably tired of hearing all about toilet paper and disinfecting products. But the constant hype and supersized demand has made eight consumer stocks serious winners in 2020.

According to Morningstar’s Susan Dziubinski, these companies have strong-but-cheap brands. Additionally, they are all benefiting from current shopping trends (think cleaning products and comfort food). Yes, some of today’s hottest companies will soon go back out of style. But Dziubinski thinks these are all stocks to buy for the long term.

Here are the eight names she’s recommending:

  • Anheuser-Busch InBev (NYSE:BUD)
  • Coca-Cola (NYSE:KO)
  • Hostess Brands (NASDAQ:TWNK)
  • Kellogg (NYSE:K)
  • Molson Coors (NYSE:TAP)
  • Reckitt Benckiser (OTCMKTS:RBGLY)
  • Kraft Heinz (NASDAQ:KHC)
  • Unilever (NYSE:UN, NYSE:UL)


3 Vaccine Stocks to Buy on Coronavirus Hopes

[Thursday, April 30, 10:15 a.m.]
Contributed by Sarah Smith

Based on how the market reacted to good news from Gilead Sciences (NASDAQ:GILD) yesterday about its remdesivir, imagine the rally when a vaccine is declared to be a winner.

That’s why InvestorPlace’s Ian Cooper has identified three top vaccine stocks for investors to consider now. He’s inspired by all the efforts going toward fighting the virus — and he thinks these vaccine stocks will seriously benefit:

  • Inovio Pharmaceuticals (NASDAQ:INO)
  • Moderna (NASDAQ:MRNA)
  • BioNTech (NASDAQ:BNTX)

Stocks Open Lower Thursday on Jobless Report

[Thursday, April 30, 9:31 a.m.]
Contributed by Sarah Smith

Wednesday’s optimism is struggling to hold in the stock market today. Right before market open, investors learned that another 3.8 million Americans had filed for unemployment benefits. Will sentiment shift during the day’s trading?

It’s hard to say. The S&P 500Dow Jones Industrial Average and the Nasdaq Composite are all opening in the red.

  • The S&P 500 opened lower by 0.86%
  • The Dow Jones Industrial Average opened lower by 1.24%
  • The Nasdaq Composite opened lower by 0.24%

Loop Capital: Buy Netflix Stock on Subscriber Growth

[Wednesday, April 29, 4:35 p.m.]
Contributed by Sarah Smith

In his daily column, InvestorPlace’s Bret Kenwell wrote that one analyst is particularly bullish on Netflix (NASDAQ:NFLX) stock. Loop Capital’s Alan Gould reiterated his “buy” rating, assigning a new price target of $500. That implies more than 20% upside from its current price.

Netflix added 15.8 million subscribers — although it only anticipated adding 8.5 million. That’s a huge surprise. Why else does Gould like the name? He thinks Netflix continues to have the largest amount of streaming content and ongoing production, and that after 2020, it should be able to add 30 million subscribers per year. Plus, he thinks it could be cash-flow positive by 2022.

Gould isn’t alone. InvestorPlace analyst Matt McCall wrote yesterday that investors should buy NFLX stock as its long-term growth “remains in motion.”

From McCall:

“Even in a severe downturn, households are more likely to ‘cut the cord’ (cable) than get rid of relatively inexpensive Netflix. If anything, this company will thrive, not merely survive, in the coming years. A great hedge against recession, and on the winning side of the streaming megatrend, consider NFLX stock a buy.”


Stocks Close Higher Wednesday on Gilead’s Success

[Wednesday, April 29, 4:01 p.m.]
Contributed by Sarah Smith

Gilead Sciences (NASDAQ:GILD) brought a sense of hope to the market today that is working wonders. Dr. Anthony Fauci, the nation’s top infectious disease expert, says its remdesivir looks promising. Investors drove stocks higher on the thought of a safe reopening — and an effective five-day treatment. GILD stock closed up by 5.7%.

Elsewhere in the market, the Federal Reserve promised to keep interest rates near 0% until economic activity truly rebounds. It looks like investors shrugged off this morning’s GDP figure.

Small-cap stocks had a great day, as the Russell 200 closed higher by more than 5%. The S&P 500Dow Jones Industrial Average and the Nasdaq Composite also are closing in the green.

  • The S&P 500 closed higher by 2.66%
  • The Dow Jones Industrial Average closed higher by 2.19%
  • The Nasdaq Composite closed higher by 3.57%

4 Epic Video Game Stocks to Buy in 2020

[Wednesday, April 29, 3:42 p.m.]
Contributed by Sarah Smith

Video games provide a chance to escape reality. They also are a really effective means of killing time. As a pandemic rages across the world, it’s not surprising then that record numbers of consumers are embracing a variety of games.

Before Covid-19, the future viability of consoles was in question. Now, InvestorPlace Markets Analyst Luke Lango writes that Nintendo (OTCMKTS:NTDOY) keeps selling out of its Switch console. He also argues that the coming launch of the Switch 2 should have investors excited headed into 2021.

Why all the buzz around Nintendo? Well, Animal Crossing: New Horizons has consumers hooked. The Atlantic’s Ian Bogost even wrote that in a pandemic-driven world, the game offers a new political imagining. There are no losers, he writes, and players aren’t focused on making a living. No wonder the Switch is flying off shelves.

InvestorPlace’s Chris Tyler is adding to Lango’s recommendation. He likes Electronic Arts (NASDAQ:EA), Take-Two Interactive (NASDAQ:TTWO) and Zynga (NASDAQ:ZNGA) for many of the same reasons.

Whether you’re a die-hard Star Wars fan or a lover of the Grand Theft Auto franchise, Tyler writes that these video game stocks to buy are certainly winners now. You don’t want to miss out.


Jolt Your Portfolio Now with Starbucks Stock

[Wednesday, April 29, 2:45 p.m.]
Contributed by Sarah Smith

Starbucks (NASDAQ:SBUX) broadly disappointed investors when it reported first-quarter earnings. But CEO Kevin Johnson thinks a “gravitational pull” and consumers’ desire for a “daily uplift” will help the coffee chain return to normal.

For investors, betting on a gravitational pull sounds pretty speculative. But InvestorPlace analyst Matt McCall doesn’t see it that way.

Instead, he sees a post-earnings dip as the perfect time to buy shares. He believes Starbucks will get back on track soon, especially since the company had a front-row seat to China’s recovery from Covid-19. That experience is sure to be useful as the U.S. begins to reopen.

From McCall:

“Very few companies are immune to the impacts of the coronavirus and Starbucks is no exception. But with decades of growth and experience, this leading consumer brand is not one to bail on after a few quarters of non-company-specific issues.”


2 Fitness Stocks to Buy with Solid Balance Sheets

[Wednesday, April 29, 2:24 p.m.]
Contributed by Sarah Smith

Gyms may be closed, but Americans are still working out. And according to analysts at BTIG, consumers still want to dress the part of the gym buff. That’s why the firm is initiating Nike (NYSE:NKE) and Lululemon (NASDAQ:LULU) with “buy” ratings.

From BTIG, via CNBC (subscription required):

“[W]e focus on companies with sturdy balance sheets that will allow them to survive the volatility that will likely continue throughout the rest of the year. Cash flow security is paramount to surviving this pandemic with the fewest scars. Also, these companies have robust and flexible supply chains that can handle and accommodate sharp changes in order patterns with little threat to their own cash flow needs.”

InvestorPlace’s Chris Markoch is also hot on NKE and LULU. In fact, he recently recommended both stocks, along with Peloton (NASDAQ:PTON) and Fitbit (NYSE:FIT). Markoch writes that as many states prepare for longer-lasting lockdowns, these fitness stocks have a lot of room to “run.”


Beyond Meat Stock Gets a Boost from Pandemic Preppers

[Wednesday, April 29, 2:04 p.m.]
Contributed by Sarah Smith

If you’re anything like me, high-flying Beyond Meat (NASDAQ:BYND) flew right off your radar when the novel coronavirus struck the U.S. Chances are many Americans forgot about plant-based burgers and breakfast sandwiches, opting to stock up on toilet paper and chicken breasts.

But not all investing experts made the same mistake. InvestorPlace Markets Analyst Luke Lango wrote yesterday that plant-based meat is the future, and he’s still bullish on BYND stock. In fact, he models that shares will hit $300 by 2029. That’s triple their current price.

There’s also a more pandemic-focused catalyst. As Kiplinger’s Kyle Woodley writes, meat shortages around the U.S. — driven by Covid-19 plant closures — are making plant-based alternatives increasingly popular. Nielsen reports that year-over-year sales of plant-based meat are up 265%.

It seems like Americans are catching on to a key fact: In an emergency, plant-based diets are much easier to sustain. That’s why doomsday preppers have long opted to eat off the Earth, even recommending dandelions and other edible plants.

Granted, while grocery stores remain open, most Americans aren’t choosing to stomach their local weeds. Instead, they’re buying Beyond Meat’s plant-based products. That’s a huge catalyst for BYND stock. It’s time to buy shares now before they triple.


6 Media Stocks to Buy While You’re Stuck at Home

[Wednesday, April 29, 1:25 p.m.]
Contributed by Sarah Smith

Chances are, you have TV on in the background while you’re reading this. That’s OK — viewership is up 33% year-over-year as Americans are largely stuck at home.

Whether you’re binge-watching The Walking Dead, planning home-improvement projects with HGTV or aimlessly flipping through regional channels, you’re helping media companies profit.

That’s why InvestorPlace’s Mark Hake writes there are six media stocks you should be buying now:

  • AMC Networks (NASDAQ:AMCX)
  • ViacomCBS (NASDAQ:VIAC, NASDAQ:VIACA)
  • Discovery (NASDAQ:DISCA, NASDAQ:DISCK)
  • Gray Television (NYSE:GTN)
  • E.W. Scripps (NASDAQ:SSP)
  • Nexstar Media Group (NASDAQ:NXST)


Buy Spotify Stock on Record-Breaking Streaming

[Wednesday, April 29, 1:07 p.m.]
Contributed by Sarah Smith

According to Spotify, every day now looks (and feels) like the weekend. More consumers than ever are streaming music and podcasts — and that’s great news for SPOT stock. Shares are up 12.4% in intraday trading.

Barron’s Callum Keown writes that Spotify’s first-quarter revenue climbed 22% and global premium subscribers jumped 31% to 130 million. Although the company initially feared less commuters would mean lower revenue, it’s now clear Spotify will survive the coronavirus crisis intact.

That’s why InvestorPlace Markets Analyst Luke Lango recently wrote that SPOT stock was one of 30 top consumer stocks to buy. At the time, he argued that Spotify was a great investment because consumer spending on entertainment was increasing. His one worry? Lango mentioned that as less Americans went to gyms and commuted to work, shares faced a tough headwind.

Well, Spotify proved him (and many others) wrong. Don’t miss out on shares now.


4 Retail Stocks to Buy Now as States Reopen

[Wednesday, April 29, 12:43 p.m.]
Contributed by Sarah Smith

It’s no secret that retailers have underperformed the broader market in 2020, as stay-at-home orders and lockdowns forced many to close. But as we reported yesterday, some retailers are starting to see light at the other end of the tunnel.

U.S. mall operator Simon Property Group (NYSE:SPG) announced Tuesday that it would begin reopening 49 of its properties. The real estate investment trust is following in the footsteps of many southern states leading the push to reopen.

According to Bank of America analysts, four retail stocks will particularly benefit (subscription required). The firm’s buy list includes Burlington Stores (NYSE:BURL), Ross Stores (NASDAQ:ROST), Five Below (NASDAQ:FIVE) and TJX Companies (NYSE:TJX).

Analyst Lorraine Hutchinson said these are stocks to buy because they are in off-mall locations and lack e-commerce presences. This means they will rally the most as states reopen.

BURL, ROST, FIVE and TJX stock are all up more than 4% in intraday trading.


9 Stocks to Buy for the Post-Pandemic World

[Wednesday, April 29, 12:21 p.m.]
Contributed by Sarah Smith

InvestorPlace’s Josh Enomoto has a wake-up call for investors. The novel coronavirus is changing life as we know it, and some of these drastic shifts won’t reverse. With that in mind, how should investors plan to profit from the world’s new normal?

Well, Enomoto is looking at nine quirky stocks to buy that capitalize on post-pandemic trends:

  • Coupa Software (NASDAQ:COUP)
  • Glu Mobile (NASDAQ:GLUU)
  • Axon Enterprise (NASDAQ:AAXN)
  • Match Group (NASDAQ:MTCH)
  • Turning Point Brands (NYSE:TPB)
  • Champignon Brands (OTCMKTS:SHRMF)
  • MindMed (OTCMKTS:MMEDF)
  • Carvana (NYSE:CVNA)
  • RCI Hospitality (NASDAQ:RICK)


Buy Gilead Stock on Clinical Trial News

[Wednesday, April 29, 11:53 a.m.]
Contributed by Sarah Smith

On Wednesday morning, Gilead Sciences (NASDAQ:GILD) released news that has the market soaring. GILD stock itself is up 5.7% in intraday trading.

Gilead’s remdesivir has long been a leading candidate in the fight against the novel coronavirus. Remdesivir is an antiviral medication, originally developed as a potential treatment for the Ebola virus. On Wednesday, the U.S. National Institute of Allergy and Infectious Diseases reported that remdesivir helped patients recover more quickly than standard care.

In other words, the drug met its primary endpoint in the study.

In a separate press release from Gilead, the company reported that five-day and 10-day doses of remdesivir have similar outcomes in terms of patient status. More results from this study — which did not include a comparison group — will be released in a peer-reviewed journal in the coming weeks.

Both news items have investors cheering. And InvestorPlace contributors have long been telling readers to buy GILD stock. Just last week, InvestorPlace Markets Analyst Luke Lango recommended buying shares even as they sunk on bad news. At the time, leaked World Health Organization documents indicated remdesivir wasn’t effective in China-based trials.

Now, GILD stock is certainly one to buy. Its star drug has the potential to reopen the economy and protect the world from what has been a life-changing pandemic.


Someone Watching Tonight Could Become a Millionaire

[Wednesday, April 29, 11:26 a.m.]
Contributed by Matt McCall

The cryptocurrency “Halvening” event will occur in the middle of May…

Which is just days from now.

This special situation will cut the amount of new bitcoins in HALF overnight.

But more importantly, it will send certain altcoins soaring higher than most people imagine possible.

The last time the Halvening event occurred four years ago, these extraordinary gains were seen in the altcoin market:

  • Verge shot up 1,362,400%.
  • Reddcoin soared 72,400%.
  • And NEO rose 134,453%.

You must discover how to position yourself before this historic event takes place — and the biggest profits are made.

That’s why I’m making it easier than ever to join my Ultimate Crypto research service … and discover the full cryptocurrency model portfolio we’ve created.

For tonight only…

I’m giving all my readers an instant $2,000 savings off the normal Ultimate Crypto rate.

This means we’re cutting the price in more than half.

But this is important: This $2,000 discount is only available tonight.

To discover the full details, all you have to do is attend our online event, the 2020 Crypto Millionaire Summit.

It all happens tonight, April 29, at 7 p.m. ET. You don’t want to miss this…

Click here to reserve your spot for free.


Stocks Open Higher Even as GDP Contracts

[Wednesday, April 29, 9:31 a.m]
Contributed by Sarah Smith

Investors are gearing up for a good today, even as they learn GDP contracted by 4.8% in the first quarter. Perhaps that’s just not surprising — even though it came in worse than estimates.

Regardless, there’s a lot of green in the major indices today. The S&P 500, Dow Jones Industrial Average and the Nasdaq Composite all opened solidly higher.

  • The S&P 500 opened higher by 1.92%
  • The Dow Jones Industrial Average opened higher by 1.5%
  • The Nasdaq Composite opened higher by 2.15%

3 Stocks That Will Benefit from Oil Storage Demand

[Tuesday, April 28, 3:40 p.m.]
Contributed by Sarah Smith

It’s no secret that crude oil storage — or the lack thereof — is driving the market. Last week, panic over the supply-demand imbalance sent crude oil prices negative. Stocks went tumbling, too.

But as research firm CFRA points out, there are winners in this chaos. Companies that are well-positioned in terms of storage capacity should see their stocks gain.

From CFRA analyst Stewart Glickman, via CNBC (subscription required):

“Firms with available storage space are going to fetch strong pricing, given too many producers are seeking places to shelve unneeded crude.”

So who are the winners? West Texas Intermediate, the U.S. benchmark for crude, is trading at $13 for June delivery. But later months are trading at higher prices, which incentivizes storage. With this logic, companies with the most storage space win.

Plains All American (NYSE:PAA) and NuStar (NYSE:NS) each have 10%-12% of the country’s storage capacity. Glickman is also hot on Phillips 66 (NYSE:PSX). Phillips 66 is most known for being in the refiner business, but it has 5.5% of U.S. storage capacity.

InvestorPlace’s Will Ashworth agreed with Glickman at the end of March. He included PSX stock on his list of the top 10 best value stocks to own for 2020. Ashworth says it’s simply a triple threat.

As oil continues to be in focus, keep an eye on these three stocks.


Meat Stocks Are Climbing on Trump’s Plan

[Tuesday, April 28, 1:51 p.m.]
Contributed by Sarah Smith

Smithfield Foods’ CEO warned of devastating impacts to the supply chain when his company was forced to close a pork plant in Sioux Falls, South Dakota. Over the weekend, Tyson Foods (NYSE:TSN) took out a full-page ad in The New York Times, declaring that meat plant closures were “breaking” the supply chain in the United States.

Certainly these CEOs were not the only ones worried about the U.S. supply chain. Higher prices for meat — and grocery store shortages — had many consumers afraid.

On Tuesday, President Donald Trump hinted at a major response to the meat problem. According to Bloomberg, he’s planning to use the Defense Production Act to keep meat-processing plants open. Because plants have closed as workers contracted Covid-19, the government would issue them additional personal protective equipment.

Prior to this announcement, estimates showed that as much as 80% of the country’s meat production could shut down. The Sioux Falls plant alone accounted for 5% of U.S. pork.

Investors like the news. TSN stock is up 6.4% in intraday trading, and JBS (OTCMKTS:JBSAY) stock is up 5.2% on the day.


Ignore the Pandemic Pseudoscience and Buy 5G Stocks

[Monday, April 27, 4:55 p.m.]
Contributed by Sarah Smith

InvestorPlace analyst Louis Navellier is fed up with the pandemic pseudoscience. Conspiracy theorists are claiming exposure to 5G radiation weakens the body’s immune system, making people more susceptible to the novel coronavirus.

But as Navellier writes, there’s no real science to that. And there’s definitely no science behind people burning down 5G cellular towers in Europe.

Pseudoscientists conveniently don’t take the time to explain that there’s two types of radiation — ionizing and non-ionizing. 5G technology relies on non-ionizing radiation. It can’t hurt you.

With that in mind, investors should get serious about major opportunities in 5G ahead, like Navellier’s favorite company in the space. This pick relies on radio-frequency technology and is set to profit off of every aspect of 5G.

So, don’t listen to the conspiracy theorists. Stay inside, stay safe. And if you’re ready to learn more about opportunities in 5G, read the rest of Navellier’s thoughts here.


Japan’s Plan to Approve Remdesivir Is a Catalyst for Gilead

[Monday, April 27, 4:38 p.m.]
Contributed by Sarah Smith

In his daily column, InvestorPlace’s Bret Kenwell highlighted a serious catalyst for Gilead Sciences (NASDAQ:GILD) stock. On Monday, Japanese news site Kyodo reported that Prime Minister Shinzo Abe is set to fast track approval for remdesivir. A different official said Monday remdesivir could be in use as early as next month to treat Covid-19.

Despite the good news, GILD stock closed higher by only 0.33% on Monday. For investors, remdesivir is still a critical treatment to watch, as trials are underway around the world.

Reuters reported Friday that key results from a U.S. trial could come as early as mid-May, and preliminary results could come sooner. This trial, led by the National Institute of Allergy and Infectious Diseases, began in February.

Coronavirus competitor Regeneron (NASDAQ:REGN) didn’t have the same fate today. Along with Sanofi (NYSE:SNY), the company announced that its Kevzara failed to show clinical benefits in Phase 2 and Phase 3 trials. REGN stock closed down by 3.3% on the day.


Article printed from InvestorPlace Media, https://investorplace.com/stocks-to-buy-during-coronavirus/.

©2020 InvestorPlace Media, LLC